Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026179	s-normet	nmol/l (nmol/l)	5488	7043	0.07%
3026179	s-normet	— (—)	283	307	100.00%	Distribution not available
3026179	s-normet	umol/l (nmol/l)	6	9	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cardiovascular diseases

903

1015

4.86

313.69

1.3

0.52

0.53

nmol/l

0.09

874

982

Benign neoplasm of other and unspecified endocrine glands

1291

534

31.11

307.65

1.5

1.3

0.65

0.59

nmol/l

1.65

1264

508

Benign neoplasm: Adrenal gland

1165

288

65.47

307.65

1.4

1.3

0.64

0.63

nmol/l

0.20

1139

273

Hypertensive diseases (excluding secondary)

1123

1011

6.65

307.65

1.2

1.3

1.76

0.55

nmol/l

0.61

1082

981

Secondary hypertension

336

174

20.89

307.65

1.3

3.76

0.57

nmol/l

0.51

318

167

Hypertensive diseases

1484

1748

4.91

307.65

1.2

1.3

1.76

0.57

nmol/l

0.82

1430

1700

Hypertension

1484

1747

4.91

307.65

1.2

1.3

1.76

0.57

nmol/l

0.82

1430

1699

Hypertension, essential

1523

1714

5.16

307.65

1.3

1.74

0.57

nmol/l

0.82

1464

1668

Antihypertensive medication - note that there are other indications

897

910

5.32

307.65

1.3

0.52

0.50

nmol/l

0.71

863

881

Cardiovascular diseases (excluding rheumatic etc)

1033

1259

4.81

307.65

1.2

1.3

1.84

0.53

nmol/l

0.62

996

1218

Disorders of other endocrine glands

908

2308

3.98

306.06

1.6

1.2

0.84

1.82

nmol/l

0.76

877

2216

Hyperaldosteronism

196

25.73

268.75

1.2

0.56

0.57

nmol/l

0.21

185

Malaise and fatigue

851

1924

3.63

239.34

1.3

1.58

nmol/l

0.00

809

1847

Headache

1020

2585

3.20

236.65

1.3

2.49

1.31

nmol/l

0.38

991

2487

Abnormalities of heart beat

643

1528

4.23

236.09

1.3

2.51

0.76

nmol/l

0.64

616

1468

Benign neoplasms

1343

2595

2.89

234.53

1.4

1.2

2.19

0.88

nmol/l

0.59

1305

2489

Metabolic disorders

1402

3181

2.73

227.84

1.3

1.34

1.16

nmol/l

0.08

1347

3082

Other heart diseases

651

992

4.36

217.55

1.3

0.59

0.54

nmol/l

2.87

626

962

Exclusions for E4_PCOS_BROAD

427

803

5.56

215.89

2.2

1.2

1.10

0.58

nmol/l

0.73

415

776

General symptoms and signs

1475

2808

2.66

215.73

1.3

1.34

1.25

nmol/l

0.04

1429

2706

Pain in throat and chest

1191

2502

2.90

214.92

1.3

1.79

0.69

nmol/l

0.62

1148

2410

Other disorders of fluid, electrolyte and acid-base balance

570

1331

4.19

204.70

1.2

1.3

0.94

1.84

nmol/l

0.45

539

1275

Cardiac arrhythmias

866

1778

3.22

190.14

1.3

1.06

1.20

nmol/l

0.06

830

1725

Abnormalities of breathing

1176

2554

2.71

186.24

1.3

0.58

0.69

nmol/l

0.70

1127

2459

Endocrine, nutritional and metabolic diseases

997

1750

2.92

172.40

1.3

1.2

0.76

1.21

nmol/l

0.30

959

1695

Hypokalaemia

291

485

6.29

167.52

1.2

1.3

1.18

2.99

nmol/l

0.34

281

469

Symptoms and signs involving the circulatory and respiratory systems

1273

2564

2.51

167.02

1.3

2.58

0.68

nmol/l

0.89

1230

2469

Anaemias

282

243

7.71

163.33

1.4

1.3

0.61

0.51

nmol/l

3.10

266

232

Other disorders of adrenal gland

169

163

11.33

155.51

3.2

1.2

1.89

0.58

nmol/l

0.72

164

154

Other arrhythmias

932

2707

2.64

150.71

1.3

2.16

1.15

nmol/l

0.37

890

2626

Other heart diseases, wide

1236

3254

2.35

149.26

1.3

1.77

1.04

nmol/l

0.34

1181

3160

Medical observation and evaluation for suspected diseases and conditions

891

1627

2.84

147.20

1.3

0.58

2.35

nmol/l

1.12

872

1557

Hypertensive heart and/or renal disease

347

548

4.82

137.50

1.3

3.11

0.63

nmol/l

0.51

331

527

Diseases of arteries, arterioles and capillaries (FINNGEN)

338

478

5.00

135.15

1.3

3.82

0.59

nmol/l

0.51

316

463

Cerebrovascular diseases (FINNGEN)

397

667

4.28

134.25

1.4

1.2

0.61

0.57

nmol/l

1.26

381

643

Dyspnoea

1190

3986

2.23

133.84

1.3

0.75

1.31

nmol/l

0.71

1143

3845

Disorders of lipoprotein metabolism and other lipidaemias

1054

2764

2.39

132.63

1.3

1.59

1.26

nmol/l

0.12

1014

2677

Neoplasms

871

1740

2.68

131.93

1.4

1.1

0.56

0.90

nmol/l

0.69

842

1666

Hypothyroidism (congenital or acquired)

281

257

6.26

127.85

1.5

1.3

0.51

0.50

nmol/l

0.16

272

246

Any gastric operation

927

1835

2.56

126.31

1.3

1.2

0.57

2.22

nmol/l

1.20

897

1762

GASTRO-related operations

927

1835

2.56

126.31

1.3

1.2

0.57

2.22

nmol/l

1.20

897

1762

Episodal and paroxysmal disorders

1315

3151

2.14

122.17

1.2

1.3

1.75

1.01

nmol/l

0.34

1272

3022

Hypothyroidism, levothyroxine purchases

273

257

6.08

121.30

1.5

1.3

0.52

0.50

nmol/l

0.20

264

246

Hypothyroidism and >3 levothyroxin purchases

273

257

6.08

121.30

1.5

1.3

0.52

0.50

nmol/l

0.20

264

246

Abnormal blood-pressure reading, without diagnosis

140

149

10.05

119.62

1.2

1.3

8.78

0.68

nmol/l

0.48

133

142

Diseases of oesophagus, stomach and duodenum

1329

3903

2.06

115.96

1.3

1.37

1.11

nmol/l

0.12

1273

3770

Other diseases of intestines

1284

3535

2.08

114.78

1.3

0.58

1.43

nmol/l

1.20

1237

3415

Hypertensive Heart Disease

296

508

4.65

114.75

1.3

1.2

3.45

0.64

nmol/l

0.50

283

489

Paroxysmal tachycardia

292

542

4.59

114.20

1.3

1.2

4.18

0.57

nmol/l

0.50

277

525

Sleep apnoea

1204

3741

2.11

113.92

1.3

1.76

1.26

nmol/l

0.24

1162

3604

Sleep apnoea, including avohilmo

1256

3803

2.07

111.98

1.3

1.70

1.25

nmol/l

0.23

1211

3660

Symptoms and signs involving cognition, perception, emotional state and behaviour

1217

4054

2.07

111.11

1.3

1.11

1.19

nmol/l

0.06

1164

3917

Dizziness and giddiness

985

3561

2.22

111.06

1.3

1.64

1.28

nmol/l

0.15

942

3436

Tramadol

998

2757

2.25

109.46

1.3

0.60

1.63

nmol/l

1.11

958

2661

Heart failure and antihypertensive medication

289

405

4.75

107.14

1.3

4.35

0.58

nmol/l

0.52

274

389

Abdominal and pelvic pain

1161

2751

2.14

107.07

1.3

0.95

1.48

nmol/l

0.38

1112

2663

Other headache syndromes

584

2190

2.71

106.30

1.3

1.98

1.19

nmol/l

0.22

568

2094

Pain in joint

699

1740

2.59

105.10

1.3

1.76

1.35

nmol/l

0.12

665

1683

Atrial fibrillation and flutter

362

613

3.89

105.04

1.3

0.65

0.58

nmol/l

2.81

348

591

Other soft tissue disorders, not elsewhere classified

1132

3200

2.09

103.11

1.2

1.3

1.09

1.03

nmol/l

0.04

1096

3082

Examination and observation for other reasons

710

1620

2.56

101.69

1.3

0.59

2.36

nmol/l

1.11

688

1550

Type 2 diabetes, wide definition

996

2976

2.17

100.96

1.3

2.29

1.28

nmol/l

0.38

962

2863

Pure hypercholesterolaemia

880

2561

2.27

100.11

1.3

0.61

1.32

nmol/l

0.84

847

2479

Symptoms and signs involving the digestive system and abdomen

1132

2751

2.08

97.30

1.3

0.96

1.48

nmol/l

0.36

1086

2663

Other CVD (FINNGEN)

174

209

6.63

96.44

1.4

1.2

0.62

nmol/l

0.04

163

200

Pain in limb

981

3114

2.13

96.40

1.2

1.3

0.76

1.05

nmol/l

0.31

948

2997

Condition for Implicit Sepsis (Organ dysfunction codes)

1105

3807

2.02

95.30

1.3

1.00

1.26

nmol/l

0.20

1059

3679

Syncope and collapse

548

1771

2.68

95.23

1.3

0.59

1.67

nmol/l

1.01

526

1700

All kidney diseases

1195

4195

1.96

95.16

1.3

1.32

1.30

nmol/l

0.01

1146

4047

All chronic kidney diseases

692

2383

2.41

94.78

1.3

1.90

1.87

nmol/l

0.01

660

2284

Nausea and vomiting

380

1178

3.22

94.04

1.3

2.13

1.60

nmol/l

0.14

360

1139

Sleep disorders (combined)

1315

3619

1.92

92.49

1.2

1.3

1.04

1.27

nmol/l

0.17

1269

3483

Hard cardiovascular diseases

1029

2992

2.07

91.72

1.3

1.62

1.25

nmol/l

0.13

993

2893

Implicit Sepsis

1011

3652

2.04

91.14

1.3

1.88

1.30

nmol/l

0.25

963

3528

Depression medications

262

271

4.91

89.95

1.2

1.3

0.53

0.50

nmol/l

0.60

251

260

Dorsalgia

1153

3139

1.98

89.16

1.3

0.58

1.55

nmol/l

1.22

1105

3030

Other functional intestinal disorders

575

2152

2.51

88.93

1.3

2.05

2.00

nmol/l

0.01

549

2075

Symptoms and signs involving the nervous and musculoskeletal systems

744

3383

2.23

88.68

1.3

0.60

1.50

nmol/l

1.22

713

3248

Low back pain

897

3070

2.12

88.60

1.3

1.51

1.57

nmol/l

0.02

861

2963

Condition for Implicit Sepsis (Organ dysfunction codes)

1043

3718

2.00

87.88

1.3

1.83

1.29

nmol/l

0.23

995

3594

Pain, not elsewhere classified

377

1242

3.09

87.57

1.3

2.76

1.96

nmol/l

0.13

363

1191

Atrial fibrillation and flutter with reimbursement

291

471

3.99

86.88

1.3

4.24

0.60

nmol/l

0.51

279

456

Codeine

1075

2958

1.99

84.34

1.3

0.60

1.55

nmol/l

1.08

1029

2850

Implicit Sepsis

920

3440

2.04

82.89

1.3

1.55

1.47

nmol/l

0.03

881

3316

Migraine

610

2090

2.39

82.80

1.2

1.3

3.74

0.69

nmol/l

0.73

592

2006

Persons encountering health services in other circumstances, wide

1336

3771

1.84

81.74

1.3

0.90

1.29

nmol/l

0.34

1287

3639

Gastro-oesophageal reflux disease

824

3443

2.09

81.29

1.3

0.57

1.18

nmol/l

1.05

797

3326

Type 2 diabetes

1150

3552

1.91

81.28

1.3

2.07

1.15

nmol/l

0.41

1110

3424

Opioids

1110

2980

1.95

81.25

1.3

0.58

1.54

nmol/l

1.11

1065

2872

Diabetes, varying definitions

1184

3708

1.89

81.18

1.3

2.02

1.12

nmol/l

0.42

1144

3573

Diabetes mellitus

1188

3713

1.89

81.15

1.3

2.01

1.12

nmol/l

0.42

1149

3576

Fever of other and unknown origin

601

2305

2.34

79.57

1.4

1.3

0.61

1.40

nmol/l

0.94

582

2216

Ischemic heart diseases

986

3007

1.99

78.97

1.3

1.66

1.26

nmol/l

0.14

954

2898

Percutaneous Coronary Intervention

937

2871

2.02

78.80

1.3

1.73

1.29

nmol/l

0.15

901

2767

Type 2 diabetes, strict (exclude DM1)

1111

3450

1.91

78.56

1.3

1.20

1.17

nmol/l

0.02

1073

3321

Spondylopathies

919

2721

2.04

78.53

1.2

1.3

0.60

1.72

nmol/l

1.21

878

2628

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

487

1948

2.55

78.25

1.5

1.3

0.59

1.42

nmol/l

0.73

471

1871

Coronary revascularization (ANGIO or CABG)

936

2871

2.02

78.21

1.3

1.73

1.29

nmol/l

0.15

901

2767

Type 2 diabetes, definitions combined

1103

3426

1.91

77.93

1.3

1.20

1.18

nmol/l

0.02

1065

3302

Benzodiazepine use

1170

4396

1.85

77.82

1.3

1.68

1.18

nmol/l

0.25

1125

4233

Other nutritional deficiencies

816

3795

2.05

77.61

1.2

1.3

1.08

1.27

nmol/l

0.12

786

3653

Neurological diseases

939

2326

2.04

77.55

1.2

1.3

2.21

0.70

nmol/l

0.62

910

2224

Lower back pain or/and sciatica

1217

4388

1.83

77.14

1.3

1.28

nmol/l

0.00

1166

4234

Major coronary heart disease event

986

3060

1.96

76.32

1.3

1.67

1.25

nmol/l

0.15

952

2950

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

367

569

3.26

76.23

1.3

0.59

0.57

nmol/l

0.20

354

551

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1133

4251

1.85

76.20

1.3

0.63

1.49

nmol/l

1.35

1084

4107

Codeine or tramadol medication

1289

3937

1.80

75.67

1.3

0.74

1.52

nmol/l

1.00

1240

3792

Emergency coronary revascularization (for ACS)

995

3136

1.95

75.36

1.3

1.67

1.24

nmol/l

0.15

957

3024

Disorders of thyroid, IBD co-morbidities

218

358

4.34

75.25

1.2

1.3

0.55

0.60

nmol/l

0.86

209

344

Type 2 diabetes, definitions combined, including avohilmo

1095

3425

1.88

73.79

1.3

1.20

1.17

nmol/l

0.02

1060

3298

General examination and investigation of persons without complaint and reported diagnosis

695

1626

2.25

73.49

1.3

0.59

2.35

nmol/l

1.11

677

1556

Anxiety disorders, excluding more controls

972

3335

1.91

71.10

1.3

1.86

1.36

nmol/l

0.20

933

3223

Neurological diseases, wide definition

321

478

3.41

70.95

1.3

0.55

0.57

nmol/l

0.42

310

458

Irritable bowel syndrome

380

1413

2.74

70.82

1.2

1.3

2.74

2.43

nmol/l

0.04

368

1366

Parasetamol

795

1933

2.10

70.65

1.2

1.3

0.57

1.49

nmol/l

0.84

759

1873

Symptoms and signs concerning food and fluid intake

169

374

4.64

70.55

1.2

1.3

0.60

0.66

nmol/l

1.17

159

360

Diverticular disease of intestine

806

2555

2.03

69.78

1.3

0.63

1.79

nmol/l

1.18

776

2470

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1229

3767

1.79

69.69

1.3

0.92

1.29

nmol/l

0.31

1190

3637

Asthma, unspecified (mode), excluding more controls

614

2084

2.23

69.52

1.2

1.3

2.24

0.89

nmol/l

0.47

587

2015

Other symptoms and signs involving the nervous and musculoskeletal systems

541

2390

2.30

69.46

1.3

0.61

1.79

nmol/l

1.10

522

2301

Heart failure, not strict

875

3065

1.96

69.11

1.3

1.86

1.46

nmol/l

0.12

839

2959

Obesity and other hyperalimentation

760

3717

1.99

67.31

1.2

1.3

1.11

1.29

nmol/l

0.10

732

3577

Obesity

758

3711

1.99

67.23

1.2

1.3

1.11

1.29

nmol/l

0.10

730

3571

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1055

3493

1.83

66.79

1.3

2.19

1.16

nmol/l

0.43

1021

3368

Other dorsopathies, not elsewhere classified

1092

3149

1.83

66.19

1.3

0.58

1.54

nmol/l

1.22

1050

3040

Mood disorders, excluding more controls

1059

3490

1.83

65.93

1.3

1.80

1.33

nmol/l

0.20

1016

3374

Hyperlipidaemia, other/unspecified

449

1710

2.45

65.88

1.3

4.82

1.69

nmol/l

0.52

432

1645

Asthma, unspecified (mode)

629

2220

2.16

65.84

1.2

1.3

2.20

1.35

nmol/l

0.26

601

2145

Spondylosis

630

2432

2.13

65.37

1.2

1.3

1.94

1.85

nmol/l

0.02

599

2350

Obesity due to excess calories

591

2775

2.16

65.29

1.2

1.3

1.25

1.45

nmol/l

0.08

573

2673

STROKE

644

2065

2.14

64.85

1.3

0.61

1.54

nmol/l

0.92

620

1998

Anxiety disorders

1046

4079

1.80

64.47

1.3

1.76

1.19

nmol/l

0.26

1006

3932

First line medication for Crohn's disease

1214

3772

1.75

64.46

1.3

0.60

1.38

nmol/l

1.18

1161

3648

Neurotic, stress-related and somatoform disorders

1037

4053

1.80

64.34

1.3

1.77

1.19

nmol/l

0.26

998

3905

Oedema, not elsewhere classified

370

1407

2.63

63.94

1.3

0.63

1.80

nmol/l

0.83

358

1351

Asthma, excluding more controls

835

2226

1.97

63.35

1.2

1.3

0.78

0.86

nmol/l

0.11

798

2150

Disorders of parathyroid gland

301

1045

2.91

62.49

1.3

1.2

1.18

2.16

nmol/l

0.34

287

991

Diabetes medication

1149

3916

1.75

62.47

1.3

2.06

1.10

nmol/l

0.44

1110

3772

Chronic kidney disease

357

1349

2.63

61.75

1.4

1.3

0.74

2.39

nmol/l

0.81

337

1296

Other antidepressants

1115

3234

1.78

61.59

1.3

0.99

1.39

nmol/l

0.29

1069

3122

Other specific joint derangements/joint disorders

825

2798

1.92

61.24

1.3

1.07

1.08

nmol/l

0.00

785

2693

Hyperparathyroidism

269

892

3.05

60.79

1.3

1.2

1.25

2.42

nmol/l

0.35

256

848

Functional dyspepsia

359

1409

2.59

60.15

1.3

2.90

1.73

nmol/l

0.20

342

1359

Persons encountering health services in other circumstances

485

2169

2.25

59.71

1.2

1.3

0.59

1.71

nmol/l

0.92

463

2081

Complications of surgical and medical care, not elsewhere classified

1096

4351

1.74

59.69

1.3

1.36

1.29

nmol/l

0.03

1055

4188

Other (not insulin) diabetes medications

1076

3652

1.76

59.52

1.3

1.21

1.15

nmol/l

0.04

1038

3519

Renal tubulo-interstitial diseases

964

4033

1.79

59.48

1.3

1.53

1.33

nmol/l

0.08

921

3891

Asthma (only as main-diagnosis), excluding more controls

762

2226

1.97

59.37

1.3

0.79

0.86

nmol/l

0.09

727

2150

Asthma

857

2376

1.91

59.09

1.2

1.3

0.77

1.29

nmol/l

0.50

819

2294

Other intervertebral disc disorders

896

2928

1.86

59.07

1.2

1.3

0.59

1.63

nmol/l

1.21

862

2827

Sciatica+with lumbago

586

2618

2.08

58.33

1.2

1.3

0.60

1.75

nmol/l

1.21

564

2525

Diabetes, insulin treatment (Kela reimbursement)

1104

3871

1.74

58.30

1.3

2.12

1.11

nmol/l

0.45

1069

3728

Other special examinations and investigations of persons without complaint or reported diagnosis

665

1627

2.08

58.20

1.3

0.56

2.35

nmol/l

1.14

638

1557

Dorsopathies

1087

3159

1.76

58.00

1.3

0.58

1.54

nmol/l

1.23

1050

3049

Used for control exclusion in common control thyroid runs

1101

3194

1.75

57.82

1.3

2.93

0.66

nmol/l

0.93

1062

3077

Pain (limb, back, neck, head abdominally)

714

1784

2.02

57.32

1.2

1.3

2.17

1.33

nmol/l

0.21

686

1727

Asthma (mode)

844

2410

1.89

57.11

1.2

1.3

0.78

1.28

nmol/l

0.49

809

2328

ILD medications: prednisolone, methylprednisolone, prednisone

1186

3934

1.70

56.98

1.3

0.60

1.36

nmol/l

1.18

1132

3793

Depression or dysthymia

747

2117

1.96

56.92

1.3

0.63

1.82

nmol/l

0.98

720

2047

Gastrointestinal diseases

600

1407

2.15

56.72

1.2

1.3

0.56

1.67

nmol/l

0.74

580

1358

Disorders of gallbladder, biliary tract and pancreas

1078

3961

1.73

56.69

1.3

0.61

1.36

nmol/l

1.19

1038

3818

Hypo-osmolality and hyponatraemia

229

728

3.19

56.26

1.2

1.3

0.66

2.80

nmol/l

0.69

214

697

Depression

1069

4249

1.72

55.75

1.3

1.77

1.20

nmol/l

0.26

1027

4100

Mood disorders

1133

4360

1.69

55.62

1.3

1.71

1.18

nmol/l

0.25

1088

4209

Mood [affective] disorders

1131

4360

1.69

55.51

1.3

1.71

1.18

nmol/l

0.25

1086

4209

Oral corticosteroids

1153

4078

1.69

55.09

1.3

0.60

1.33

nmol/l

1.18

1100

3937

Migraine without aura

254

873

2.96

55.00

1.3

4.98

0.55

nmol/l

0.49

246

846

Exclusions for E4_PCOS_CONSORTIUM

833

2843

1.85

54.88

1.5

1.2

0.80

1.43

nmol/l

0.59

800

2742

Asthma (only as main-diagnosis)

776

2376

1.90

54.88

1.3

0.79

1.29

nmol/l

0.47

741

2294

Primary hyperparathyroidism

199

599

3.43

54.40

1.3

0.63

2.56

nmol/l

0.50

187

575

Persons encountering health services for specific procedures and health care

1158

4174

1.67

53.74

1.3

0.61

1.27

nmol/l

1.06

1113

4023

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

734

3545

1.87

53.51

1.3

1.75

1.47

nmol/l

0.09

706

3411

Anxiety (asthma-related co-morbidities)

685

2773

1.93

53.41

1.3

1.16

1.43

nmol/l

0.13

658

2680

Dysphagia

291

1094

2.70

53.21

1.3

0.64

2.66

nmol/l

0.82

275

1055

Implicit viral Sepsis

355

1468

2.45

53.20

1.3

3.00

2.50

nmol/l

0.07

336

1418

Biguanides

1033

3686

1.72

53.11

1.3

1.23

1.42

nmol/l

0.12

1000

3552

Symptoms and signs involving the skin and subcutaneous tissue

783

4279

1.81

51.84

1.3

1.65

1.30

nmol/l

0.12

759

4118

Intracranial trauma

570

1974

2.05

51.67

1.2

1.3

0.57

0.72

nmol/l

0.74

554

1896

Hypopituitarism

115

242

4.90

51.34

1.4

1.2

0.59

0.54

nmol/l

0.43

110

231

Renal failure

493

2083

2.12

50.95

1.3

0.73

1.97

nmol/l

0.96

466

1996

Ischaemic heart disease, wide definition

847

2949

1.79

50.43

1.3

1.86

1.28

nmol/l

0.18

814

2841

All anxiety disorders

695

2952

1.88

50.20

1.3

1.15

1.38

nmol/l

0.11

668

2856

Inflammatory bowel disease treatment related agents

1205

4156

1.63

49.97

1.3

0.60

1.31

nmol/l

1.18

1150

4012

Somatoform disorder

240

846

2.90

49.84

1.3

0.57

1.93

nmol/l

0.51

227

822

Statin medication

723

2165

1.89

49.83

1.2

1.3

0.85

1.49

nmol/l

0.43

698

2101

ILD medications

1191

3972

1.64

49.51

1.3

0.60

1.35

nmol/l

1.18

1145

3830

Disorders of mineral metabolism

135

332

4.19

49.51

1.2

1.3

0.67

0.63

nmol/l

0.35

129

319

Complications of procedures, not elsewhere classified

877

4221

1.73

49.07

1.3

1.54

1.31

nmol/l

0.08

845

4067

Any mental disorder

1154

3528

1.65

48.50

1.3

0.98

1.32

nmol/l

0.26

1100

3410

Concussion

491

1945

2.08

47.85

1.2

1.3

0.57

0.71

nmol/l

0.73

479

1867

Disturbances of skin sensation

353

1532

2.34

47.57

1.3

2.88

1.60

nmol/l

0.22

345

1482

Hernia of abdominal wall, postoperative

198

642

3.13

47.54

1.4

1.2

0.65

5.25

nmol/l

1.17

191

619

Vocal cord dysfunction

161

406

3.61

47.19

1.4

1.3

0.61

0.59

nmol/l

0.23

154

395

Disorders of the thyroid gland

981

3824

1.68

47.19

1.3

2.23

1.18

nmol/l

0.41

947

3675

Non-invasive ventilation

233

734

2.87

46.84

1.5

1.3

2.37

2.14

nmol/l

0.03

228

708

Constipation

943

3890

1.69

46.71

1.3

0.63

1.37

nmol/l

1.12

905

3754

Infections, IBD-co-morbidities

159

304

3.78

46.49

1.4

1.2

0.58

0.62

nmol/l

0.57

151

292

Continuous positive airway pressure

197

530

3.17

46.44

1.2

1.3

0.58

2.76

nmol/l

0.51

182

512

Chronic lower respiratory diseases

1253

4228

1.59

46.02

1.3

0.74

1.26

nmol/l

0.71

1199

4081

Spinal stenosis

536

2061

1.99

45.96

1.2

1.3

2.20

2.10

nmol/l

0.02

510

1985

Any reimbursement code in KELA

577

1451

2.01

45.76

1.3

0.56

0.53

nmol/l

1.30

555

1410

Asthma (diagnoses ohter than nonallergic)

917

4577

1.67

45.27

1.2

1.3

1.68

1.22

nmol/l

0.19

875

4414

Other/unspecified dorsalgia

413

1934

2.14

45.03

1.3

2.62

2.07

nmol/l

0.09

393

1858

Obesity related asthma

418

2003

2.11

44.09

1.2

1.3

2.98

2.01

nmol/l

0.18

401

1932

Soft tissue disorders

1029

3226

1.65

44.06

1.2

1.3

1.99

1.03

nmol/l

0.40

989

3106

Recurrent or chronic depression

444

1489

2.12

44.03

1.2

1.3

0.59

2.20

nmol/l

0.92

423

1439

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

344

924

2.37

43.48

1.2

1.3

0.60

0.57

nmol/l

0.57

328

895

Lumbar disc prolapse

663

2820

1.82

43.19

1.3

0.59

1.67

nmol/l

1.22

642

2722

Migraine with aura

282

1161

2.46

42.78

1.2

1.3

0.53

0.57

nmol/l

1.96

272

1120

Follow-up examination after treatment for conditions other than malignant neoplasms

439

1388

2.11

42.72

1.3

0.59

2.67

nmol/l

1.11

428

1322

Cough

394

1763

2.13

42.44

1.2

1.3

0.61

0.74

nmol/l

0.60

380

1696

Nerve, nerve root and plexus disorders

1102

4267

1.59

42.22

1.2

1.3

1.53

1.26

nmol/l

0.11

1071

4100

Abnormal weight loss

147

430

3.52

42.08

1.2

1.3

0.61

0.65

nmol/l

0.69

138

410

Hypotension

202

725

2.83

40.59

1.4

1.3

0.62

0.69

nmol/l

1.30

189

690

Psychiatric diseases

1013

3140

1.62

40.50

1.3

1.02

1.42

nmol/l

0.27

967

3030

Other CVD

229

878

2.65

40.45

1.4

1.3

0.61

0.68

nmol/l

1.60

216

839

Weight loss

152

469

3.33

39.97

1.2

1.3

0.61

0.65

nmol/l

0.57

143

448

Other anxiety disorders

500

2270

1.93

39.93

1.3

1.38

1.15

nmol/l

0.09

483

2197

Symptoms and signs involving the urinary system

797

3630

1.68

39.88

1.3

1.69

1.44

nmol/l

0.09

761

3500

Other pulmonary diagnosis

815

2397

1.71

39.79

1.3

1.99

1.28

nmol/l

0.20

788

2315

Disorders of calcium metabolism

104

249

4.31

39.65

1.2

1.3

0.68

0.64

nmol/l

0.22

238

Major coronary heart disease event excluding revascularizations

617

2273

1.82

39.57

1.4

1.3

2.34

1.50

nmol/l

0.20

591

2181

Diarrhoea and gastroenteritis of presumed infectious origin

731

3885

1.71

39.49

1.3

1.71

1.37

nmol/l

0.11

705

3732

Cholelithiasis

862

3623

1.65

39.25

1.3

0.61

1.44

nmol/l

1.20

835

3489

Cholelithiasis, broad definition with cholecystitis

891

3683

1.64

39.23

1.3

0.61

1.43

nmol/l

1.20

864

3547

Viral Sepsis

238

947

2.55

38.98

1.3

4.11

2.93

nmol/l

0.12

228

914

Disorder of lipoprotein metabolism, unspecified

161

522

3.14

38.87

1.4

1.3

1.74

0.65

nmol/l

0.50

149

503

Implicit viral Sepsis

237

943

2.55

38.82

1.3

4.12

2.94

nmol/l

0.12

227

910

Excluding asthma or asthma-COPD overlap

808

2397

1.70

38.27

1.3

2.01

1.28

nmol/l

0.20

780

2315

Abnormal findings on examination of blood, without diagnosis

475

2290

1.92

38.11

1.3

0.63

1.93

nmol/l

1.18

454

2204

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

138

413

3.42

38.08

1.6

1.3

0.68

0.64

nmol/l

0.57

133

399

Hypothyroidism, other/unspecified

889

3625

1.62

37.53

1.3

2.40

1.22

nmol/l

0.43

858

3482

Abnormal findings on diagnostic imaging of other body structures

193

709

2.78

37.27

1.4

1.3

4.87

2.25

nmol/l

0.25

187

681

476

2510

1.90

37.27

1.3

2.33

1.71

nmol/l

0.13

455

2419

Persons encountering health services for examination and investigation

595

1627

1.84

37.18

1.3

0.59

2.35

nmol/l

1.11

574

1557

Endocrine disorders, other/unspecified

8.53

37.09

2.1

1.2

0.60

0.51

nmol/l

1.20

Asthma, hospital admission 2, infections

608

3412

1.76

37.05

1.3

1.97

1.43

nmol/l

0.15

578

3278

Asthma-related infections

608

3412

1.76

37.05

1.3

1.97

1.43

nmol/l

0.15

578

3278

Other general symptoms and signs

155

5.12

36.78

1.3

0.52

0.61

nmol/l

1.17

149

Malignant neoplasm of urinary organs

130

384

3.46

36.64

1.5

1.3

0.67

0.64

nmol/l

0.33

125

371

Cervicalgia

244

1016

2.44

36.27

1.3

1.2

0.58

3.19

nmol/l

1.01

233

976

Other disorders of kidney and ureter

174

614

2.89

36.26

1.4

1.3

0.74

0.64

nmol/l

0.49

163

590

Haemorrhage from respiratory passages

314

1300

2.20

36.24

1.3

0.65

0.82

nmol/l

0.51

295

1249

Valvular heart disease excluding rheumatic fever

463

1745

1.93

36.15

1.4

1.3

4.70

1.49

nmol/l

0.56

447

1688

Cholecystectomy

734

3835

1.66

35.76

1.3

1.72

1.41

nmol/l

0.10

713

3683

Intestinal infectious diseases

1152

4353

1.52

35.69

1.3

1.30

1.29

nmol/l

0.00

1112

4190

COPD differential diagnosis

799

2410

1.67

35.64

1.3

2.02

1.28

nmol/l

0.21

772

2328

Autoimmune diseases excluding thyroid diseases

1029

3617

1.56

35.60

1.3

1.72

0.66

nmol/l

0.47

990

3484

Non-rheumatic valve diseases

460

1739

1.92

35.52

1.4

1.3

4.74

1.50

nmol/l

0.56

444

1682

Complications of medical and surgical care

759

4282

1.64

35.48

1.3

1.68

1.31

nmol/l

0.13

732

4125

Bleeding

837

3703

1.62

35.47

1.3

0.63

1.65

nmol/l

1.42

802

3574

ILD differential diagnosis

798

2410

1.67

35.43

1.3

2.02

1.28

nmol/l

0.21

771

2328

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

978

4097

1.56

35.29

1.4

1.3

1.65

1.07

nmol/l

0.22

944

3942

Autoimmune diseases excluding thyroid diseases, strict definition

976

3410

1.58

35.23

1.3

1.78

0.66

nmol/l

0.47

939

3282

Shoulder lesions

758

2771

1.67

35.08

1.2

1.3

0.60

1.12

nmol/l

0.68

723

2671

Diarrhoea and gastroenteritis of presumed infectious origin

1019

4373

1.54

34.97

1.3

1.38

1.29

nmol/l

0.04

984

4210

Other disorders of urethra and urinary system

701

3024

1.68

34.85

1.2

1.3

0.61

1.42

nmol/l

1.10

665

2916

Diaphragmatic hernia

401

2064

1.96

34.79

1.2

1.3

0.63

2.10

nmol/l

1.20

380

1978

Certain infectious and parasitic diseases

988

3165

1.57

34.59

1.3

1.76

1.17

nmol/l

0.20

946

3056

Malignant neoplasm of kidney, except renal pelvis

121

356

3.48

34.36

1.6

1.3

0.67

0.65

nmol/l

0.26

116

343

Pain in thoracic spine

188

710

2.69

34.35

1.2

1.3

0.53

2.80

nmol/l

0.73

177

686

1148

3939

1.51

34.20

1.3

2.33

1.07

nmol/l

0.50

1104

3798

Hypothyreosis and Thyroxine purchase for inclusion criteria

922

3871

1.57

34.14

1.3

2.33

1.18

nmol/l

0.44

891

3714

Cervical disc disorders

378

1920

1.99

34.05

1.3

2.80

2.18

nmol/l

0.10

368

1849

Other joint disorders

862

2842

1.61

33.64

1.3

1.04

1.07

nmol/l

0.02

834

2735

COPD/asthma related infections

1056

3459

1.54

33.53

1.3

1.68

1.13

nmol/l

0.20

1013

3340

COPD/asthma/ILD related infections

1056

3459

1.54

33.53

1.3

1.68

1.13

nmol/l

0.20

1013

3340

Myalgia

271

1225

2.24

33.32

1.2

1.3

0.56

1.54

nmol/l

0.54

256

1179

Visual disturbances and blindness

542

3113

1.76

32.98

1.3

4.19

1.21

nmol/l

0.60

527

2983

Benign neoplasm of colon, rectum, anus and anal canal

637

3305

1.69

32.83

1.4

1.3

1.96

1.55

nmol/l

0.11

606

3180

Other neurological diseases

727

3517

1.64

32.79

1.3

1.74

1.48

nmol/l

0.08

703

3376

Selective serotonin reuptake inhibitors

963

3246

1.56

32.72

1.3

1.03

1.39

nmol/l

0.24

921

3134

Malignant neoplasm, wide definition for exclusion

880

3284

1.58

32.68

1.6

1.2

0.62

1.44

nmol/l

1.03

855

3167

Implicit bacterial Sepsis

444

2069

1.87

32.51

1.3

3.55

1.88

nmol/l

0.34

421

1985

Coronary atherosclerosis

635

2370

1.71

32.38

1.3

2.29

1.45

nmol/l

0.20

604

2281

Glucagon-like peptide-1 (GLP-1) analogues

322

1578

2.07

32.18

1.2

1.3

1.08

2.00

nmol/l

0.39

311

1519

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

322

1578

2.07

32.18

1.2

1.3

1.08

2.00

nmol/l

0.39

311

1519

Nutritional anaemias

494

2682

1.79

32.02

1.3

0.66

1.67

nmol/l

1.03

467

2572

Myocardial infarction

480

1854

1.84

31.98

1.4

1.3

2.83

1.70

nmol/l

0.21

461

1769

Intestinal infectious diseases

933

4645

1.53

31.75

1.3

1.47

1.24

nmol/l

0.09

901

4475

Autoimmune diseases

1076

3645

1.51

31.55

1.3

3.16

0.66

nmol/l

1.03

1037

3512

Insulin medication

572

2821

1.72

31.45

1.3

2.73

1.02

nmol/l

0.44

551

2712

Dipeptidyl peptidase 4 (DPP-4) inhibitors

539

2491

1.75

31.15

1.3

0.64

1.86

nmol/l

1.07

519

2391

Asthma, including avohilmo

1156

4422

1.47

31.06

1.2

1.3

0.72

1.24

nmol/l

0.72

1110

4261

Visual disturbances

507

2913

1.76

30.93

1.3

4.44

1.26

nmol/l

0.60

493

2790

Asthma, hospital admissions , main diagnosis only

813

4620

1.56

30.83

1.3

1.81

1.21

nmol/l

0.23

777

4454

Cystitis

831

3153

1.58

30.63

1.3

1.97

1.39

nmol/l

0.16

798

3041

Genitourinary diseases

542

1534

1.78

30.48

1.3

0.57

1.76

nmol/l

0.96

518

1493

Diseases of the digestive system

448

2484

1.81

30.31

1.3

0.62

1.84

nmol/l

1.21

423

2386

Migraine without aura and triptan purchases

194

793

2.48

30.15

1.2

1.3

6.39

0.55

nmol/l

0.49

187

766

Other bacterial diseases

996

4224

1.50

30.12

1.3

1.03

1.39

nmol/l

0.27

953

4082

Implicit bacterial Sepsis

403

1919

1.88

30.11

1.3

2.81

2.09

nmol/l

0.12

381

1839

Aplastic and other anaemias

440

2274

1.82

29.95

1.4

1.3

0.69

1.87

nmol/l

1.01

417

2177

Benign neoplasm of other and ill-defined parts of digestive system

220

955

2.34

29.95

1.5

1.3

0.59

2.26

nmol/l

0.72

205

920

Oxycodone

375

1789

1.91

29.76

1.3

2.86

2.21

nmol/l

0.10

358

1721

Adverse effects, not elsewhere classified

232

1033

2.28

29.70

1.2

1.3

0.52

2.09

nmol/l

0.74

220

999

Disorders of vestibular function (Vertigo)

492

2788

1.75

29.67

1.3

2.31

1.71

nmol/l

0.13

472

2679

Acute upper respiratory infections

1022

4239

1.49

29.67

1.3

2.52

1.04

nmol/l

0.54

989

4078

Disorders of eyelid, lacrimal system and orbit

843

4174

1.54

29.61

1.2

1.3

0.59

1.33

nmol/l

1.26

800

4027

Iron deficiency anaemia

426

2320

1.82

29.59

1.3

0.66

1.83

nmol/l

1.03

404

2230

Other and unspecified iron deficiency

348

1805

1.95

29.53

1.3

0.66

2.06

nmol/l

0.95

333

1742

Diseases of inner ear

555

3200

1.69

29.44

1.3

2.13

1.57

nmol/l

0.14

532

3075

Insulin, intermediate and long-acting

535

3074

1.70

29.26

1.3

2.86

1.19

nmol/l

0.39

517

2954

Finngen Rheumatological endpoints

933

3506

1.52

29.20

1.3

1.04

1.27

nmol/l

0.15

899

3380

Use of hypnotics and sedatives

1043

4053

1.48

29.11

1.3

1.05

1.22

nmol/l

0.12

1001

3910

Diseases of the ear and mastoid process

1140

3929

1.46

28.79

1.3

0.58

1.36

nmol/l

1.23

1091

3788

Angina pectoris

546

2143

1.71

28.42

1.3

4.09

1.54

nmol/l

0.51

525

2055

Abnormal involuntary movements

163

632

2.62

28.39

1.3

0.53

2.44

nmol/l

0.53

154

607

Other and unspecified effects of external causes

298

1490

2.02

28.23

1.2

0.52

1.62

nmol/l

0.76

284

1442

Osteopathies and chondropathies

572

3236

1.66

28.11

1.3

2.09

1.48

nmol/l

0.16

554

3106

Other symptoms and signs involving the digestive system and abdomen

185

765

2.45

28.07

1.3

0.59

2.13

nmol/l

0.52

178

738

Obesity, other/unspecified

362

1938

1.89

27.99

1.2

1.3

0.57

1.81

nmol/l

0.91

346

1872

Subjective visual disturbances

285

1408

2.05

27.96

1.3

3.46

0.91

nmol/l

0.42

276

1354

Nonorganic sleeping disorders, excluding more controls

206

896

2.33

27.86

1.3

0.58

1.82

nmol/l

0.49

201

873

Exposure to unspecified factor

967

4723

1.48

27.79

1.3

1.46

1.23

nmol/l

0.10

929

4553

Other bacterial diseases

919

4142

1.50

27.74

1.4

1.3

0.63

1.52

nmol/l

1.37

877

4002

Diseases of arteries, arterioles and capillaries

639

2931

1.62

27.65

1.3

3.63

1.30

nmol/l

0.55

606

2814

Care involving use of rehabilitation procedures

631

3625

1.61

27.59

1.3

1.91

1.38

nmol/l

0.15

612

3490

Chronic gastritis

277

1367

2.05

27.22

1.3

4.46

1.93

nmol/l

0.28

259

1307

Paralytic ileus and intestinal obstruction

248

1179

2.12

26.88

1.4

1.3

3.96

2.99

nmol/l

0.10

242

1141

Bacterial Sepsis

441

2152

1.76

26.85

1.3

2.62

2.03

nmol/l

0.11

417

2059

Chronic pancreatitis

149

569

2.67

26.80

1.4

1.3

0.60

0.62

nmol/l

0.29

139

544

Other diseases of upper respiratory tract

1056

3786

1.46

26.67

1.3

0.61

1.39

nmol/l

1.17

1011

3643

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

513

2989

1.68

26.66

1.3

0.57

1.60

nmol/l

1.24

493

2881

Cerebrovascular diseases

715

3226

1.57

26.65

1.4

1.3

1.80

1.57

nmol/l

0.07

681

3106

Substance abuse, excluding more controls

505

2557

1.69

26.64

1.2

1.3

0.63

1.58

nmol/l

0.93

482

2480

Any event in cancer register

891

3508

1.50

26.62

1.6

1.2

0.61

1.38

nmol/l

1.03

859

3388

Personality disorders, excluding more controls

252

1211

2.10

26.57

1.2

1.3

2.21

1.65

nmol/l

0.12

242

1181

Dermatitis and eczema

1065

4591

1.44

26.31

1.3

0.58

1.43

nmol/l

1.51

1023

4426

Urticaria and erythema

386

2150

1.81

26.30

1.2

0.56

1.32

nmol/l

0.74

378

2071

Other and unspecified anaemias

396

2116

1.80

26.16

1.4

1.3

0.70

1.97

nmol/l

1.02

376

2023

Other anaemias

399

2132

1.79

26.12

1.4

1.3

0.70

1.96

nmol/l

1.02

379

2039

Other gastritis (incl. Duodenitis)

232

1089

2.16

26.10

1.2

1.3

0.63

2.07

nmol/l

0.71

224

1049

Other systemic involvement of connective tissue (FG)

282

1406

2.00

25.95

1.3

0.61

2.19

nmol/l

0.82

271

1346

Ovarian cyst

370

1141

1.89

25.79

1.2

1.3

0.58

1.97

nmol/l

0.71

354

1092

Other reaction to severe stress, and adjustment disorders

366

2018

1.83

25.79

1.3

1.2

2.77

1.23

nmol/l

0.30

359

1959

Adjustment and management of implanted device

188

815

2.34

25.69

1.3

0.64

1.96

nmol/l

0.52

181

790

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

102

325

3.21

25.59

1.2

0.54

0.51

nmol/l

0.64

319

Diseases of the skin and subcutaneous tissue

951

3237

1.48

25.55

1.3

0.59

1.52

nmol/l

1.20

908

3132

Rotator cuff syndrome

576

2549

1.63

25.52

1.2

1.3

0.60

1.17

nmol/l

0.68

549

2455

Diseases of pulp and periapical tissues, including avohilmo

1005

3579

1.46

25.46

1.2

1.3

0.59

1.67

nmol/l

1.48

971

3445

Diseases of the musculoskeletal system and connective tissue

481

1389

1.75

25.40

1.3

0.55

1.56

nmol/l

0.64

462

1338

Myocardial infarction, without ST-elevation

363

1821

1.83

25.32

1.3

3.58

1.61

nmol/l

0.30

347

1738

Other noninfective gastroenteritis and colitis

258

1274

2.05

25.31

1.3

0.62

1.82

nmol/l

0.69

246

1228

Benign neoplasm: Colon

524

3059

1.65

25.25

1.4

1.3

2.24

1.63

nmol/l

0.14

497

2940

Urticaria

318

1690

1.90

25.24

1.2

1.3

0.55

1.51

nmol/l

0.74

311

1631

Hypothyroidism, strict autoimmune

669

2810

1.57

25.21

1.3

3.01

0.69

nmol/l

0.77

643

2699

Endometriosis

359

1128

1.88

24.99

1.3

0.56

1.99

nmol/l

0.73

347

1079

Autoimmune diseases related-to ILD

818

4722

1.49

24.96

1.3

1.62

1.23

nmol/l

0.14

790

4547

Systemic connective tissue disorders

367

2047

1.81

24.96

1.3

0.63

1.91

nmol/l

0.99

352

1958

Non-selective monoamine reuptake inhibitors

382

2074

1.79

24.93

1.3

1.74

1.78

nmol/l

0.01

371

1996

Certain infectious and parasitic diseases

715

2298

1.57

24.92

1.3

2.78

1.22

nmol/l

0.42

686

2223

Infections of the skin and subcutaneous tissue

559

3457

1.61

24.84

1.3

0.58

1.45

nmol/l

1.21

537

3329

Acute upper respiratory infections of multiple and unspecified sites

720

3496

1.53

24.76

1.2

1.3

3.30

1.13

nmol/l

0.56

694

3362

Insulin, combination of fast acting with intermediate-acting or long-acting

572

3280

1.60

24.61

1.3

2.73

1.16

nmol/l

0.40

551

3154

Covid-19 confirmed case

353

1957

1.82

24.47

1.3

2.95

1.46

nmol/l

0.27

344

1872

Malignant neoplasm

808

3197

1.50

24.21

1.6

1.2

0.62

1.47

nmol/l

1.03

783

3083

Polyuria

222

1056

2.13

24.18

1.3

0.61

2.88

nmol/l

0.91

207

1014

157

647

2.46

24.11

1.5

1.3

3.26

2.35

nmol/l

0.11

149

625

Hyperkalaemia

168

4.07

24.10

1.3

0.66

nmol/l

0.03

162

Other diseases of urinary system

929

3592

1.46

23.91

1.3

1.83

1.34

nmol/l

0.15

891

3467

Convulsions, not elsewhere classified

205

936

2.18

23.88

1.3

0.59

2.37

nmol/l

0.85

195

901

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

591

3731

1.57

23.74

1.3

1.99

1.42

nmol/l

0.16

572

3588

Polyarthropathies

615

2553

1.58

23.70

1.2

1.3

2.34

1.14

nmol/l

0.30

581

2453

Heart failure,strict

494

2108

1.67

23.67

1.3

2.86

1.87

nmol/l

0.18

467

2026

Solid cancers, helper endpoint

796

3153

1.50

23.51

1.6

1.2

0.62

1.48

nmol/l

1.04

771

3039

Panic disorder

161

680

2.40

23.40

1.3

3.12

0.55

nmol/l

0.49

154

661

Disorders of conjunctiva

800

4370

1.48

23.25

1.3

0.57

1.47

nmol/l

1.51

769

4205

Hernia

899

4177

1.45

23.03

1.3

0.62

1.51

nmol/l

1.39

861

4031

Behavioural syndromes associated with physiological disturbances and physical factors

885

4348

1.45

22.96

1.2

1.3

0.58

1.29

nmol/l

1.24

852

4189

Codes for special purposes

500

3097

1.62

22.92

1.2

1.3

4.89

1.13

nmol/l

0.73

488

2966

Provisional assignment of new diseases of uncertain etiology

499

3091

1.62

22.87

1.2

1.3

4.90

1.13

nmol/l

0.73

487

2960

Enthesopathies of lower limb, excluding foot

226

1107

2.06

22.79

1.2

4.25

3.14

nmol/l

0.11

216

1068

Other diseases of the digestive system

293

1572

1.88

22.61

1.3

0.63

2.41

nmol/l

1.08

276

1512

Diseases of the eye and adnexa

750

2491

1.51

22.61

1.2

1.3

2.08

0.84

nmol/l

0.38

725

2406

Benign paroxysmal vertigo

306

1669

1.85

22.49

1.3

3.32

2.21

nmol/l

0.15

296

1600

GI-bleeding

291

1566

1.87

22.25

1.3

0.64

2.42

nmol/l

1.08

275

1504

Falls/tendency to fall

1039

3690

1.42

22.20

1.3

2.28

0.93

nmol/l

0.57

997

3567

Abnormal findings on diagnostic imaging of lung

444

2581

1.66

22.19

1.3

0.64

1.81

nmol/l

1.20

426

2473

Sleep disorders

852

4268

1.45

22.13

1.3

0.58

1.30

nmol/l

1.24

823

4110

Fall on same level

1084

4244

1.40

22.13

1.3

0.78

1.25

nmol/l

0.57

1040

4096

Migraine with aura and triptan purchases

171

762

2.27

22.00

1.2

1.3

0.51

0.56

nmol/l

1.40

166

733

Cervicobrachial syndrome

226

1124

2.03

21.88

1.2

1.3

0.53

3.10

nmol/l

1.14

220

1086

Chronic apical periodontitis

1058

4319

1.40

21.85

1.2

1.3

0.59

1.49

nmol/l

1.47

1017

4158

Disorders of synovium and tendon

495

2704

1.61

21.80

1.2

1.3

2.65

1.12

nmol/l

0.33

483

2603

Bronchitis

1010

4542

1.41

21.74

1.2

1.3

2.55

1.01

nmol/l

0.55

966

4378

Caries of dentine

226

1094

2.03

21.73

1.3

0.58

1.85

nmol/l

0.63

219

1051

Benign neoplasm: Pancreas

109

4.78

21.69

1.6

1.3

0.56

0.63

nmol/l

1.04

102

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

829

3458

1.46

21.56

1.3

0.63

1.13

nmol/l

0.88

779

3339

829

3458

1.46

21.56

1.3

0.63

1.13

nmol/l

0.88

779

3339

Other enthesopathies

294

1605

1.85

21.53

1.2

1.3

0.57

1.47

nmol/l

0.67

289

1543

Other systemic involvement of connective tissue

288

1563

1.86

21.53

1.3

0.61

1.63

nmol/l

0.72

277

1497

Heart failure and coronary heart disease

367

1490

1.76

21.47

1.3

3.63

1.83

nmol/l

0.26

348

1419

Noninfective enteritis and colitis

447

2740

1.64

21.46

1.3

0.61

1.62

nmol/l

1.07

430

2641

Other and unspecified urticaria

214

1055

2.05

21.27

1.2

1.3

0.54

2.06

nmol/l

0.73

209

1020

Dialysis, with operation codes

137

563

2.47

21.25

1.4

1.3

0.80

0.62

nmol/l

0.85

128

539

Asthma/COPD (KELA code 203)

878

4223

1.43

21.22

1.3

0.79

1.26

nmol/l

0.57

835

4076

Unstable angina pectoris

328

1450

1.80

21.15

1.3

0.69

1.86

nmol/l

0.77

313

1381

Dental caries

249

1244

1.94

21.10

1.4

1.3

0.59

1.83

nmol/l

0.73

241

1197

Gonarthrosis [arthrosis of knee](FG)

708

2758

1.50

21.06

1.2

1.3

1.43

1.49

nmol/l

0.03

686

2655

Arthropathies

819

2848

1.46

20.96

1.2

1.3

0.55

1.07

nmol/l

0.68

790

2740

Factors influencing health status and contact with health services

244

601

2.05

20.92

1.3

0.61

2.86

nmol/l

0.61

235

580

Disorders of lacrimal system

422

2572

1.65

20.68

1.2

1.3

0.57

1.64

nmol/l

1.08

401

2480

Gonarthrosis

597

2204

1.55

20.65

1.2

1.3

1.30

1.25

nmol/l

0.02

577

2119

Hypermobility syndrome

207

3.51

20.63

1.2

1.3

0.52

0.54

nmol/l

0.21

201

Other and unspecified dermatitis

498

3170

1.58

20.58

1.3

0.58

1.56

nmol/l

1.25

479

3053

Other disorders of lacrimal gland

354

2073

1.72

20.44

1.2

1.3

0.56

1.89

nmol/l

1.06

340

1996

Care involving dialysis

348

2.87

20.43

1.4

0.67

0.65

nmol/l

0.15

337

Dermatitis

581

3818

1.52

20.42

1.3

0.58

1.61

nmol/l

1.52

561

3681

Tinnitus

244

1283

1.92

20.17

1.3

0.58

2.66

nmol/l

1.02

237

1240

Myocardial infarction, strict

405

1730

1.68

20.14

1.4

1.3

3.24

1.77

nmol/l

0.23

388

1650

Conjunctivitis

719

4125

1.46

20.13

1.2

1.3

0.57

1.48

nmol/l

1.42

692

3969

COPD (mode)

288

1239

1.84

20.07

1.3

0.70

1.82

nmol/l

0.66

274

1187

External causes of morbidity and mortality

622

2040

1.53

20.00

1.3

2.42

0.70

nmol/l

0.45

595

1974

Candidiasis

293

1640

1.80

19.84

1.3

0.59

1.56

nmol/l

0.72

283

1578

Intestinal stricture

294

1651

1.80

19.67

1.4

1.3

3.45

2.22

nmol/l

0.17

286

1582

Other or unspecified ileus, impaction or obstruction

169

785

2.17

19.64

1.3

5.57

3.94

nmol/l

0.12

163

759

Glomerular disorders in diseases classified elsewhere

126

519

2.47

19.50

1.2

1.3

0.72

0.62

nmol/l

0.32

117

497

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

540

3539

1.53

19.49

1.3

0.59

1.47

nmol/l

1.25

521

3399

Other diseases of pancreas

103

386

2.72

19.42

1.3

0.61

0.64

nmol/l

0.27

367

Glomerular diseases

181

869

2.11

19.38

1.2

1.3

0.71

1.82

nmol/l

0.45

168

834

Generalized anxiety disorder

159

726

2.21

19.33

1.3

3.14

2.11

nmol/l

0.13

153

706

Gingivitis and periodontal diseases

959

3553

1.40

19.31

1.3

0.63

1.67

nmol/l

1.39

923

3432

Epilepsy

261

1418

1.85

19.24

1.3

4.93

1.52

nmol/l

0.36

253

1359

Influenza and pneumonia

981

4529

1.38

19.23

1.4

1.3

0.63

1.24

nmol/l

1.07

926

4381

Coxibs

235

622

2.00

19.23

1.3

0.59

1.69

nmol/l

0.85

224

596

Heart failure, strict

528

2417

1.55

19.01

1.3

2.75

1.79

nmol/l

0.19

500

2313

Other external causes of accidental injury

771

2674

1.45

18.89

1.3

2.62

0.67

nmol/l

0.66

738

2589

Nephropathy related operations

132

565

2.37

18.78

1.4

1.3

0.78

0.64

nmol/l

0.59

125

541

Acute sinusitis

485

2897

1.56

18.71

1.3

2.31

1.16

nmol/l

0.29

464

2792

Insulin, fast-acting

329

1934

1.71

18.71

1.3

3.75

1.51

nmol/l

0.32

320

1865

Inflammatory diseases of female pelvic organs

598

2949

1.50

18.59

1.2

1.3

0.56

1.42

nmol/l

1.05

573

2839

Algoneurodystrophy

141

3.95

18.53

1.2

1.4

0.56

0.59

nmol/l

0.19

135

Diseases of the respiratory system

594

1965

1.52

18.43

1.3

2.52

1.44

nmol/l

0.23

572

1897

Polycystic ovarian syndrome, consortium definition

693

2819

1.46

18.42

1.3

0.58

1.15

nmol/l

0.73

667

2709

Thyrotoxicosis, other and/or unspecified

211

1091

1.95

18.40

1.2

1.3

0.62

1.67

nmol/l

0.50

200

1050

COPD

393

1973

1.64

18.37

1.3

2.84

1.98

nmol/l

0.15

372

1888

Dental pulpitis, including avohilmo

852

3957

1.40

18.35

1.2

1.3

0.55

1.34

nmol/l

1.27

825

3813

Acute renal failure

197

997

2.00

18.26

1.3

0.68

1.69

nmol/l

0.48

187

956

Acute tubulo-interstitial nephritis

558

3218

1.50

18.10

1.4

1.3

2.15

1.47

nmol/l

0.17

529

3096

Urolithiasis

284

1619

1.77

18.09

1.2

1.3

0.64

2.47

nmol/l

1.16

277

1556

Pacemaker

276

1494

1.78

18.02

1.3

0.72

1.49

nmol/l

0.55

263

1423

Nonorganic sleeping disorders

206

1064

1.96

18.02

1.3

0.58

1.64

nmol/l

0.49

201

1027

Adenomyosis (Endometriosis of uterus)

153

709

2.19

18.01

1.3

0.57

2.85

nmol/l

0.73

148

677

Injuries to the head

1019

4624

1.36

17.96

1.2

1.3

1.60

1.20

nmol/l

0.18

975

4461

Haemorrhoids and perianal venous thrombosis

277

1568

1.78

17.92

1.3

0.62

2.42

nmol/l

1.10

269

1508

Soft tissue disorders related to use, overuse and pressure

260

1451

1.81

17.83

1.3

3.84

1.58

nmol/l

0.30

249

1381

Chronic rhinitis, nasopharyngitis and pharyngitis

312

1835

1.71

17.79

1.2

1.3

0.58

2.14

nmol/l

1.11

295

1765

Noninfectious colitis NAS

143

649

2.23

17.72

1.3

0.59

2.38

nmol/l

0.51

133

624

Conduction disorders

250

1107

1.84

17.72

1.3

0.65

1.82

nmol/l

0.58

243

1067

Cyst of kidney

308

2.85

17.72

1.3

0.77

0.65

nmol/l

0.29

293

All-cause Heart Failure

514

2380

1.53

17.68

1.3

2.81

1.73

nmol/l

0.21

487

2276

Cutaneous abscess, furuncle and carbuncle

252

1397

1.82

17.68

1.3

0.57

2.59

nmol/l

1.09

242

1345

Disorders of skin appendages

450

2903

1.56

17.55

1.2

1.3

0.55

1.55

nmol/l

1.14

424

2802

Diseases of salivary glands

321

1911

1.69

17.53

1.3

0.62

2.07

nmol/l

1.07

309

1843

Insomnia

811

4245

1.40

17.43

1.3

0.58

1.26

nmol/l

1.14

784

4085

Insulin, fast-acting or short human

331

1991

1.67

17.31

1.3

3.74

1.49

nmol/l

0.32

322

1917

Other extrapyramidal and movement disorders in other diseases

233

1271

1.85

17.27

1.3

0.61

1.86

nmol/l

0.72

224

1226

Corticotropin deficiency

8.06

17.21

1.2

1.3

0.56

0.47

nmol/l

0.57

Other symptoms and signs involving cognitive functions and awareness

389

2219

1.61

17.07

1.3

1.74

1.72

nmol/l

0.01

367

2130

Cardiomyopathy

156

744

2.12

17.04

1.3

0.74

2.39

nmol/l

0.55

150

719

Thyrotoxicosis

262

1487

1.78

17.03

1.2

1.3

0.62

1.67

nmol/l

0.70

251

1429

Carpal tunnel syndrome

571

3430

1.47

16.93

1.2

1.3

2.40

1.43

nmol/l

0.22

553

3291

Cervicocranial syndrome

112

468

2.43

16.85

1.2

1.3

0.58

3.93

nmol/l

0.71

107

453

Transient ischemic attack

467

2477

1.53

16.56

1.3

0.61

1.87

nmol/l

1.25

449

2371

Substance use, excluding alcohol

199

1047

1.92

16.53

1.2

1.3

0.65

1.65

nmol/l

0.45

189

1011

Substance abuse

505

3181

1.50

16.42

1.2

1.3

0.63

1.52

nmol/l

1.11

482

3078

Injuries to the knee and lower leg

1081

4520

1.33

16.39

1.2

1.3

1.63

1.20

nmol/l

0.16

1052

4341

Persons with potential health hazards related to communicable diseases

335

2033

1.64

16.39

1.3

0.54

1.21

nmol/l

0.61

322

1966

Migraine, single triptan purchase ok & required. ICD-code if available is included

727

3507

1.41

16.29

1.3

3.22

1.06

nmol/l

0.57

710

3378

Triptan medication for migraine, single purchase ok

727

3507

1.41

16.29

1.3

3.22

1.06

nmol/l

0.57

710

3378

Osteoporosis

262

1404

1.76

16.29

1.4

1.2

3.90

1.78

nmol/l

0.28

250

1333

Mental and behavioural disorders due to psychoactive substance use

518

3240

1.49

16.24

1.2

1.3

0.63

1.50

nmol/l

1.11

495

3132

Calculus of kidney and ureter

264

1526

1.74

16.10

1.2

1.3

0.64

2.58

nmol/l

1.17

258

1467

Gastroduodenal ulcer

216

1173

1.85

16.08

1.3

0.62

2.16

nmol/l

0.84

209

1121

Accidents

751

2674

1.41

16.05

1.3

2.68

0.67

nmol/l

0.66

720

2589

Other chronic obstructive pulmonary disease, including avohilmo

466

2542

1.52

16.04

1.3

2.50

1.82

nmol/l

0.14

444

2430

Bacterial infection, other or unspecified

509

2895

1.49

16.04

1.4

1.3

0.69

1.94

nmol/l

1.33

483

2788

Pneumonias (Asthma/COPD co-morbidities)

918

4570

1.35

16.03

1.3

0.63

1.24

nmol/l

1.07

862

4428

Sequelae with surgical and medical care as external cause

199

1060

1.90

15.95

1.3

0.63

1.71

nmol/l

0.50

192

1019

Erysipelas

650

3491

1.43

15.94

1.2

1.3

1.24

1.58

nmol/l

0.17

624

3375

All pneumoniae

922

4576

1.35

15.94

1.3

0.63

1.24

nmol/l

1.07

867

4432

Arthrosis

631

2397

1.45

15.91

1.2

1.3

1.26

1.19

nmol/l

0.03

607

2305

Other disorders of ear

836

4005

1.37

15.86

1.3

0.61

1.56

nmol/l

1.45

803

3860

Sequelae of external causes of morbidity and mortality

244

1386

1.78

15.85

1.3

0.60

2.50

nmol/l

1.00

236

1336

Other chronic obstructive pulmonary disease

368

1907

1.60

15.73

1.3

2.99

2.02

nmol/l

0.16

348

1824

Other arthrosis

465

2124

1.52

15.62

1.3

0.60

1.28

nmol/l

0.66

444

2040

Other and unspecified polyneuropathies, also in other diseases

176

907

1.96

15.59

1.4

1.3

0.67

1.79

nmol/l

0.48

168

872

Congenital malformations, deformations and chromosomal abnormalities

577

3696

1.44

15.54

1.5

1.3

2.35

1.06

nmol/l

0.32

558

3556

Periodontitis

881

4373

1.35

15.33

1.3

0.64

1.47

nmol/l

1.34

844

4218

Chronic periodontitis, including avohilmo

879

4373

1.35

15.29

1.3

0.64

1.47

nmol/l

1.34

842

4218

Other diseases of intestine

138

656

2.13

15.29

1.4

1.3

0.66

2.37

nmol/l

0.49

132

633

COPD related to multimorbidity

327

1705

1.63

15.15

1.3

3.29

2.29

nmol/l

0.14

308

1625

Congenital malformations, deformations and chromosomal abnormalities

528

3458

1.46

15.15

1.5

1.3

2.52

1.09

nmol/l

0.33

511

3329

Diseases of liver

318

1964

1.63

15.13

1.3

0.64

2.05

nmol/l

1.07

308

1891

Other diseases of anus and rectum

248

1432

1.74

15.08

1.3

3.95

2.57

nmol/l

0.16

240

1378

Early onset COPD, excluding more controls

180

945

1.92

15.05

1.2

1.3

0.60

2.38

nmol/l

0.85

169

910

Pneumonia, organism unspecified

826

4273

1.36

15.04

1.3

0.64

1.28

nmol/l

1.06

774

4138

Hypothyroidism, strict autoimmune, 3 medication purchases required

737

3604

1.39

15.02

1.2

1.3

2.79

1.22

nmol/l

0.49

707

3454

Excessive, frequent and irregular menstruation

348

1177

1.63

14.86

1.3

0.55

1.92

nmol/l

0.73

334

1127

Intracranial injury

506

3278

1.47

14.83

1.2

1.3

0.58

1.46

nmol/l

1.13

491

3151

Polyneuropathies and other disorders of the peripheral nervous system

196

1065

1.86

14.79

1.4

1.3

0.67

2.70

nmol/l

0.79

188

1021

Polyarthrosis

204

1040

1.84

14.71

1.2

1.3

4.75

1.78

nmol/l

0.31

194

987

Other disorders of bladder

116

523

2.25

14.71

1.2

1.3

0.57

0.64

nmol/l

1.42

110

501

Unspecified haematuria

347

1814

1.59

14.70

1.3

3.10

2.27

nmol/l

0.13

332

1752

ILD medications: immunosuppressive drugs

564

3667

1.43

14.70

1.3

0.61

1.41

nmol/l

1.16

542

3545

Explicit Sepsis

370

2221

1.56

14.68

1.4

1.3

0.68

1.96

nmol/l

1.10

353

2132

Disorders of vitreous body

457

2973

1.49

14.68

1.2

1.3

0.59

1.86

nmol/l

1.42

436

2858

Intestinal malabsorption

207

3.06

14.59

1.2

0.56

0.62

nmol/l

0.58

198

Injuries to the ankle and foot

629

3992

1.41

14.55

1.2

1.3

0.57

1.29

nmol/l

1.13

610

3843

Disorders of vitreous body and globe

467

3039

1.48

14.55

1.2

1.3

0.59

1.84

nmol/l

1.43

446

2923

Aortic aneurysm

178

925

1.90

14.47

1.2

1.3

0.62

0.85

nmol/l

0.66

168

886

AV-block

145

624

2.05

14.38

1.3

0.68

0.93

nmol/l

0.45

140

602

Other septicaemia

317

1905

1.61

14.29

1.4

1.3

0.70

2.10

nmol/l

1.01

302

1828

Transport accidents

408

2314

1.52

14.27

1.2

1.3

2.61

0.67

nmol/l

0.47

394

2243

Personality disorders

252

1490

1.70

14.23

1.2

2.21

1.46

nmol/l

0.17

242

1439

Other disorders of skin and subcutaneous tissue

611

3874

1.41

14.21

1.3

2.02

1.39

nmol/l

0.18

582

3735

Pain and other conditions associated with female genital organs and menstrual cycle

186

922

1.87

14.17

1.2

1.3

0.51

2.26

nmol/l

0.74

180

888

Gonarthrosis,primary

783

3556

1.36

14.10

1.2

1.3

1.35

1.55

nmol/l

0.10

758

3416

Acute bronchitis

348

2195

1.56

13.89

1.2

1.3

0.59

1.89

nmol/l

1.12

330

2115

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

886

4560

1.33

13.88

1.3

1.60

1.24

nmol/l

0.14

831

4419

Stroke, excluding SAH

516

2608

1.45

13.82

1.4

1.3

2.26

1.80

nmol/l

0.10

494

2500

Unspecified kidney failure

369

2.44

13.71

1.4

1.3

0.72

0.65

nmol/l

0.70

351

Allergic asthma (mode), excluding more controls

199

1088

1.80

13.67

1.2

1.3

0.52

1.13

nmol/l

0.81

191

1050

Radiculopathy

144

726

2.00

13.65

1.4

1.3

6.33

4.22

nmol/l

0.14

139

699

Later onset COPD, excluding more controls

180

745

1.88

13.61

1.4

1.3

5.47

2.64

nmol/l

0.25

171

707

Phobic anxiety disorders

123

588

2.11

13.42

1.2

1.3

3.89

0.53

nmol/l

0.49

118

571

Stroke, including SAH

542

2763

1.43

13.39

1.4

1.3

2.18

1.73

nmol/l

0.10

519

2653

Presence of other functional implants

509

2451

1.45

13.34

1.3

2.64

1.36

nmol/l

0.27

494

2346

Bacterial infection, other or unspecified

454

2695

1.47

13.31

1.4

1.3

0.70

1.73

nmol/l

1.06

429

2594

Other noninflammatory disorders of uterus, except cervix

214

816

1.78

13.23

1.3

1.2

0.67

2.57

nmol/l

0.69

202

782

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

424

2497

1.48

13.12

1.2

1.3

0.55

1.21

nmol/l

0.76

408

2410

Cardiodefibrillation

295

1853

1.60

13.04

1.3

0.70

2.17

nmol/l

1.03

279

1769

Gastric ulcer

148

766

1.95

13.02

1.2

1.3

0.63

2.16

nmol/l

0.51

143

732

Extrapyramidal and movement disorders

331

2145

1.55

12.91

1.3

0.61

1.95

nmol/l

1.13

317

2053

Acetic acid derivatives and related substances

212

614

1.80

12.89

1.2

1.3

0.59

1.71

nmol/l

0.85

203

588

Disease of hard tissues of teeth, NOS

501

1808

1.46

12.89

1.2

1.3

0.59

1.46

nmol/l

0.75

492

1740

Ventral hernia

218

1275

1.72

12.88

1.4

1.3

0.63

2.67

nmol/l

0.98

209

1226

Benign neoplasm: Kidney

154

3.27

12.82

1.4

1.3

0.64

0.63

nmol/l

0.11

145

Asthma-related pneumonia

305

1939

1.58

12.82

1.3

3.49

1.98

nmol/l

0.21

278

1864

Asthma, hospital admissions 3, pneumonia

305

1942

1.58

12.73

1.3

3.49

1.98

nmol/l

0.21

278

1866

Asthma-related pneumonia or sepsis

305

1942

1.58

12.73

1.3

3.49

1.98

nmol/l

0.21

278

1866

Diseases of oral cavity, salivary glands and jaws

513

1832

1.45

12.70

1.3

0.62

1.46

nmol/l

0.72

489

1763

Other symptoms and signs involving the urinary system

420

2.29

12.69

1.3

0.60

0.61

nmol/l

0.17

398

Other retinal disorders

547

3039

1.41

12.62

1.3

2.55

1.17

nmol/l

0.33

528

2922

Meniscus derangement

476

2222

1.45

12.57

1.3

0.60

1.24

nmol/l

0.66

463

2137

Erysipelas

477

2951

1.44

12.52

1.2

1.3

0.60

1.63

nmol/l

1.22

456

2843

Allergic asthma (mode)

199

1118

1.75

12.51

1.2

1.3

0.52

2.05

nmol/l

0.88

191

1080

Injuries to the neck

203

1174

1.74

12.50

1.2

1.3

0.55

1.55

nmol/l

0.51

197

1131

Other diseases of liver

175

971

1.82

12.45

1.3

0.64

2.21

nmol/l

0.68

170

937

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

205

2.61

12.39

1.5

1.3

12.20

0.66

nmol/l

0.49

195

Thyroiditis, ILD-related definition

115

555

2.10

12.36

1.2

1.3

0.58

2.64

nmol/l

0.50

110

536

Benign neoplasm: Rectum, anus and anal canal

185

1046

1.79

12.36

1.5

1.3

0.68

3.14

nmol/l

0.96

177

1003

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

498

3428

1.42

12.35

1.2

1.3

0.56

1.41

nmol/l

1.15

482

3298

Restless leg syndrome

133

678

1.98

12.30

1.3

0.60

0.63

nmol/l

0.70

127

649

Certain disorders involving the immune mechanism

181

1019

1.79

12.27

1.2

1.3

0.56

2.14

nmol/l

0.73

175

985

Deforming dorsopathies

238

1445

1.66

12.23

1.2

0.65

2.57

nmol/l

1.07

229

1385

Gout

213

1100

1.71

12.19

1.2

1.3

0.64

1.93

nmol/l

0.64

192

1047

Other diseases of blood and blood-forming organs, wide

201

1169

1.73

12.16

1.4

1.3

0.66

1.94

nmol/l

0.66

193

1127

Chronic sinusitis

373

2510

1.49

12.14

1.2

1.3

2.84

1.73

nmol/l

0.20

360

2408

Artrosis, including avohilmo

716

2910

1.35

12.12

1.3

1.16

1.44

nmol/l

0.14

688

2807

Septicaemia

346

2143

1.52

12.11

1.4

1.3

0.69

2.03

nmol/l

1.10

329

2056

Special screening examination for other diseases and disorders

416

2.25

12.06

1.2

1.3

0.56

6.87

nmol/l

0.99

398

Irregular menses

427

2322

1.46

12.01

1.2

1.3

0.54

1.26

nmol/l

0.76

415

2239

Atherosclerosis, excluding cerebral and coronary sclerosis

320

1645

1.55

11.97

1.3

4.06

1.73

nmol/l

0.30

298

1571

Injuries to the abdomen, lower back, lumbar spine and pelvis

336

2198

1.52

11.94

1.2

1.3

0.61

1.90

nmol/l

1.10

323

2110

Artificial joint operation, meniscal resection

795

3922

1.32

11.88

1.2

1.3

0.82

1.55

nmol/l

0.82

765

3779

Nontoxic goitre/thyroid nodule

285

1824

1.57

11.83

1.3

0.63

1.51

nmol/l

0.73

273

1746

Non-ischemic cardiomyopathy

253

1256

1.63

11.83

1.3

0.71

2.04

nmol/l

0.75

241

1197

Injury, poisoning and certain other consequences of external causes

462

1597

1.46

11.82

1.2

1.3

0.59

0.73

nmol/l

0.73

446

1538

Thoracic aortic aneurysm

119

592

2.03

11.80

1.3

0.63

0.64

nmol/l

0.17

114

568

COPD, hospital admissions

365

2072

1.50

11.79

1.3

3.01

2.00

nmol/l

0.17

345

1977

Rosacea

114

559

2.06

11.77

1.2

1.3

0.62

0.61

nmol/l

0.06

105

539

Inflammatory disease of uterus

136

710

1.93

11.74

1.2

0.53

2.16

nmol/l

0.51

129

690

Allergic conjunctivitis

519

3640

1.40

11.74

1.2

1.3

0.56

1.36

nmol/l

1.16

502

3500

COPD, early/later onset

368

2088

1.49

11.73

1.3

2.99

1.99

nmol/l

0.17

348

1992

Other diseases of hard tissues of teeth

503

1829

1.43

11.72

1.3

0.64

1.46

nmol/l

0.69

485

1761

Malignant neoplasm of small intestine, including Hilmo

127

3.40

11.72

1.2

0.71

0.63

nmol/l

0.33

119

Mouth breathing

347

2319

1.50

11.70

1.2

1.3

0.56

1.82

nmol/l

1.15

337

2239

Other and unspecified disorders of vitreous body

382

2570

1.47

11.68

1.2

1.3

0.61

2.05

nmol/l

1.39

364

2464

Oxicams

179

560

1.83

11.67

1.3

0.64

1.83

nmol/l

0.82

172

537

Venous thromboembolism

456

3105

1.42

11.63

1.3

1.54

1.74

nmol/l

0.07

442

2972

Adhesive capsulitis of shoulder

155

849

1.84

11.54

1.3

0.66

1.99

nmol/l

0.49

147

815

Other specified/unspecified arthritis

236

1453

1.63

11.51

1.2

1.3

0.61

1.56

nmol/l

0.62

220

1392

Trochanteric bursitis

138

730

1.91

11.47

1.2

1.3

6.66

2.25

nmol/l

0.32

132

693

Other acute lower respiratory infections

435

2904

1.43

11.47

1.3

0.58

1.58

nmol/l

1.13

412

2798

Nontoxic multinodular goitre

189

1100

1.73

11.46

1.3

0.63

1.71

nmol/l

0.52

181

1049

Disorders of adult personality and behaviour

250

1564

1.61

11.43

1.2

2.21

1.41

nmol/l

0.18

241

1511

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

218

1315

1.66

11.33

1.3

0.58

2.35

nmol/l

0.88

209

1273

Viral infections characterized by skin and mucous membrane lesions

744

4851

1.32

11.30

1.3

1.70

1.22

nmol/l

0.17

716

4672

Other and unspecified nerve root and plexus disorders, also in other diseases

182

1052

1.74

11.30

1.2

1.3

0.56

2.29

nmol/l

0.85

175

1016

Specific personality disorders

209

1254

1.68

11.30

1.2

2.56

1.63

nmol/l

0.17

200

1210

Fenamates

127

434

2.00

11.28

1.4

1.2

0.66

2.15

nmol/l

0.77

120

412

Nonalcoholic fatty liver disease

104

502

2.10

11.24

1.3

0.61

0.62

nmol/l

0.06

485

Temporomandibular joint disorders, including avohilmo

388

2641

1.46

11.16

1.3

0.56

1.24

nmol/l

0.83

370

2547

Conjunctivitis (acute, non atopic)

246

1537

1.61

11.14

1.3

0.56

1.74

nmol/l

0.85

230

1485

Missing teeth due to accident, extraction or parodontitis

517

3537

1.38

11.09

1.3

1.42

1.60

nmol/l

0.07

496

3399

Pregnancy hypertension

368

2252

1.47

11.05

1.2

1.3

0.53

1.27

nmol/l

0.77

355

2175

Neuromuscular dysfunction of bladder

420

2.19

11.04

1.3

0.63

nmol/l

0.02

404

Other postsurgical states

278

2.48

10.91

1.7

1.3

0.53

0.64

nmol/l

2.26

264

Other and unspecified drugs and medicaments

403

2.21

10.89

1.2

1.3

0.53

0.63

nmol/l

2.71

385

Diseases of pulp and periapical tissues and dental caries

563

2095

1.38

10.88

1.3

0.63

1.56

nmol/l

0.93

538

2019

Dental operations

530

1958

1.40

10.88

1.3

0.63

1.40

nmol/l

0.70

506

1890

Chronic laryngitis and laryngotracheitis

129

680

1.92

10.86

1.2

1.3

0.61

2.33

nmol/l

0.51

129

651

Procreative management

299

1636

1.53

10.82

1.8

1.3

0.51

1.65

nmol/l

0.89

293

1583

Dental caries, including avohilmo

636

2412

1.35

10.81

1.3

0.63

1.43

nmol/l

0.92

610

2322

Benign neoplasm: Rectum

164

933

1.77

10.81

1.4

1.3

0.69

1.87

nmol/l

0.48

158

896

Other arthritis (FG)

268

1731

1.56

10.71

1.2

1.3

0.61

2.00

nmol/l

0.90

252

1661

Asthma and allergy, excluding more controls

110

544

2.01

10.68

1.2

1.3

0.50

0.54

nmol/l

0.79

105

532

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

446

2.13

10.65

1.2

1.3

0.52

0.62

nmol/l

2.78

426

Disorders of choroid and retina

684

3686

1.32

10.61

1.3

3.85

1.06

nmol/l

0.65

653

3548

Combinations of oral blood glucose lowering drugs

229

1430

1.61

10.60

1.3

0.68

2.17

nmol/l

0.77

218

1371

Type 1 diabetes

198

1190

1.67

10.60

1.4

1.2

5.75

1.53

nmol/l

0.37

192

1144

Caries of dentine, including avohilmo

677

2602

1.33

10.46

1.3

0.63

1.37

nmol/l

0.91

649

2511

Asthma and allergy

110

549

1.99

10.42

1.2

1.3

0.50

0.55

nmol/l

1.20

105

535

Ischaemic Stroke, excluding all haemorrhages

462

2464

1.40

10.41

1.3

2.45

1.88

nmol/l

0.12

441

2357

Dentofacial anomalies [including malocclusion]

612

3689

1.34

10.39

1.3

0.56

1.34

nmol/l

1.14

586

3561

Mycoses

730

4900

1.30

10.25

1.3

0.59

1.38

nmol/l

1.46

697

4728

Retention of urine

249

1303

1.58

10.24

1.3

0.64

1.58

nmol/l

0.61

239

1254

Menorrhagia

295

1068

1.54

10.21

1.3

0.59

2.07

nmol/l

0.71

278

1024

Peripheral artery disease

333

1799

1.48

10.20

1.3

3.88

1.63

nmol/l

0.31

314

1720

COPD-related respiratory insufficiency

467

2.08

10.18

1.4

1.3

0.74

0.65

nmol/l

1.25

447

Primary gonarthrosis, bilateral

429

2621

1.41

10.16

1.2

1.3

0.60

1.90

nmol/l

1.26

414

2504

Disorders of lens

572

2652

1.35

10.04

1.3

4.47

0.87

nmol/l

0.73

545

2560

Exposure to other specified factors

641

4482

1.32

10.01

1.3

0.56

1.26

nmol/l

1.29

618

4324

Pulmonary heart disease, diseases of pulmonary circulation

263

1720

1.54

9.97

1.4

1.3

2.27

1.92

nmol/l

0.07

252

1649

Dissociative [conversion] disorders

151

2.97

9.96

1.6

1.3

0.44

0.58

nmol/l

2.35

143

Superficial injury of lower leg

215

1346

1.61

9.89

1.2

1.3

0.60

0.90

nmol/l

0.49

206

1301

COPD, hospital admission 2, with asthma infections

241

1323

1.57

9.82

1.3

4.26

2.77

nmol/l

0.16

223

1261

Other bacterial intestinal infections

152

873

1.75

9.73

1.3

0.58

1.95

nmol/l

0.53

143

841

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

312

2118

1.47

9.66

1.3

0.51

1.39

nmol/l

0.88

304

2044

Symptoms and signs involving speech and voice

291

1961

1.49

9.60

1.3

0.61

1.95

nmol/l

1.00

274

1889

Leiomyoma of uterus

569

2405

1.35

9.60

1.3

1.2

0.59

1.62

nmol/l

1.04

542

2322

Benign neoplasm: Stomach

100

506

2.00

9.58

1.5

1.3

0.62

0.64

nmol/l

0.27

485

Localized swelling, mass and lump of skin and subcutaneous tissue

267

1771

1.52

9.51

1.4

1.2

0.65

2.08

nmol/l

0.95

261

1708

Other bacterial intestinal infections

191

1174

1.64

9.49

1.3

0.59

2.83

nmol/l

1.00

181

1130

Gout, strict definition

138

779

1.79

9.39

1.3

0.62

2.00

nmol/l

0.52

120

747

Heart failure and bmi 25plus

307

1402

1.49

9.38

1.3

0.69

1.64

nmol/l

0.80

291

1347

Special screening examination for infectious and parasitic diseases

172

750

1.70

9.36

1.3

0.50

4.29

nmol/l

1.12

165

724

Voice disturbances

236

1532

1.55

9.32

1.3

0.62

1.63

nmol/l

0.70

223

1479

Fissure and fistula of anal and rectal regions

189

1164

1.63

9.32

1.2

1.3

0.59

3.01

nmol/l

1.10

177

1127

Liquid cancers, helper endpoint

299

1773

1.48

9.26

1.4

1.2

0.65

2.09

nmol/l

0.96

289

1705

Cystic kidney disease

126

3.08

9.18

1.5

1.3

0.71

0.63

nmol/l

0.46

119

Hernia of abdominal wall

377

2690

1.41

9.17

1.3

0.63

1.74

nmol/l

1.18

364

2591

Benign neoplasm: Colon, unspecified

210

1334

1.59

9.13

1.3

0.64

2.60

nmol/l

0.99

197

1280

Other disorders of eyelid

366

2475

1.41

9.08

1.2

1.3

2.89

1.80

nmol/l

0.19

351

2373

Other abnormal uterine and vaginal bleeding

198

878

1.63

9.08

1.2

1.3

0.66

2.41

nmol/l

0.68

189

841

Cerebral aneurysm, nonruptured

434

2.05

9.08

1.5

1.2

0.65

3.28

nmol/l

0.49

415

Diseases of external ear

277

1871

1.49

9.06

1.3

0.58

2.00

nmol/l

1.02

265

1803

Pulmonary embolism

241

1582

1.53

9.04

1.4

1.3

2.37

2.03

nmol/l

0.06

234

1518

Triptan medication for migraine, min. 3 purchases

485

2742

1.35

9.01

1.3

2.86

0.80

nmol/l

0.42

472

2650

Pulmonary heart disease

241

1583

1.53

9.01

1.4

1.3

2.37

2.03

nmol/l

0.06

234

1517

Hyperfunction of pituitary gland

179

2.66

8.80

1.6

1.2

0.56

0.57

nmol/l

0.07

170

Metatarsalgia

460

2.00

8.77

1.2

1.3

0.59

3.12

nmol/l

0.51

441

Spondylolisthesis/Spondylolysis

154

916

1.69

8.74

1.2

1.3

0.65

3.46

nmol/l

0.97

149

881

Familial hypercholesterolemia

111

600

1.86

8.74

1.4

1.3

0.64

1.36

nmol/l

0.52

106

576

Diseases of the myoneural junction and muscle

108

580

1.88

8.70

1.5

1.3

0.66

0.64

nmol/l

0.29

102

550

Chronic periodontitis, complicated

459

3382

1.35

8.67

1.3

0.65

1.51

nmol/l

1.14

448

3252

Appendicitis, broad definition

622

4361

1.29

8.60

1.2

1.3

0.57

1.28

nmol/l

1.25

597

4209

Diseases of appendix

629

4402

1.29

8.59

1.2

1.3

0.57

1.28

nmol/l

1.25

604

4246

Appendectomy

554

4049

1.31

8.57

1.3

0.57

1.28

nmol/l

1.13

533

3898

Senile cataract

515

2366

1.34

8.55

1.3

2.68

0.81

nmol/l

0.44

489

2282

Gout, FINNGEN

213

1375

1.55

8.54

1.2

1.3

0.64

0.80

nmol/l

0.70

192

1323

Cellulitis

182

1137

1.61

8.53

1.2

1.3

0.57

1.51

nmol/l

0.52

174

1093

Necrosis of pulp, including avohilmo

481

3601

1.34

8.52

1.2

1.3

0.58

1.41

nmol/l

1.20

468

3466

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

151

797

1.69

8.50

1.2

1.3

0.48

0.47

nmol/l

0.09

145

773

Haemorrhage, not elsewhere classified

121

3.02

8.49

1.3

1.2

1.29

0.65

nmol/l

0.85

115

Glomerulonephritis

445

2.00

8.49

1.2

1.3

0.66

0.62

nmol/l

0.28

427

Gout, idiopatic and unspecified

183

1147

1.61

8.46

1.3

0.64

1.73

nmol/l

0.63

164

1099

Cystic kidney disease

138

2.88

8.43

1.5

1.3

0.71

0.63

nmol/l

0.46

130

Benign neoplasm: Caecum

524

1.91

8.37

1.3

0.65

0.66

nmol/l

0.16

501

Paracetamol or NSAID medication

113

300

1.90

8.31

1.3

1.2

0.55

2.69

nmol/l

0.79

105

291

Emotionally unstable personality disorder

102

546

1.88

8.31

1.1

1.3

0.53

nmol/l

0.05

529

Delirium, not induced by alcohol and other psychoactive substances

489

1.93

8.29

1.2

1.3

0.61

0.69

nmol/l

1.47

464

Internal derangement of knee

298

2068

1.44

8.29

1.3

0.60

1.28

nmol/l

0.64

287

1989

Malignant neoplasm of small intestine

3.35

8.28

1.2

0.63

0.64

nmol/l

0.06

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

191

2.55

8.26

1.4

1.3

0.73

0.65

nmol/l

0.41

181

Alcohol use disorder, Swedish definition

426

2889

1.36

8.25

1.2

1.3

0.64

1.62

nmol/l

1.12

405

2796

Acute appendicitis

583

4219

1.30

8.20

1.2

1.3

0.57

1.30

nmol/l

1.24

559

4077

Other diseases of lip and oral mucosa

344

2469

1.40

8.16

1.3

6.05

1.34

nmol/l

0.64

331

2365

Deviated nasal septum

258

1757

1.47

8.11

1.3

0.59

2.31

nmol/l

1.21

253

1696

Mental and behavioural disorders due to alcohol, excluding acute intoxication

344

2460

1.40

8.09

1.2

1.3

0.62

1.80

nmol/l

1.14

326

2380

Iron deficiency anaemia secondary to blood loss (chronic)

131

763

1.73

8.07

1.3

0.68

2.15

nmol/l

0.48

122

729

Gout, unspecified

151

914

1.66

8.06

1.3

0.62

1.98

nmol/l

0.62

135

878

Other viral diseases

300

2090

1.43

8.06

1.2

1.3

0.55

1.89

nmol/l

1.10

292

2021

Other female pelvic inflammatory diseases

156

953

1.65

8.06

1.3

1.2

0.61

2.24

nmol/l

0.70

150

922

Coxarthrosis

393

1889

1.38

8.04

1.3

0.66

1.37

nmol/l

0.61

378

1813

Bipolar affective disorders

156

953

1.65

8.03

1.2

1.3

3.30

1.74

nmol/l

0.22

149

926

Neuroendocrine tumor and carcinoma of small intestine

4.07

7.97

1.1

1.2

0.61

0.60

nmol/l

0.07

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

268

2.26

7.96

1.2

0.59

0.65

nmol/l

0.91

255

Dermatographic urticaria

301

2.19

7.95

1.2

1.3

0.52

0.58

nmol/l

0.91

290

Viral infections of the central nervous system

342

2.10

7.85

1.4

1.3

17.35

0.59

nmol/l

0.50

326

Early onset COPD

180

1146

1.58

7.83

1.2

1.3

0.60

2.88

nmol/l

0.99

169

1104

Atopic dermatitis

480

2980

1.32

7.82

1.3

0.55

1.51

nmol/l

1.13

460

2879

Presence of cardiac and vascular implants and grafts

335

1780

1.40

7.80

1.3

3.84

1.75

nmol/l

0.29

320

1698

Other diseases of pleura

339

2138

1.40

7.79

1.3

0.68

1.95

nmol/l

1.04

321

2046

Oter anti-inflammatory and antirheumatic agents, non-steroids

156

516

1.68

7.75

1.2

1.3

0.62

1.94

nmol/l

0.84

146

493

Sequelae of cerebrovascular disease

266

1582

1.46

7.75

1.3

3.82

2.43

nmol/l

0.17

250

1511

Bacterial intestinal infections, IBD co-morbidities

146

886

1.66

7.73

1.3

0.59

1.93

nmol/l

0.53

137

852

Diabetic nephropathy

150

906

1.65

7.71

1.3

0.73

2.65

nmol/l

0.88

143

875

Rash and other nonspecific skin eruption

469

1.92

7.66

1.3

0.60

0.62

nmol/l

0.24

451

Non-allergic asthma (mode), excluding more controls

144

867

1.65

7.56

1.3

1.2

0.56

1.09

nmol/l

0.56

136

832

KRA_PSY_EATING, excluding more controls

267

2.22

7.53

1.4

1.2

0.47

nmol/l

0.05

262

Aneurysms, operations, SAH

136

817

1.68

7.52

1.5

1.3

0.65

2.55

nmol/l

0.69

129

783

Other menopausal disorders

241

911

1.50

7.51

1.3

0.61

2.33

nmol/l

0.71

232

877

Gonarthrosis, primary, with knee surgery

459

2772

1.32

7.43

1.2

1.3

1.00

1.76

nmol/l

0.52

442

2650

Diabetic nephropathy, excluding more controls

147

739

1.65

7.41

1.3

1.4

0.74

1.70

nmol/l

0.82

140

717

Acute appendicitis, no complications

454

3438

1.32

7.40

1.2

1.3

0.56

1.40

nmol/l

1.14

441

3324

Sequelae of injuries, of poisoning and of other consequences of external causes

195

1282

1.53

7.38

1.3

0.54

2.77

nmol/l

1.13

188

1240

Chronic diseases of tonsils and adenoids

656

3285

1.27

7.31

1.3

0.58

1.45

nmol/l

1.11

635

3166

COPD, hospital admissions 3, with asthma pneumonia sepsis

188

1044

1.55

7.31

1.3

5.40

3.33

nmol/l

0.17

170

998

445

3051

1.32

7.31

1.2

1.3

0.62

1.57

nmol/l

1.14

425

2953

Vitamin D deficiency

3.46

7.31

1.2

0.66

0.53

nmol/l

1.09

Achilles tendinitis

471

1.89

7.24

1.2

1.3

0.56

3.92

nmol/l

0.72

455

DVT of lower extremities and pulmonary embolism

326

2360

1.38

7.21

1.3

1.91

1.74

nmol/l

0.04

317

2257

Disorders of sclera, cornea, iris and ciliary body

449

3426

1.32

7.20

1.3

4.92

1.14

nmol/l

0.65

438

3283

Mental and behavioural disorders due to alcohol

387

2776

1.34

7.19

1.2

1.3

0.62

1.66

nmol/l

1.14

369

2685

Viral pneumonia

107

612

1.76

7.09

1.3

0.61

0.62

nmol/l

0.08

101

594

Impingement syndrome of shoulder

193

1278

1.52

7.08

1.3

0.58

1.71

nmol/l

0.66

181

1221

Monoamine oxidase A inhibitors

106

606

1.76

7.05

1.4

1.3

0.64

2.49

nmol/l

0.49

101

586

Postmenopausal bleeding

230

826

1.49

7.02

1.2

1.3

0.63

2.55

nmol/l

0.71

225

791

Fracture of lower leg, including ankle

452

3429

1.31

7.01

1.2

1.3

0.61

1.39

nmol/l

1.23

443

3291

Disorders of continuity of bone

471

1.86

6.94

1.2

1.3

0.57

0.61

nmol/l

0.44

455

Female genital prolapse

244

944

1.47

6.93

1.3

0.61

2.28

nmol/l

0.71

239

906

Abnormal serum enzyme levels

208

1369

1.49

6.91

1.3

0.67

1.69

nmol/l

0.70

201

1310

Vasomotor and allergic rhinitis

297

2105

1.39

6.85

1.2

1.3

0.54

1.91

nmol/l

1.14

289

2033

Injuries to the thorax

348

2579

1.35

6.82

1.3

0.61

1.78

nmol/l

1.21

333

2479

Degeneration of macula and posterior pole

370

2194

1.35

6.81

1.3

0.68

1.32

nmol/l

0.84

353

2089

Contact with and exposure to communicable diseases

235

1624

1.45

6.81

1.3

0.53

1.23

nmol/l

0.50

225

1576

Coxarthrosis [arthrosis of hip](FG)

429

2293

1.32

6.79

1.3

0.67

1.69

nmol/l

0.88

412

2200

N06DA Anticholinesterases

1339

0.58

6.77

1.4

1.3

0.62

0.83

nmol/l

0.94

1265

Use of anticholinesterases

1339

0.58

6.77

1.4

1.3

0.62

0.83

nmol/l

0.94

1265

Later onset COPD

188

989

1.52

6.77

1.4

1.3

5.25

2.35

nmol/l

0.28

179

942

Non-allergic asthma (mode)

144

893

1.61

6.77

1.3

0.56

2.25

nmol/l

0.75

136

859

Early lumbar disc prolapse, operated

404

1.92

6.75

1.3

1.2

0.47

1.04

nmol/l

0.59

394

Polycystic kidney disease

2.99

6.74

1.4

1.3

0.74

0.61

nmol/l

0.65

Other medical care

357

2390

1.35

6.73

1.4

1.3

1.15

1.73

nmol/l

0.32

339

2291

Other and unspecified tonsillitis

252

1488

1.43

6.69

1.4

1.3

0.53

0.69

nmol/l

0.56

247

1438

Unspecific neurodegenerative disorder

146

1558

0.64

6.67

1.3

0.66

1.76

nmol/l

0.86

134

1481

Injuries to the shoulder and upper arm

688

4490

1.24

6.59

1.3

1.20

1.37

nmol/l

0.09

665

4324

Zoster [herpes zoster]

401

3005

1.32

6.57

1.3

2.71

1.56

nmol/l

0.22

382

2888

463

3158

1.29

6.57

1.2

1.3

0.63

1.53

nmol/l

1.12

442

3055

Otitis externa, unspecified

516

1.80

6.56

1.5

1.3

0.58

0.61

nmol/l

0.25

498

L04AA Selective immunosuppressants

188

1261

1.50

6.54

1.3

0.60

1.83

nmol/l

0.70

180

1220

Excessive attrition of teeth

451

3494

1.30

6.51

1.3

2.86

1.10

nmol/l

0.35

435

3365

Other skin changes

143

904

1.59

6.51

1.2

1.3

6.51

1.90

nmol/l

0.35

136

869

Superficial injury of head

186

1246

1.50

6.49

1.2

1.3

5.05

1.87

nmol/l

0.31

180

1199

COPD, hospital admissions 1, only main diagnosis

246

1483

1.43

6.48

1.2

1.3

0.66

2.55

nmol/l

1.08

229

1416

Dislocation, sprain and strain of joints and ligaments of knee

488

3516

1.28

6.47

1.2

1.3

0.53

1.06

nmol/l

0.98

478

3388

Mycoses

211

1452

1.46

6.45

1.3

0.60

2.39

nmol/l

0.99

204

1404

Autonomic disorders

3.08

6.39

1.5

1.3

0.50

0.61

nmol/l

1.00

Other disorders of the musculoskeletal system and connective tissue

124

762

1.64

6.36

1.2

1.3

0.58

2.14

nmol/l

0.52

114

732

308

2076

1.37

6.35

1.3

3.47

2.02

nmol/l

0.21

285

1982

Problems related to lifestyle

457

1.83

6.30

1.3

0.63

0.57

nmol/l

0.99

439

Otitis externa

177

1182

1.51

6.30

1.3

0.55

2.79

nmol/l

1.01

166

1140

Other blood glucose lowering drugs, excl. Insulins

123

758

1.63

6.24

1.3

0.81

3.58

nmol/l

0.74

117

718

Persistent mood disorders

157

1028

1.54

6.14

1.3

0.61

1.70

nmol/l

0.49

150

993

Diseases of male genital organs

348

1303

1.35

6.13

1.3

1.4

0.54

1.69

nmol/l

0.80

331

1264

Benign leiomyoma with endometriosis

150

974

1.55

6.12

1.3

0.57

2.24

nmol/l

0.74

145

939

Examination and encounter for administrative purposes

151

2.48

6.12

1.2

1.3

0.63

nmol/l

0.02

144

Noninflammatory disorders of female genital tract

322

1187

1.37

6.06

1.2

1.3

0.57

1.91

nmol/l

0.71

309

1137

Other diseases of the respiratory system

145

937

1.56

6.03

1.4

1.3

0.66

1.75

nmol/l

0.49

137

899

Other respiratory disorders and diseases

145

937

1.56

6.03

1.4

1.3

0.66

1.75

nmol/l

0.49

137

899

Fracture of rib(s), sternum and thoracic spine

222

1563

1.43

6.03

1.3

0.61

2.17

nmol/l

0.93

212

1499

Viral and other specified intestinal infections

200

1331

1.46

6.02

1.3

0.53

0.71

nmol/l

0.59

195

1284

206

1242

1.45

6.01

1.3

0.72

1.16

nmol/l

0.64

194

1183

Atopic dermatitis, strict definition with reimbursement

231

1581

1.42

6.00

1.2

1.3

0.53

1.65

nmol/l

0.83

224

1531

Calcific aortic valvular stenosis

196

1308

1.46

5.98

1.2

1.3

5.93

0.82

nmol/l

0.48

191

1236

Calcific aortic valvular stenosis, operated

196

1308

1.46

5.98

1.2

1.3

5.93

0.82

nmol/l

0.48

191

1236

Arthropathies in other diseases classified elsewhere

153

2.46

5.98

1.3

27.55

0.63

nmol/l

0.49

145

Alcohol use disorder, ICD-based

308

2292

1.35

5.97

1.2

1.3

0.61

1.89

nmol/l

1.16

294

2213

Superficial injury of abdomen, lower back and pelvis

117

721

1.63

5.95

1.3

0.56

0.59

nmol/l

0.47

111

687

Ulcer of lower limb, not elsewhere classified

109

660

1.66

5.95

1.2

1.3

0.78

0.65

nmol/l

0.39

100

630

Hyperplasia of prostate

227

899

1.44

5.91

1.4

1.3

0.61

2.23

nmol/l

0.76

212

867

Propionic acid derivatives

191

644

1.50

5.91

1.3

0.59

1.65

nmol/l

0.84

181

618

Misadventures to patients during surgical and medical care

114

700

1.64

5.90

1.5

1.3

0.59

2.26

nmol/l

0.51

109

673

Calcific aortic valvular stenosis, diagnosis (helper)

195

1308

1.45

5.80

1.2

1.3

5.96

0.82

nmol/l

0.48

190

1236

Operations 2 for CAVS

195

1308

1.45

5.80

1.2

1.3

5.96

0.82

nmol/l

0.48

190

1236

Unspecified fall

388

2952

1.30

5.79

1.2

1.3

5.66

1.19

nmol/l

0.65

373

2828

Any dementia

132

1415

0.65

5.79

1.3

0.68

1.85

nmol/l

0.84

120

1349

Gluteal tendinitis

162

2.38

5.75

1.2

1.3

0.54

0.61

nmol/l

0.89

156

Alzheimer disease

1107

0.59

5.74

1.3

0.69

0.71

nmol/l

0.16

1049

All influenza

186

1280

1.46

5.73

1.6

1.3

5.07

2.62

nmol/l

0.22

179

1241

Poisoning by drugs, medicaments and biological substances

186

1281

1.46

5.72

1.3

1.2

0.64

1.44

nmol/l

0.44

176

1243

Cauda equina syndrome

3.79

5.69

1.6

1.3

0.69

0.54

nmol/l

0.54

Calcific aortic valvular stenosis, including rheumatic fever

195

1313

1.44

5.67

1.2

1.3

5.96

0.82

nmol/l

0.48

190

1240

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

226

1617

1.40

5.63

1.4

1.3

2.38

2.07

nmol/l

0.06

220

1562

Other peripheral vertigo

453

1.78

5.60

1.3

0.62

0.65

nmol/l

0.41

434

Skin changes due to chronic exposure to nonionizing radiation

286

1959

1.35

5.59

1.3

3.70

2.10

nmol/l

0.21

264

1868

Alzheimer disease, including avohilmo

117

1294

0.63

5.59

1.4

1.3

0.68

0.83

nmol/l

0.57

107

1231

L04AD Calcineurin inhibitors

528

1.72

5.56

1.3

0.64

0.60

nmol/l

0.52

509

Other disorders of central nervous system

3.72

5.53

1.4

0.55

0.56

nmol/l

0.03

Dementia, including avohilmo

185

1819

0.70

5.50

1.3

0.64

2.05

nmol/l

1.15

170

1730

Actinic keratosis

275

1886

1.36

5.49

1.3

3.84

2.16

nmol/l

0.22

253

1796

Alzheimer’s disease, strict definition

922

0.54

5.44

1.4

1.3

0.69

0.72

nmol/l

0.18

876

Sub-endpoint used in defining T1D endpoints

210

1468

1.41

5.44

1.4

1.3

5.52

1.36

nmol/l

0.39

204

1411

Use of pramipexole

177

1222

1.46

5.41

1.2

1.3

0.61

1.92

nmol/l

0.72

169

1173

Disorders of breast

417

2980

1.27

5.34

1.3

1.2

2.58

1.13

nmol/l

0.33

405

2867

Dementia

169

1679

0.69

5.32

1.3

0.65

1.67

nmol/l

0.87

155

1596

Supplementary factors related to causes of morbidity and mortality classified elsewhere

239

1745

1.38

5.30

1.3

0.56

2.20

nmol/l

1.13

230

1680

Other orthopaedic follow-up care

254

2.03

5.30

1.3

0.60

0.66

nmol/l

0.50

245

Periapical abscess

355

2746

1.30

5.29

1.2

1.3

0.60

1.62

nmol/l

1.09

344

2643

In situ neoplasms

291

2191

1.33

5.28

1.3

0.64

1.83

nmol/l

0.99

273

2104

Postmenopausal atrophic vaginitis

217

848

1.42

5.25

1.2

1.3

0.64

2.49

nmol/l

0.71

211

814

Alzheimer’s disease (Late onset)

842

0.53

5.23

1.4

1.3

0.71

0.73

nmol/l

0.11

798

Nonhereditary hypogammaglobulinemia

3.58

5.23

1.2

1.3

0.48

0.50

nmol/l

0.16

Malignant neoplasm of bladder, including Hilmo

408

1.79

5.22

1.2

1.3

0.67

3.19

nmol/l

0.49

392

Hyperprolactinaemia

120

2.53

5.22

1.2

0.54

0.53

nmol/l

0.10

112

Family history of other specific disorders

3.55

5.21

3.4

1.3

0.44

0.45

nmol/l

0.06

Ganglion

160

1093

1.47

5.18

1.3

0.57

1.65

nmol/l

0.52

155

1055

Poisoning by medicine

167

1152

1.46

5.14

1.3

0.63

1.54

nmol/l

0.45

157

1120

Use of other anti-dementia drugs

1014

0.58

5.09

1.2

1.3

0.66

0.72

nmol/l

0.53

962

Use of memantine

1014

0.58

5.09

1.2

1.3

0.66

0.72

nmol/l

0.53

962

Viral infections characterized by skin and mucous membrane lesions

323

2482

1.30

5.05

1.3

3.13

1.74

nmol/l

0.22

314

2390

Malignant neoplasm of pancreas, including Hilmo

338

1.85

4.95

1.7

1.3

0.59

0.66

nmol/l

0.75

324

Conductive and sensorineural hearing loss

621

3461

1.21

4.94

1.3

0.62

1.73

nmol/l

1.46

597

3333

Other and unspecified diseases of blood and blood-forming organs

100

2.64

4.92

1.5

1.2

0.72

0.62

nmol/l

0.53

Respiratory insufficiency

295

1.91

4.92

1.6

1.3

0.76

0.65

nmol/l

1.30

285

Fracture of skull and facial bones

163

1130

1.45

4.91

1.3

0.57

2.52

nmol/l

0.82

154

1090

Tuberous sclerosis 1

12.59

4.91

2.1

1.6

0.57

0.50

nmol/l

—

Background retinopathy and retinal vascular changes

2.97

4.90

2.0

1.2

0.65

0.56

nmol/l

0.47

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

171

1182

1.44

4.89

1.7

1.3

1.70

2.85

nmol/l

0.31

164

1129

Any event in hilmo or specialist outpatient

+∞

4.87

2.0

0.0

0.40

—

nmol/l

—

Polyp of the female genital tract

239

1004

1.37

4.87

1.2

1.3

0.60

2.17

nmol/l

0.71

228

965

Fall on same level involving ice and snow

457

3685

1.24

4.86

1.3

3.32

1.31

nmol/l

0.47

439

3544

Any death

336

3080

0.78

4.80

1.3

1.21

1.82

nmol/l

0.36

314

2962

Pre-eclampsia or poor fetal growth

233

1722

1.35

4.73

1.2

1.3

0.53

1.45

nmol/l

0.73

225

1667

145

930

1.47

4.72

1.3

1.2

0.71

0.68

nmol/l

0.53

136

887

Excessive earwax

416

3251

1.25

4.70

1.3

0.63

1.55

nmol/l

1.18

404

3111

Leisure time condition

135

912

1.49

4.67

1.2

1.3

0.57

0.61

nmol/l

0.56

130

875

Other benign neoplasms of skin

285

2185

1.31

4.62

1.3

0.60

1.83

nmol/l

1.02

279

2099

Allergic rhinitis

230

1690

1.35

4.61

1.2

1.3

0.51

1.60

nmol/l

0.88

223

1637

Type of accident

219

1618

1.36

4.58

1.2

1.3

0.55

2.33

nmol/l

1.13

211

1558

Colonic or urogenital fistula

204

1493

1.37

4.54

1.2

1.3

0.58

2.49

nmol/l

1.12

192

1441

Injuries to the wrist and hand

807

4769

1.17

4.52

1.3

1.83

1.19

nmol/l

0.21

786

4587

Aortic valve malfunction, age under 60 years

454

1.69

4.49

1.3

0.67

0.61

nmol/l

0.34

438

Left ventricular outflow tract obstruction (LVOTO), broad definition

485

1.66

4.46

1.3

0.66

0.61

nmol/l

0.26

469

Other disorders of pigmentation

189

2.09

4.42

1.3

0.63

0.67

nmol/l

0.27

180

Anti-inflammatory and antirheumatic products, non-steroids

181

644

1.42

4.37

1.3

0.58

1.65

nmol/l

0.86

173

618

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

218

1623

1.35

4.36

1.3

1.2

0.58

1.39

nmol/l

0.59

209

1571

Other disorders of conjunctiva

107

700

1.54

4.35

1.2

1.3

0.62

2.28

nmol/l

0.51

102

673

Blepharochalasis

229

1720

1.34

4.33

1.2

1.3

0.62

2.19

nmol/l

1.03

219

1645

Medical abortion

525

2340

1.22

4.32

1.3

1.2

0.60

1.28

nmol/l

0.71

512

2236

Eating disorder

331

1.79

4.32

1.4

1.3

0.47

nmol/l

0.05

320

Haemorrhage in early pregnancy

222

1616

1.34

4.30

1.1

1.3

0.57

1.54

nmol/l

0.72

214

1562

Other obstetric conditions, not elsewhere classified

215

1008

1.36

4.29

1.3

1.2

0.48

0.50

nmol/l

0.37

209

976

Amiodarone users

415

1.70

4.26

1.4

1.3

0.71

0.67

nmol/l

0.27

395

Atopic dermatitis, strict definition

215

1572

1.34

4.22

1.2

0.52

1.66

nmol/l

0.84

208

1521

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

135

933

1.45

4.21

1.5

1.3

1.92

3.44

nmol/l

0.32

129

893

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

166

2.13

4.21

1.2

1.3

0.64

0.67

nmol/l

0.20

157

Sulfonylureas

221

1314

1.34

4.20

1.4

1.3

0.69

2.35

nmol/l

0.79

211

1247

Benign neoplasm of meninges

540

1.61

4.20

1.5

1.3

0.68

0.64

nmol/l

0.23

516

Complications of internal orthopaedic prosthetic devices, implants and grafts

165

1183

1.40

4.20

1.3

0.65

2.86

nmol/l

0.98

158

1133

Sensorineural hearing loss

579

3285

1.20

4.16

1.3

0.63

1.79

nmol/l

1.45

556

3161

Degenerative diseases of the nervous system

121

1295

0.68

4.13

1.3

0.69

0.83

nmol/l

0.51

111

1229

Scleritis

3.15

4.12

1.1

1.3

0.64

0.52

nmol/l

0.87

Arterial embolism and thrombosis

201

2.00

4.12

1.4

1.2

0.69

0.65

nmol/l

0.28

190

Striking against or struck by other objects

236

1794

1.32

4.09

1.2

1.3

0.51

1.90

nmol/l

0.96

223

1733

Myocardial infarction, unclassifiable

130

798

1.46

4.09

1.5

1.3

8.74

0.71

nmol/l

0.49

124

760

Glaucoma

418

2927

1.23

4.08

1.3

0.63

1.96

nmol/l

1.49

401

2804

Papulosquamous disorders

304

2393

1.27

4.07

1.2

1.3

3.41

1.79

nmol/l

0.24

287

2305

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

209

983

1.35

4.07

1.3

1.2

0.48

0.50

nmol/l

0.39

203

951

Other viral diseases

212

1585

1.34

4.07

1.2

1.3

0.55

1.41

nmol/l

0.62

205

1531

Pre-eclampsia or eclampsia

171

1241

1.38

4.06

1.1

1.3

0.54

1.82

nmol/l

0.73

165

1205

Colorectal neuroendocrine tumor and carcinoma

3.00

4.04

1.2

1.3

0.59

0.61

nmol/l

0.13

Fibroblastic disorders

154

1099

1.41

4.03

1.2

1.3

7.30

1.71

nmol/l

0.39

149

1051

Renal cell carcinoma of kidney

117

2.34

4.03

2.3

1.3

0.64

0.68

nmol/l

0.31

110

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

349

1885

1.26

4.03

1.3

1.2

0.70

2.02

nmol/l

0.91

331

1812

Disorders of ocular muscles, binocular movement, accommodation and refraction

353

2817

1.25

3.90

1.3

2.92

1.58

nmol/l

0.24

344

2712

Inflammatory bowel disease

234

1792

1.31

3.90

1.3

0.60

2.14

nmol/l

1.07

228

1731

Umbilical hernia

187

1388

1.35

3.87

1.2

1.3

0.62

2.44

nmol/l

0.98

177

1341

Viral haemorrhagic fevers, not elsewhere classified/unspecified

117

801

1.47

3.86

1.2

1.3

0.57

0.62

nmol/l

0.89

110

770

Polycythaemia vera

139

2.19

3.85

1.1

1.3

0.65

0.69

nmol/l

0.28

130

Sequelae of injuries of lower limb

444

1.63

3.82

1.3

0.56

0.60

nmol/l

0.54

428

Malignant neoplasm of colon, including Hilmo

126

878

1.44

3.78

1.3

1.2

0.61

3.62

nmol/l

1.00

118

841

Other and unspecified mononeuropathies of lower limb

108

2.35

3.78

1.1

1.3

0.59

0.60

nmol/l

0.07

102

Family history of malignant neoplasm

564

1.55

3.75

2.1

1.3

0.55

3.34

nmol/l

0.72

547

Unspecified privation

509

1.58

3.74

1.2

1.3

5.92

0.63

nmol/l

0.49

488

Other hearing loss

185

1350

1.35

3.71

1.3

0.61

2.75

nmol/l

1.12

176

1286

Unspecified mental disorder

302

2406

1.26

3.69

1.2

1.3

0.66

1.74

nmol/l

0.98

286

2316

Congenital iodine-deficiency syndrome/hypothyroidism

122

2.24

3.69

1.4

1.1

0.64

0.61

nmol/l

0.22

112

Benign neoplasm: Brain, supratentorial

2.91

3.65

2.1

1.3

0.71

0.50

nmol/l

0.67

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

121

844

1.44

3.65

1.3

0.61

1.91

nmol/l

0.48

112

818

Benign neoplasm: Cerebral meninges

497

1.58

3.64

1.4

1.3

0.60

0.65

nmol/l

0.85

476

Injuries to the elbow and forearm

551

4098

1.18

3.63

1.3

0.61

1.48

nmol/l

1.31

515

3956

Other and unspecified mononeuropathies, also in other diseases

104

2.34

3.61

1.4

1.3

0.70

0.63

nmol/l

0.28

Neurofibromatosis, type 2

10.80

3.57

2.5

1.2

0.58

0.42

nmol/l

—

Pericarditis

137

2.14

3.56

1.9

1.3

0.59

0.60

nmol/l

0.06

131

Speech disturbances, not elsewhere classified

391

1.65

3.55

1.3

0.58

0.65

nmol/l

0.98

368

Scar conditions and fibrosis of skin

185

1.97

3.54

1.2

1.3

0.60

0.61

nmol/l

0.02

177

Malignant neoplasm of skin

353

1962

1.24

3.52

1.3

1.2

0.69

1.96

nmol/l

0.92

332

1886

Follow-up examination after treatment for malignant neoplasms

384

1.65

3.52

1.8

1.3

0.64

4.77

nmol/l

0.70

365

Erosion of teeth , including avohilmo

179

1343

1.34

3.50

1.3

0.55

1.72

nmol/l

0.71

171

1301

Early lumbar disc prolapse operation

494

1.57

3.49

1.3

0.47

0.94

nmol/l

0.60

486

Dependent personality disorder

2.51

3.49

1.2

1.3

20.57

0.57

nmol/l

0.48

Infections with a predominantly sexual mode of transmission

282

2090

1.26

3.48

1.2

1.3

0.53

1.38

nmol/l

0.83

272

2019

Salpingitis and oophoritis

147

1071

1.38

3.48

1.2

0.55

2.07

nmol/l

0.75

140

1041

Malignant melanoma, including Hilmo

116

812

1.44

3.46

1.2

0.64

3.85

nmol/l

0.98

108

777

Other congenital malformations of skin

166

2.01

3.45

1.1

1.3

0.55

0.59

nmol/l

0.40

158

Ulcerative colitis

175

1312

1.34

3.44

1.3

0.59

1.60

nmol/l

0.60

169

1270

Keratitis

263

2084

1.27

3.41

1.3

3.71

1.41

nmol/l

0.33

256

2006

Loose body in joint

2.42

3.41

1.0

1.5

0.52

0.61

nmol/l

0.48

Malignant melanoma

659

1.48

3.39

1.2

1.3

0.66

3.97

nmol/l

0.80

632

Other cataract

321

1964

1.24

3.37

1.3

4.77

0.85

nmol/l

0.55

307

1892

Retinal vascular disorders

531

1.53

3.36

1.2

1.3

0.59

0.67

nmol/l

1.79

505

Benign neoplasm: Ascending colon

103

710

1.46

3.35

1.6

1.3

8.99

2.26

nmol/l

0.37

681

Retinal vascular occlusion

524

1.54

3.33

1.2

1.3

0.60

0.67

nmol/l

1.67

498

Prolonged pregnancy

652

0.57

3.32

1.3

0.45

0.50

nmol/l

1.57

631

Bronchiectasis

345

1.66

3.30

1.4

1.3

0.66

0.65

nmol/l

0.07

327

Other fall from one level to another

150

1106

1.36

3.30

1.2

1.3

6.07

1.71

nmol/l

0.36

145

1064

Infections with a predominantly sexual mode of transmission

219

1702

1.29

3.30

1.2

1.3

0.53

1.46

nmol/l

0.72

211

1645

Perforation of tympanic membrane

463

1.56

3.26

1.3

0.57

0.63

nmol/l

0.94

444

Diabetes mellitus in pregnancy

216

1068

1.30

3.24

1.2

1.3

0.48

1.59

nmol/l

0.53

211

1037

Benign neoplasm: Nasopharynx

3.63

3.23

1.1

1.4

0.43

0.50

nmol/l

0.33

Basal cell carcinoma, including avohilmo

320

1789

1.24

3.22

1.3

1.2

3.34

2.09

nmol/l

0.18

302

1716

Viral warts

449

1.57

3.21

1.2

1.3

0.61

0.60

nmol/l

0.07

433

Hallux rigidus

106

742

1.44

3.19

1.2

1.3

0.64

2.22

nmol/l

0.50

100

702

Follicular cysts of skin and subcutaneous tissue

134

977

1.38

3.19

1.2

1.3

0.56

1.78

nmol/l

0.53

124

944

Urethritis and urethral syndrome

2.34

3.19

1.6

1.2

0.52

0.60

nmol/l

0.58

Sequelae of injuries of head

207

1.85

3.17

1.2

1.3

0.55

0.62

nmol/l

0.79

197

Arterial embolism and thrombosis of lower extremity artery

104

2.23

3.16

1.4

1.2

0.67

0.62

nmol/l

0.31

Arthropod-borne viral fevers and viral haemorrhagic fevers

127

919

1.39

3.16

1.2

1.3

0.57

1.86

nmol/l

0.52

120

884

Graves disease, strict definition

515

1.52

3.16

1.2

1.3

0.59

0.61

nmol/l

0.14

495

Methotrexate

103

719

1.44

3.15

1.2

1.3

0.62

2.77

nmol/l

0.69

692

Other factor of the environment

2.85

3.11

1.6

1.1

0.51

nmol/l

0.02

Suicide or other Intentional self-harm

176

1343

1.31

3.10

1.3

1.2

0.61

1.57

nmol/l

0.58

167

1300

Other maltreatment syndromes

132

2.07

3.08

1.3

1.4

0.60

0.55

nmol/l

0.25

126

Psoriasis

208

1625

1.28

3.08

1.2

1.3

4.65

2.33

nmol/l

0.24

198

1572

Other misadventures during surgical and medical care

2.41

3.07

1.2

0.57

0.56

nmol/l

0.06

Malignant neoplasm of pancreas

261

1.74

3.07

1.8

1.3

0.60

0.66

nmol/l

0.51

249

Speech therapy

194

1504

1.29

3.05

1.3

4.92

2.36

nmol/l

0.25

185

1447

Diagnoses used for exclusion with ILD

174

1330

1.31

3.04

1.3

0.61

2.58

nmol/l

1.00

163

1284

Entropion and trichiasis of eyelid

330

1.65

3.04

1.2

1.3

0.69

nmol/l

0.01

313

Reimbursement for rheumatic diseases

439

3697

1.18

3.04

1.2

1.3

0.60

1.60

nmol/l

1.37

418

3557

Eating disorders

431

1.56

3.03

1.4

1.3

0.53

0.52

nmol/l

0.04

415

Any dementia, excluding more controls

130

1213

0.74

3.00

1.3

0.68

1.68

nmol/l

0.60

118

1159

L04AC Interleukin inhibitors

263

1.72

3.00

1.1

1.4

0.54

0.59

nmol/l

0.56

253

Diseases of spleen

2.44

2.99

1.4

1.3

0.59

0.57

nmol/l

0.09

Endometriosis of intestine

2.86

2.93

1.1

0.52

0.47

nmol/l

0.38

Malignant neoplasm of digestive organs

255

1618

1.25

2.90

1.4

1.2

0.68

2.25

nmol/l

0.94

240

1548

Bronchitis, not specified as acute or chronic

374

1.59

2.88

1.4

1.3

0.61

0.60

nmol/l

0.04

362

Idiopathic gout

382

1.58

2.88

1.2

1.3

0.61

0.65

nmol/l

0.34

363

Diseases of middle ear and mastoid

414

2860

1.19

2.86

1.4

1.3

2.56

1.55

nmol/l

0.20

398

2755

Intussusception

2.32

2.86

1.1

1.2

0.55

0.57

nmol/l

0.12

Polyglandular dysfunction, other/unspecified

9.40

2.84

2.8

1.2

0.60

0.45

nmol/l

—

Non-small cell lung cancer, including Hilmo

613

1.43

2.83

1.1

1.3

0.62

4.88

nmol/l

0.99

589

Biological medicines for asthma

2.43

2.82

1.2

0.48

0.50

nmol/l

0.16

Recurrent aphthous stomatitis , including avohilmo

101

720

1.41

2.80

1.3

0.59

0.62

nmol/l

0.33

690

Hypertrophy of breast in women and men

149

1131

1.32

2.78

1.2

1.3

0.61

1.96

nmol/l

0.68

143

1093

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

188

1454

1.28

2.77

1.4

1.2

0.54

1.33

nmol/l

0.50

182

1402

Paraplegia, diplegia of upper limbs

2.34

2.76

1.2

0.53

0.57

nmol/l

0.16

Pedal cyclist injured in other and unspecified transport accidents

548

1.47

2.76

1.2

1.3

10.61

0.60

nmol/l

0.50

524

Hypothyroidism due to medicaments and other exogenous substances

2.76

2.74

1.4

1.3

0.60

0.58

nmol/l

0.07

Superficial injury of forearm

443

1.52

2.74

1.3

0.62

0.58

nmol/l

0.32

429

Other facial nerve disorders

111

2.09

2.74

1.2

1.4

0.47

0.63

nmol/l

2.06

105

Other diseases of spinal cord

111

2.09

2.74

1.3

0.54

0.61

nmol/l

0.40

103

Monoplegia

2.47

2.73

1.3

1.4

0.53

0.60

nmol/l

0.46

Other disorders of thyroid

2.64

2.72

1.4

1.3

0.45

0.61

nmol/l

1.38

Hidradenitis suppurativa

139

1.96

2.71

1.3

0.60

0.54

nmol/l

0.49

132

Rheumatoid arthritis

224

1609

1.25

2.71

1.2

1.3

0.64

1.36

nmol/l

0.50

212

1537

Postprocedural musculoskeletal disorders, not elsewhere classified

334

1.60

2.69

1.2

1.3

0.63

0.66

nmol/l

0.22

318

Hallux valgus (acquired)

245

1422

1.24

2.68

1.2

1.3

2.37

1.45

nmol/l

0.20

233

1362

Ulcerative ileocolitis

168

1.86

2.68

1.2

1.4

0.55

0.61

nmol/l

0.48

160

Lung cancer and mesothelioma

119

751

1.36

2.66

1.2

1.3

0.65

2.59

nmol/l

0.71

112

717

Basal cell carcinoma

299

1706

1.22

2.66

1.3

1.2

3.56

2.17

nmol/l

0.19

280

1635

Suppurative and unspecified otitis media

244

1752

1.24

2.65

1.4

1.3

3.92

1.19

nmol/l

0.37

235

1693

Unspecified threat to breathing

2.99

2.64

1.2

1.4

0.45

0.52

nmol/l

0.31

Stomatitis and related lesions

140

1062

1.32

2.64

1.3

0.58

2.07

nmol/l

0.72

135

1022

Seborrhoeic dermatitis

448

1.50

2.62

1.4

1.3

0.67

0.63

nmol/l

0.39

430

Other inflammatory liver diseases

298

1.62

2.59

1.2

1.3

0.65

nmol/l

0.05

283

Injury of muscle and tendon at shoulder and upper arm level

249

2035

1.23

2.56

1.2

1.3

0.61

1.90

nmol/l

1.02

241

1953

Wet age-related macular degeneration

105

743

1.38

2.56

1.2

1.3

0.73

0.69

nmol/l

0.47

712

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.46

2.56

2.3

1.3

0.47

0.54

nmol/l

0.60

Vascular syndromes of brain in cerebrovascular disorders

171

1.83

2.55

1.2

1.3

0.64

0.66

nmol/l

0.14

159

5-aminosalicylic acid

145

1113

1.31

2.53

1.2

1.3

0.56

3.07

nmol/l

1.09

136

1077

Macular pucker

106

778

1.37

2.51

1.3

0.68

1.20

nmol/l

0.47

101

745

Preterm labour and delivery

198

1582

1.26

2.51

1.2

1.3

4.74

1.56

nmol/l

0.34

192

1530

Malignant neoplasm of prostate

147

671

1.31

2.48

1.4

1.3

0.65

2.15

nmol/l

0.48

140

650

Malignant melanoma of skin, including Hilmo

653

1.40

2.47

1.2

1.3

0.64

2.24

nmol/l

0.50

627

Medicines for HER+ breast cancer

205

2402

0.81

2.45

1.3

4.64

1.29

nmol/l

0.39

199

2306

malignant neoplasm of male genital organs

153

718

1.30

2.43

1.4

1.3

0.64

2.05

nmol/l

0.49

146

696

Congenital malformations of the nervous system

2.19

2.42

1.3

0.67

0.48

nmol/l

0.38

Open wound of head

371

3047

1.18

2.42

1.2

1.3

1.18

1.53

nmol/l

0.19

354

2935

6-mercaptopurine

117

1.98

2.41

1.4

1.3

0.55

0.57

nmol/l

0.08

112

Use of antiglaucoma preparations and miotics

328

1.56

2.40

1.3

0.57

0.68

nmol/l

1.51

308

Pregnancy with abortive outcome

519

2354

1.15

2.40

1.2

0.61

1.27

nmol/l

0.69

503

2250

Crohn disease (strict definition, require KELA, min 2 HDR)

281

1.61

2.40

1.4

0.65

0.59

nmol/l

0.58

270

Other and unspecified disorders of autonomic nervous system

4.27

2.39

1.6

1.4

0.37

0.42

nmol/l

—

Presbyopia

321

1.57

2.38

1.5

1.4

0.61

0.62

nmol/l

0.09

308

Dislocation, sprain and strain of joints and ligaments of thorax

125

1.94

2.36

1.3

0.67

0.57

nmol/l

0.49

119

Other other unspecified disorders of the circulatory system

154

1.83

2.35

1.3

1.2

0.53

0.62

nmol/l

1.17

145

Subacute thyroiditis

169

1.79

2.33

1.2

0.51

0.61

nmol/l

1.81

158

Acute suppurative otitis media

170

1256

1.27

2.33

1.4

1.3

0.52

nmol/l

0.06

165

1213

Viral warts

146

1138

1.29

2.30

1.2

1.3

0.57

1.58

nmol/l

0.51

140

1099

Fitting and adjustment of other devices

236

1751

1.22

2.30

1.2

1.3

0.65

2.16

nmol/l

1.00

231

1673

Crowding of teeth, including avohilmo

279

1.55

2.30

1.2

0.49

0.48

nmol/l

0.11

270

Other arterial embolism and thrombosis

2.14

2.29

1.2

0.67

0.58

nmol/l

0.49

Burn and corrosion confined to eye and adnexa

2.09

2.28

1.2

1.3

0.61

0.57

nmol/l

0.17

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

293

1.58

2.28

1.3

0.54

0.64

nmol/l

1.62

279

Bitten or struck by other mammals

529

1.42

2.28

1.4

1.3

0.60

0.59

nmol/l

0.11

511

Cerebral atherosclerosis

2.78

2.27

1.3

0.75

0.51

nmol/l

1.30

Benign neoplasm of other and unspecified sites

134

1.88

2.27

1.9

1.3

0.53

0.63

nmol/l

1.22

124

Pedal cyclist injured in transport accident

153

1202

1.28

2.27

1.2

1.3

6.04

1.71

nmol/l

0.36

147

1159

Fall on and from ladder

309

1.56

2.27

1.3

0.58

0.63

nmol/l

0.65

290

Otitis media, unspecified

448

1.44

2.27

1.3

12.79

0.55

nmol/l

0.49

431

Benign neoplasm of thyroid gland

156

1.81

2.27

1.6

1.3

0.62

nmol/l

0.00

148

Crohn disease (strict definition, require KELA)

286

1.58

2.25

1.4

0.65

0.59

nmol/l

0.61

275

Nontoxic diffuse goitre

142

1.85

2.24

1.3

1.2

0.52

0.62

nmol/l

1.76

131

Burns and corrosions confined to eye and internal organs

100

2.02

2.21

1.2

1.4

0.60

0.57

nmol/l

0.14

Retinal detachments and breaks

241

1997

1.21

2.21

1.3

5.39

0.94

nmol/l

0.45

228

1909

Ulcerative enterocolitis

114

1.95

2.21

1.4

1.2

0.65

0.54

nmol/l

0.65

107

Schizophrenia or delusion, excluding more controls

189

1512

1.24

2.21

1.3

0.66

2.15

nmol/l

0.83

176

1463

Tonsillectomy and adenotomy

403

2421

1.16

2.18

1.3

0.52

1.27

nmol/l

0.86

386

2345

Congenital malformations of genital organs

424

1.46

2.16

1.3

0.51

0.53

nmol/l

0.23

410

Glaucoma suspect

256

2141

1.20

2.14

1.2

1.3

0.63

1.88

nmol/l

1.03

250

2049

Malignant neoplasm of prostate, including Hilmo

149

693

1.28

2.14

1.4

1.3

0.63

2.10

nmol/l

0.49

142

671

Alcohol dependence

170

1364

1.25

2.14

1.2

1.3

0.61

2.36

nmol/l

0.90

160

1309

Other congenital malformations of skin

371

1.49

2.12

1.3

0.53

0.62

nmol/l

1.81

358

Other malignant neoplasms of skin (=non-melanoma skin cancer)

305

1770

1.18

2.12

1.3

1.2

3.47

2.11

nmol/l

0.19

288

1697

Tuberculosis of other organs

2.23

2.12

1.9

1.2

0.69

0.62

nmol/l

0.14

Use of cabergoline

2.48

2.12

1.1

1.3

0.57

0.49

nmol/l

0.75

Idiopathic thrombocytopenic purpura

109

1.94

2.11

1.6

1.3

0.55

0.60

nmol/l

0.45

102

Malignant melanoma of skin

488

1.42

2.09

1.2

1.3

0.66

2.77

nmol/l

0.49

468

Acute appendicitis, with complications

129

1005

1.29

2.08

1.1

1.3

0.61

1.95

nmol/l

0.61

118

971

Hypertrophy of breast

131

1025

1.28

2.05

1.2

0.60

2.09

nmol/l

0.68

126

992

Laparoscopic left hemicolectomy

2.25

2.02

1.2

1.4

0.75

0.58

nmol/l

0.88

Second line medication for Crohn's disease

429

3756

1.14

2.02

1.2

1.3

0.61

1.35

nmol/l

1.06

413

3614

Benign neoplasm: Short bones of lower limb

2.68

2.02

1.1

1.3

0.66

0.47

nmol/l

—

Benign neoplasm: Other parts of oropharynx

2.86

2.01

1.9

1.3

122.78

0.47

nmol/l

—

Melanocytic naevi

204

1683

1.22

2.00

1.4

1.3

0.61

1.52

nmol/l

0.68

199

1624

Phlebitis and thrombophlebitis (not including DVT)

159

1280

1.25

1.97

1.2

1.3

0.59

2.64

nmol/l

1.00

153

1238

Other respiratory diseases principally affecting the interstitium

107

820

1.31

1.97

1.4

1.3

8.70

1.93

nmol/l

0.39

785

Sequelae of injuries of upper limb

486

1.41

1.97

1.5

1.3

0.56

0.62

nmol/l

0.73

468

Benign neoplasm: Vulva

1.96

1.4

1.2

0.61

0.63

nmol/l

0.13

Somnolence

2.39

1.96

1.7

1.2

67.24

0.50

nmol/l

0.47

Orchitis and epididymitis

346

1.48

1.94

1.2

1.3

0.50

3.60

nmol/l

0.52

334

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.08

1.92

1.9

1.2

0.94

0.65

nmol/l

0.71

Disorder of thyroid, unspecified

2.27

1.92

1.4

1.3

0.46

0.63

nmol/l

1.42

Benign neoplasm: Liver/bile ducts

1.94

1.91

1.1

1.2

0.50

0.55

nmol/l

0.50

L04AX Other immunosuppressants

416

3653

1.14

1.90

1.2

1.3

0.61

1.37

nmol/l

1.07

400

3514

Cardiomyopathy, Hypertrophic obstructive

2.18

1.89

1.1

1.2

0.72

0.60

nmol/l

0.62

Superficial injury of neck

2.10

1.87

1.1

1.4

0.60

0.51

nmol/l

0.68

Symptoms and signs involving emotional state

107

1.88

1.87

1.2

1.4

0.53

0.58

nmol/l

0.26

100

Other and unspecified vasculitis limited to skin

1.95

1.86

1.4

1.2

0.53

0.60

nmol/l

0.64

Benign neoplasm of ovary

135

1077

1.26

1.84

1.3

0.62

2.08

nmol/l

0.71

128

1039

Crohn's disease of small intestine

310

1.49

1.83

1.3

0.65

0.59

nmol/l

0.43

299

Lesion of lateral popliteal nerve

191

1.63

1.81

1.4

0.57

0.65

nmol/l

0.72

181

Deficiency of other B group vitamins

2.02

1.81

1.1

1.2

0.56

0.57

nmol/l

0.03

Lifestyle-related condition

2.38

1.79

1.8

1.1

0.49

0.50

nmol/l

0.01

Other disorders of binocular vision

2.37

1.78

1.5

1.3

0.43

0.45

nmol/l

0.13

Vestibular neuronitis

429

1.41

1.76

1.2

1.3

0.57

0.64

nmol/l

1.04

411

Disorders of speech understanding and production

151

1.70

1.76

1.2

0.54

0.50

nmol/l

0.35

142

Benign neoplasm: Scapula and long bones of upper limb

2.53

1.75

1.1

1.3

0.49

0.47

nmol/l

—

Malignant neoplasm of oropharynx

2.25

1.75

2.3

1.2

0.53

0.65

nmol/l

0.88

Superficial injury of thorax

722

1.31

1.74

1.3

0.63

0.61

nmol/l

0.14

694

Nonsuppurative otitis media

142

992

1.24

1.73

1.4

1.3

0.56

0.53

nmol/l

0.38

136

952

Kela-code for severe mental illness

251

2143

1.17

1.73

1.2

1.3

0.69

1.88

nmol/l

0.95

237

2071

Tracheo-bronchomalasia

3.92

1.72

1.6

1.3

0.44

0.52

nmol/l

—

Retinal haemorrhage

1.93

1.70

1.1

1.3

0.55

0.65

nmol/l

0.98

Right bundle-branch block

133

1.74

1.70

1.3

0.64

0.65

nmol/l

0.02

127

Tuberculosis of other organs, strict

1.97

1.70

1.9

1.2

0.69

0.63

nmol/l

0.13

Golimumab

156

1.68

1.69

1.3

0.56

nmol/l

0.03

147

Injuries involving multiple body regions

156

1.68

1.69

1.0

1.3

0.60

nmol/l

0.04

148

Seborrhoeic keratosis

154

1261

1.22

1.68

1.3

6.29

2.71

nmol/l

0.27

143

1212

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

425

2982

1.13

1.68

1.3

0.61

1.46

nmol/l

0.95

410

2874

Other secondary gonarthrosis

243

1.53

1.68

1.1

1.4

0.58

0.69

nmol/l

1.55

232

Lymphoid leukaemia

211

1.57

1.68

1.6

1.3

0.63

0.65

nmol/l

0.07

199

Benign neoplasm of other and unspecified intrathoracic organs

2.54

1.67

2.0

1.4

0.63

0.53

nmol/l

—

Chronic lymphocytic leukaemia

1.87

1.66

1.5

1.2

0.69

0.66

nmol/l

0.11

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

1.87

1.66

1.5

1.2

0.69

0.66

nmol/l

0.11

Chronic lymphocytic leukaemia, helper endpoint

1.87

1.66

1.5

1.2

0.69

0.66

nmol/l

0.11

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

725

4231

1.10

1.66

1.3

0.64

1.51

nmol/l

1.35

693

4083

Malignant neoplasm of colon

658

1.31

1.65

1.3

0.60

3.98

nmol/l

0.82

631

Crohn disease (strict definition, all UC cases excluded)

212

1.57

1.65

1.5

1.4

0.66

0.59

nmol/l

0.58

201

Disorders of eyelid in diseases classified elsewhere

127

1.74

1.64

1.6

1.2

36.90

0.59

nmol/l

0.48

121

Fracture of forearm

411

3339

1.13

1.64

1.3

0.61

1.69

nmol/l

1.33

386

3226

Vasculitis limited to skin, not elsewhere classified

105

1.83

1.63

1.4

1.2

0.52

0.61

nmol/l

0.88

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

310

1.46

1.63

1.4

0.65

0.59

nmol/l

0.57

299

Purpura and other haemorrhagic conditions

644

1.31

1.61

1.4

1.3

0.61

0.62

nmol/l

0.05

616

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

303

1.46

1.61

1.3

0.53

0.57

nmol/l

0.28

291

Disorders of brain, other and unspecified

2.53

1.60

1.1

1.3

0.79

0.48

nmol/l

—

Female infertility

195

991

1.20

1.60

1.2

1.3

0.53

2.14

nmol/l

0.73

190

957

Congenital malformations of the circulatory system

667

1.30

1.60

1.5

1.3

0.56

0.59

nmol/l

0.30

641

Maltreatment syndromes

198

1.57

1.60

1.1

1.4

0.55

0.54

nmol/l

0.11

189

Foreign body in alimentary tract

206

1.56

1.59

1.4

1.3

0.57

0.63

nmol/l

0.44

195

Focal brain injury

206

1.56

1.59

1.1

1.3

0.65

nmol/l

0.03

197

Malignant neoplasm of renal pelvis

3.06

1.59

1.0

1.2

0.75

0.59

nmol/l

—

False labour

195

1021

1.19

1.56

1.2

1.3

0.48

1.67

nmol/l

0.54

190

982

Ectopic pregnancy

124

1003

1.24

1.55

1.3

1.2

0.59

2.14

nmol/l

0.70

117

967

Abnormal findings on diagnostic imaging of breast

2.00

1.55

1.3

1.2

0.66

0.62

nmol/l

0.19

Coxarthrosis, primary

417

3146

1.12

1.55

1.3

2.68

1.60

nmol/l

0.22

398

3019

Fracture at wrist and hand level

232

1986

1.17

1.54

1.3

5.06

1.47

nmol/l

0.37

224

1913

Premenstrual syndrome

2.45

1.54

1.3

1.2

0.46

0.50

nmol/l

—

Superficial injuries involving multiple body regions

100

1.81

1.53

1.1

1.3

0.58

0.54

nmol/l

0.22

Psoriasis vulgaris

121

979

1.24

1.51

1.3

7.58

2.83

nmol/l

0.30

115

944

Dermatophytosis

431

3856

1.12

1.51

1.4

1.3

0.59

1.38

nmol/l

1.20

409

3712

Other mental disorders due to brain damage and dysfunction and to physical disease

520

1.33

1.51

1.5

1.3

0.68

nmol/l

0.01

493

ILD, hospital admission 2, with pulmonary infections

383

1.39

1.50

1.5

1.4

17.66

0.66

nmol/l

0.49

367

Osteonecrosis due to drugs

2.10

1.50

1.2

1.3

0.53

0.59

nmol/l

0.35

Other specified disorders of external ear

131

1.69

1.50

1.3

0.61

0.65

nmol/l

0.23

123

Lichen planus

687

1.29

1.49

1.3

0.66

2.90

nmol/l

0.69

662

Malignant cancer of tonsil and base of tongue

1.96

1.49

2.1

1.3

0.54

0.65

nmol/l

0.76

Endometriosis of rectovaginal septum and vagina

393

1.38

1.48

1.1

1.2

0.56

4.58

nmol/l

0.71

378

Non-Hodgkin lymphoma, all

147

1.64

1.47

1.2

0.75

0.64

nmol/l

0.34

138

Erythema nodosum

132

1.68

1.46

1.5

1.3

0.55

0.61

nmol/l

0.45

126

Malignant neoplasm of brain, including Hilmo

203

1.54

1.46

1.4

1.3

0.65

0.66

nmol/l

0.03

193

Systemic sclerosis, icd10

117

1.73

1.46

1.3

1.2

0.80

0.61

nmol/l

0.99

112

Unspecified abortion

254

0.55

1.46

1.1

1.3

0.59

5.01

nmol/l

0.50

248

Benign neoplasm: Tonsil

2.14

1.45

1.5

1.3

0.60

0.55

nmol/l

0.14

Allergic purpura

117

1.72

1.45

1.2

1.3

0.49

0.56

nmol/l

0.66

108

Other specified/unspecified necrotizing vasculopathies

2.14

1.45

1.3

0.84

0.54

nmol/l

0.96

Malignant neoplasm of tonsil

2.14

1.45

2.4

1.3

0.50

0.65

nmol/l

1.08

Need for immunization against other single viral diseases

1.94

1.44

1.4

1.3

0.67

0.56

nmol/l

0.53

Wilms' tumor, including Hilmo

2.77

1.44

2.2

1.5

0.57

0.51

nmol/l

—

Exposure to other and unspecified animate mechanical forces

125

1.69

1.44

1.1

1.3

0.41

0.56

nmol/l

2.08

117

Other and unspecified aplastic anaemias

2.34

1.44

1.0

1.3

0.59

0.47

nmol/l

—

Separation of retinal layers (serosa)

172

1.58

1.43

1.3

1.4

0.64

0.65

nmol/l

0.06

165

Colorectal cancer

134

1080

1.22

1.42

1.3

1.2

0.61

3.06

nmol/l

1.00

126

1034

Benign neoplasm: Liver

1.83

1.42

1.1

1.2

0.50

0.54

nmol/l

0.33

Lichen planus, including avohilmo

133

1097

1.22

1.41

1.3

0.66

2.05

nmol/l

0.68

125

1056

Other disorders of veins

294

2573

1.14

1.40

1.3

0.61

1.63

nmol/l

1.00

283

2482

Asymmetry of jaw

2.10

1.39

1.7

1.2

0.46

0.48

nmol/l

0.11

LSIL lesion of the vulva

142

1.63

1.39

1.1

1.3

0.44

0.59

nmol/l

2.88

136

Disorder of the sleep-wake schedule

1.96

1.39

1.3

0.57

0.55

nmol/l

0.08

Bacterial, viral and other infectious agents

381

1.37

1.38

1.8

1.3

0.50

0.59

nmol/l

1.86

367

Adult respiratory distress syndrome

2.22

1.37

1.3

0.47

0.50

nmol/l

—

Malignant neoplasm, without specification of site, including Hilmo

166

1.57

1.37

1.5

1.3

0.65

0.68

nmol/l

0.19

158

Sulfasalazine

191

1634

1.17

1.36

1.2

1.3

0.66

2.32

nmol/l

1.03

181

1573

Manic episode

120

1.68

1.34

1.3

0.63

0.60

nmol/l

0.10

114

Diabetic retinopathy, excluding more controls

208

999

1.17

1.34

1.3

1.4

5.57

1.43

nmol/l

0.39

201

964

Perichondritis of external ear

1.93

1.34

1.2

1.3

0.53

0.58

nmol/l

0.24

Complications associated with artificial fertilization

2.14

1.34

2.3

1.1

0.49

0.48

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.79

1.33

1.1

1.3

0.55

0.59

nmol/l

0.22

Family history of other conditions

2.06

1.33

2.3

1.2

0.45

0.48

nmol/l

0.16

Lung diseases due to external agents

584

1.29

1.33

1.4

1.3

0.65

nmol/l

0.02

562

Female infertility, associated with anovulation

291

1.41

1.32

1.5

1.3

0.44

0.49

nmol/l

0.83

284

Female infertility, cervical, vaginal, other or unspecified origin

177

977

1.18

1.31

1.2

1.3

0.54

2.17

nmol/l

0.72

172

943

Additional codes for the location of defect, injury or illness

258

1.44

1.31

1.1

1.3

0.65

nmol/l

0.01

244

Right side

2.55

1.31

1.2

1.4

0.72

0.48

nmol/l

—

Benign neoplasm: Skin of lower limb, including hip

121

1.67

1.31

1.3

0.64

0.63

nmol/l

0.05

114

Presence of other devices

134

1111

1.20

1.31

1.2

1.3

0.64

2.24

nmol/l

0.81

129

1053

Other congenital malformations of intestine

2.12

1.31

2.7

1.2

0.54

0.49

nmol/l

—

Injury of urinary and pelvic organs

1.86

1.30

1.8

1.3

0.56

0.59

nmol/l

0.12

Specific development disorders of speech and language

209

1.48

1.30

1.3

1.2

0.52

0.48

nmol/l

0.42

195

Anomalies of pupillary function

1.77

1.29

1.3

1.4

0.60

0.54

nmol/l

0.26

Fall on and from stairs and steps

169

1439

1.18

1.29

1.3

0.61

2.41

nmol/l

0.98

160

1387

Other prurigo

2.03

1.28

1.0

1.3

0.45

0.60

nmol/l

1.60

Benign neoplasm: Connective and other soft tissue, unspecified

2.03

1.28

1.1

1.3

0.58

0.55

nmol/l

0.11

Malignant neoplasm of floor of mouth, including Hilmo

2.32

1.28

1.1

1.3

0.56

0.55

nmol/l

—

Astigmatism

251

1.44

1.27

1.1

1.3

0.54

0.60

nmol/l

0.80

241

Strabismus

168

1428

1.18

1.27

1.3

5.50

1.67

nmol/l

0.35

163

1378

Increased muscle tone

2.43

1.25

1.0

1.4

0.30

0.44

nmol/l

—

Infections specific to the perinatal period

2.42

1.24

1.2

0.42

nmol/l

—

Inguinal hernia

383

2303

1.11

1.24

1.4

1.3

0.60

1.89

nmol/l

1.18

367

2227

Nasal polyp

116

960

1.21

1.23

1.3

0.61

3.56

nmol/l

1.09

110

922

Maternal care for cervical incompetence

204

1.48

1.23

1.1

1.3

0.59

0.64

nmol/l

0.47

196

severe traumatic brain injury, does not include concussion

126

1051

1.20

1.22

1.1

1.3

0.62

1.64

nmol/l

0.52

121

1006

Postzoster neuralgia

2.06

1.22

1.1

1.3

0.55

0.61

nmol/l

—

Primary open-angle glaucoma

199

1667

1.16

1.22

1.3

0.65

2.27

nmol/l

1.01

186

1581

Labour and delivery complicated by umbilical cord complications

213

1.46

1.20

1.1

1.3

0.57

0.56

nmol/l

0.07

205

Other and unspecified iridocyclitis

197

1.48

1.19

1.1

1.4

0.61

0.63

nmol/l

0.09

187

Other protozoal intestinal diseases

1.76

1.19

1.2

1.3

0.55

0.52

nmol/l

0.21

Blindness, monocular

2.13

1.19

1.3

0.56

0.52

nmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.89

1.18

1.2

1.3

0.57

0.54

nmol/l

0.11

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

307

1.37

1.17

1.0

1.3

0.61

0.54

nmol/l

0.62

293

Malignant neoplasm of oesophagus, including Hilmo

129

0.46

1.16

1.2

0.65

0.63

nmol/l

—

122

Microscopic polyangiitis

0.00

1.16

0.0

1.2

—

0.48

—

Alopecia areata

110

1.65

1.16

1.2

1.3

0.58

0.57

nmol/l

0.04

104

Benign neoplasm: Lip

1.74

1.15

1.0

1.2

0.68

0.59

nmol/l

0.42

Certolizumab pegol

1.82

1.15

1.2

1.3

0.50

0.49

nmol/l

0.06

Malignant cancer of tonsil and base of tongue, including Hilmo

1.74

1.15

2.1

1.4

0.53

0.68

nmol/l

1.24

Malnutrition

1.82

1.15

1.8

1.3

0.62

0.57

nmol/l

0.22

Primary open-angle glaucoma, strict

164

1406

1.17

1.15

1.3

0.64

2.56

nmol/l

1.03

153

1340

Benign neoplasm: Skin of scalp and neck

1.70

1.14

1.2

1.3

0.56

0.55

nmol/l

0.01

Other degenerative diseases of the nervous system

153

975

1.17

1.13

1.3

0.68

0.67

nmol/l

0.03

142

929

Traumatic amputation of wrist and hand

159

1.52

1.12

1.4

0.50

0.65

nmol/l

1.92

151

Personal history of allergy to drugs, medicaments and biological substances

1.98

1.12

1.1

1.2

0.45

0.51

nmol/l

—

Dependence on enabling machines and devices, not elsewhere classified

2.01

1.12

1.1

1.3

0.51

0.52

nmol/l

—

Deep endometriosis

511

1.28

1.12

1.1

1.2

0.55

0.60

nmol/l

0.75

494

Sequelae of other accidents

1.98

1.11

1.2

0.46

0.53

nmol/l

—

Other protozoal intestinal diseases

1.80

1.11

1.2

1.3

0.58

0.52

nmol/l

0.31

Noise effects on inner ear

135

1.56

1.11

1.2

1.4

0.55

0.62

nmol/l

0.29

129

Open wound of shoulder and upper arm

1.79

1.11

1.8

1.3

0.60

0.56

nmol/l

0.16

Contraceptive management

232

1842

0.88

1.11

1.2

1.3

0.55

1.54

nmol/l

0.87

224

1784

Contusion of other and unspecified parts of foot

209

1.44

1.10

1.2

1.4

0.51

0.58

nmol/l

0.76

200

Moderate visual impairment, binocular

1.68

1.10

1.2

1.3

0.69

0.62

nmol/l

0.45

Congenital malformations of ovaries, fallopian tubes and broad ligaments

243

1.41

1.09

1.2

0.54

0.56

nmol/l

0.22

236

Psoriasis (vulgaris), strict definition

136

1.55

1.09

1.0

1.4

0.61

0.62

nmol/l

0.05

129

Malignant immunoproliferative diseases

2.21

1.08

1.1

1.4

0.56

0.48

nmol/l

—

Other maternal disorders predominantly related to pregnancy

419

2394

1.10

1.08

1.2

1.3

0.54

1.24

nmol/l

0.77

403

2313

Guillain-Barre syndrome

1.88

1.08

1.4

0.56

0.55

nmol/l

0.06

Fracture of shoulder and upper arm

237

2099

1.13

1.08

1.4

1.3

2.40

1.77

nmol/l

0.13

226

2009

Multiple delivery

466

0.73

1.06

1.2

1.3

0.64

1.48

nmol/l

0.46

449

Benign neoplasm: other/unspecified salivary gland

105

1.63

1.06

1.4

1.2

0.69

0.63

nmol/l

0.21

Embedded teeth, including avohilmo

374

1.31

1.06

1.3

0.48

0.52

nmol/l

0.29

360

Alcoholic liver disease

436

1.29

1.05

1.4

1.3

0.73

0.64

nmol/l

0.76

414

Other intracranial haemorrhages

1.64

1.03

1.5

1.2

0.74

0.64

nmol/l

0.63

Other and unspecified paralytic syndromes

1.85

1.03

1.5

1.3

0.42

0.54

nmol/l

0.89

Injury of nerves and spinal cord at neck level

1.74

1.03

1.2

1.3

0.58

0.62

nmol/l

0.18

Chondromalacia

114

1.59

1.03

1.1

1.3

0.74

0.59

nmol/l

0.26

106

Sequelae of tuberculosis

1.93

1.02

1.2

1.4

0.51

0.58

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.70

1.02

1.6

1.3

0.70

0.59

nmol/l

0.84

Uterine polyps

510

1.26

1.01

1.1

1.2

0.56

3.66

nmol/l

0.72

494

Retinoschisis and retinal cysts

1.66

1.01

1.2

0.63

nmol/l

0.00

Lesion of radial nerve

139

1.52

1.00

1.2

1.5

0.66

0.65

nmol/l

0.02

130

Benign neoplasm: Choroid

291

1.35

0.99

1.3

0.59

0.65

nmol/l

0.49

278

Malignant neoplasm of tonsil, including Hilmo

1.82

0.99

2.4

1.3

0.50

0.64

nmol/l

1.07

Bacterial, viral and other infectious agents

414

1.28

0.98

1.8

1.3

0.50

0.61

nmol/l

2.26

400

Lichen ruber planus, wide definition including periferal and oral lichen planus

152

1319

1.15

0.98

1.3

0.65

1.82

nmol/l

0.69

144

1270

Osteitis due to dental implant

1.97

0.98

1.0

1.4

0.50

0.51

nmol/l

—

Obstructed labour due to maternal pelvic abnormality

937

0.82

0.97

1.3

0.62

2.26

nmol/l

0.69

908

Special screening examination for neoplasms

215

1.40

0.97

1.5

1.2

0.69

6.02

nmol/l

0.49

203

therapeutic use

132

1.52

0.97

1.0

1.2

0.66

nmol/l

0.00

123

Open wound of wrist and hand

287

2533

1.11

0.97

1.3

0.53

1.35

nmol/l

1.02

282

2439

Burn and corrosion of trunk

108

1.58

0.97

1.1

1.3

0.56

0.59

nmol/l

0.08

100

Lesion of sciatic nerve

157

1.47

0.96

1.2

1.3

0.62

0.66

nmol/l

0.17

147

Spontaneous abortion

329

2014

1.10

0.96

1.2

3.09

1.37

nmol/l

0.30

321

1930

Organic, including symptomatic, mental disorders

275

2170

0.90

0.96

1.3

0.65

2.35

nmol/l

1.36

258

2066

Malignant neoplasm of bronchus and lung, including Hilmo

117

833

1.18

0.95

1.2

1.3

0.64

3.78

nmol/l

0.98

110

796

Malignant neoplasm of oropharynx, including Hilmo

1.70

0.95

2.2

1.3

0.54

0.63

nmol/l

0.73

LSIL lesion of the cervix uteri, vagina or vulva

750

1.20

0.95

1.2

0.48

2.08

nmol/l

0.54

728

Optic atrophy

1.79

0.94

1.5

1.3

0.45

0.58

nmol/l

1.01

Other melanin hyperpigmentation

1.62

0.94

1.5

1.2

0.69

0.64

nmol/l

0.25

Endometriosis of fallopian tube

2.25

0.94

1.2

0.48

0.59

nmol/l

—

Unspecified event, undetermined intent

101

1.59

0.94

1.4

1.3

0.48

0.58

nmol/l

0.62

Other interstitial pulmonary diseases

697

1.21

0.93

1.5

1.3

10.88

0.66

nmol/l

0.49

666

Chronic myeloproliferative disease

1.84

0.92

1.1

1.3

0.63

0.55

nmol/l

—

Hereditary retinal dystrophy

1.83

0.92

1.0

1.3

0.49

0.57

nmol/l

—

Disorder of external ear, unspecified

142

1.49

0.92

1.1

1.3

0.63

0.61

nmol/l

0.11

134

Nystagmus and other irregular eye movements

1.83

0.92

1.1

1.3

0.63

0.50

nmol/l

—

Convalescence

261

1.35

0.91

1.1

1.3

0.52

0.65

nmol/l

2.32

253

Other and unspecified injuries of wrist and hand

159

1.45

0.91

1.3

0.57

0.63

nmol/l

0.31

150

Interstitial lung disease endpoints

699

1.20

0.91

1.5

1.3

10.88

0.66

nmol/l

0.49

668

Interstitial lung disease

699

1.20

0.91

1.5

1.3

10.88

0.66

nmol/l

0.49

668

Type 1 diabetes, definitions combined

418

1.27

0.91

1.8

1.2

0.48

0.51

nmol/l

0.40

406

Optic atrophy

1.76

0.90

1.5

1.3

0.45

0.57

nmol/l

0.89

Reactive arthropathies, FINNGEN

314

1.31

0.90

1.2

1.3

0.60

0.59

nmol/l

0.05

301

Lower leg

2.10

0.90

1.0

1.4

0.66

0.48

nmol/l

—

Sequelae of poliomyelitis

2.09

0.90

1.0

1.4

1.08

0.54

nmol/l

—

Injury of muscle and tendon at lower leg level

737

1.20

0.89

1.2

1.3

0.61

2.30

nmol/l

0.62

708

Horner syndrome

1.92

0.89

1.6

1.3

0.63

0.48

nmol/l

—

Other and unspecified haemorrhagic conditions

1.80

0.88

1.2

1.3

0.88

0.52

nmol/l

—

Other specific arthropathies, wide

1.62

0.88

1.2

1.3

0.46

0.57

nmol/l

0.73

Premature separation of placenta [abruptio placentae]

1.62

0.88

1.1

1.2

0.47

0.51

nmol/l

0.36

Seropositive rheumatoid arthritis

160

1402

1.14

0.88

1.2

1.3

0.64

2.21

nmol/l

0.80

150

1342

ILD, hospital admissions

693

1.20

0.88

1.5

1.3

11.02

0.66

nmol/l

0.49

662

Use of galantamine

276

0.69

0.86

1.7

1.3

0.58

0.71

nmol/l

1.17

254

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.73

0.86

1.1

1.3

0.70

0.58

nmol/l

0.53

Embolic stroke

153

1.44

0.85

1.4

1.3

0.65

0.66

nmol/l

0.04

142

Embolic stroke with flimmer

1.67

0.85

1.2

1.3

0.75

0.60

nmol/l

0.76

Other secondary coxarthrosis

154

1.44

0.83

1.5

1.3

0.71

0.64

nmol/l

0.30

146

Type 1 diabetes, strict (exclude DM2)

417

1.25

0.80

1.8

1.2

0.48

0.51

nmol/l

0.32

405

Benign neoplasm of other and unspecified female genital organs

233

1.34

0.79

1.5

1.2

0.63

0.65

nmol/l

0.19

223

Benign neoplasm: Orbit, unspecified

0.00

0.79

0.0

1.4

—

0.45

—

Other noninflammatory disorders of cervix uteri

251

1.32

0.78

1.3

0.61

6.82

nmol/l

0.70

243

Colon adenocarcinoma

501

1.22

0.78

1.3

0.62

0.66

nmol/l

0.37

481

Keratoconus

0.51

0.78

1.0

1.4

0.52

0.62

nmol/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

278

1.30

0.77

1.1

1.3

0.62

nmol/l

0.05

265

Deep bite

448

1.22

0.76

1.3

0.58

0.56

nmol/l

0.11

430

Enteropathic arthropathies

1.52

0.76

1.3

1.4

0.51

0.64

nmol/l

0.75

Other deformities of toe(s)

166

1.39

0.76

1.1

1.3

0.65

0.64

nmol/l

0.09

158

Traumatic ischaemia of muscle

1.71

0.75

2.0

1.3

0.72

0.47

nmol/l

—

Abscess of lung

1.71

0.75

1.4

0.96

0.63

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

1.65

0.75

1.2

1.3

0.72

0.56

nmol/l

0.48

Other superficial mycoses

1.58

0.75

2.0

1.3

0.57

nmol/l

0.00

Impetigo

175

1.38

0.74

1.3

1.4

0.61

0.60

nmol/l

0.05

167

Habitual aborter

1.67

0.74

1.3

1.1

0.68

0.46

nmol/l

—

Gestational diabetes (for exclusion)

221

1393

1.10

0.74

1.2

1.3

0.46

1.35

nmol/l

0.56

213

1352

Polyarteritis nodosa and related conditions

1.65

0.74

1.7

1.3

0.51

nmol/l

—

Other osteochondropathies

298

1.28

0.73

1.1

1.4

0.61

0.60

nmol/l

0.07

285

Dysplasia of cervi uteri

145

929

1.13

0.73

1.2

1.3

0.50

2.26

nmol/l

0.75

139

893

Varicose veins

430

3029

1.07

0.73

1.2

1.3

0.69

1.82

nmol/l

1.22

406

2913

Status post-ami

129

864

1.14

0.73

1.2

1.3

9.23

0.87

nmol/l

0.49

119

821

Blepharospasm

1.81

0.73

1.0

1.3

0.49

0.59

nmol/l

—

Carcinoma in situ of rectum

1.81

0.73

1.3

0.59

0.50

nmol/l

—

Toxic liver disease

1.68

0.72

1.2

1.3

0.60

0.59

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.56

0.70

1.2

0.63

0.56

nmol/l

—

Other/unspecified reactive arthropathies

283

1.28

0.69

1.2

1.3

0.62

nmol/l

0.03

269

Malignant neoplasm of renal pelvis, including Hilmo

1.68

0.68

1.1

1.4

0.74

0.69

nmol/l

—

Type 1 diabetes, strict definition, subgroup 1

301

1.26

0.68

1.1

1.2

0.46

0.48

nmol/l

0.25

295

Alzheimer’s disease (Late onset), excluding more controls

399

0.82

0.68

1.4

1.3

0.73

0.72

nmol/l

0.11

379

Corneal scars and opacities

102

1.48

0.67

1.3

1.2

0.65

0.59

nmol/l

0.22

Contact with venomous snakes and lizards

1.64

0.67

1.0

1.4

0.41

0.48

nmol/l

—

Use of rotigotine

1.64

0.67

1.4

1.2

0.73

0.54

nmol/l

—

1.64

0.67

1.3

0.46

0.48

nmol/l

—

Hepatocellular carcinoma, including Hilmo

1.50

0.67

1.2

1.79

0.63

nmol/l

0.53

Left hemicolectomy

1.52

0.66

1.6

1.3

0.58

0.62

nmol/l

0.27

ILD, hospital admissions 3, with pneumonia sepsis

348

1.24

0.66

1.5

1.3

22.26

0.68

nmol/l

0.49

336

Generalized epilepsy

163

1.35

0.64

1.2

1.3

0.55

0.58

nmol/l

0.21

155

Other renal tubulo-interstitial diseases

1.48

0.64

1.1

1.3

0.66

0.55

nmol/l

0.61

Congenital malformations of spine and bony thorax

1.74

0.64

1.2

1.4

0.46

0.45

nmol/l

—

Melanoma in situ of upper limb, including shoulder

1.74

0.64

1.2

0.78

0.48

nmol/l

—

Crystalline deposits in vitreous body

1.74

0.64

1.0

1.4

0.54

0.55

nmol/l

—

Inguinal hernia, unilateral

112

1.44

0.63

1.3

0.63

0.66

nmol/l

0.16

104

Femoral hernia, unilateral

112

1.44

0.63

1.3

0.62

0.66

nmol/l

0.16

104

Inguinal of femoral hernia, unilateral

112

1.44

0.63

1.3

0.63

0.65

nmol/l

0.16

104

Malignant neoplasm, without specification of site

112

1.43

0.63

1.4

1.3

0.66

0.67

nmol/l

0.08

105

Other spirochaetal diseases

205

1874

1.10

0.63

1.3

0.57

2.01

nmol/l

1.04

192

1807

Pregnancy, childbirth and the puerperium

192

910

1.10

0.63

1.2

1.3

0.63

1.10

nmol/l

0.50

185

857

Other vitreous opacities

164

1.35

0.62

1.1

1.3

0.50

0.67

nmol/l

2.48

154

Bicuspidal aortic valve syndrome

147

1.37

0.62

1.1

1.4

0.53

0.62

nmol/l

0.72

140

Septal defects

256

1.26

0.61

2.2

1.3

0.60

0.59

nmol/l

0.03

244

Benign neoplasm of major salivary glands

480

1.19

0.61

1.2

1.3

0.67

0.65

nmol/l

0.19

458

Molar incisor enamel hypoplasia, with caries

0.00

0.60

0.0

1.2

—

0.47

—

Hypoplasia of dental enamel

0.00

0.60

0.0

1.2

—

0.49

—

Open wound of abdomen, lower back and pelvis

114

1.41

0.59

1.3

1.4

0.56

0.59

nmol/l

0.16

105

Contact with other hot metals

1.52

0.58

1.4

0.71

0.51

nmol/l

—

Car occupant injured in noncollision transport accident

140

1.36

0.58

1.2

1.3

0.51

0.57

nmol/l

0.59

132

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

228

1.27

0.58

1.2

1.4

1.15

0.66

nmol/l

0.45

219

Complications of labour and delivery

417

2462

0.94

0.58

1.2

1.3

2.54

1.23

nmol/l

0.29

409

2368

Other congenital malformations of intestine

1.73

0.58

2.2

1.3

0.48

nmol/l

—

Benign neoplasm: Bronchus and lung

1.49

0.57

1.0

1.3

0.56

0.53

nmol/l

—

Sixth [abducent] nerve palsy

132

1.37

0.57

1.1

1.3

0.69

0.63

nmol/l

0.32

123

Right hemicolectomy

247

1.26

0.56

1.3

0.68

nmol/l

0.01

231

Overjet

0.58

0.56

1.0

1.2

0.42

0.44

nmol/l

—

Chronic hepatitis NAS

1.46

0.56

1.0

1.3

0.63

0.57

nmol/l

—

Ventricular septal defect, a heart condition

1.51

0.55

1.1

1.2

0.51

0.49

nmol/l

0.09

Malignant neoplasm of larynx, including Hilmo

1.55

0.55

1.2

0.72

0.63

nmol/l

—

Femoral hernia

177

1.30

0.54

1.2

0.59

0.67

nmol/l

0.61

165

Congenital malformations of cardiac septa

267

1.24

0.54

2.1

1.3

0.59

0.58

nmol/l

0.01

255

Foreign body in respiratory tract

222

1.26

0.54

1.2

1.3

0.63

nmol/l

0.00

213

Hepatocellular carcinoma

1.48

0.54

1.3

1.2

2.42

0.61

nmol/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.47

0.53

1.1

0.51

0.44

nmol/l

—

Other injuries of spine and trunk, level unspecified

1.55

0.53

1.0

1.3

0.67

0.51

nmol/l

—

Severe visual impairment, monocular

1.55

0.53

1.2

1.3

0.73

0.55

nmol/l

—

Other degenerative diseases of the basal ganglia

1.46

0.53

1.0

1.3

0.58

0.57

nmol/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.46

0.53

1.7

1.2

2.43

0.63

nmol/l

—

Primary coxarthrosis, bilateral

177

1625

1.09

0.53

1.3

0.66

2.28

nmol/l

1.00

169

1553

Otosclerosis

377

1.20

0.53

1.5

1.3

0.78

0.65

nmol/l

0.62

360

Other spirochaetal diseases

199

1837

1.08

0.53

1.3

0.57

2.04

nmol/l

1.04

186

1772

Congenital malformations of the respiratory system

1.52

0.52

1.2

1.3

0.52

0.56

nmol/l

—

Dyshidrosis [pompholyx]

1.43

0.52

1.2

1.4

0.43

0.55

nmol/l

—

Open bite

205

1.27

0.52

1.9

1.3

0.52

0.51

nmol/l

0.09

197

Type 1 diabetes, strict definition

322

1.21

0.52

1.1

1.2

0.46

0.48

nmol/l

0.36

316

Rubella [German measles]

132

0.68

0.52

1.1

1.4

0.61

nmol/l

—

127

Benign neoplasm: Short bones of upper limb

1.41

0.51

1.0

1.3

0.53

0.55

nmol/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

1.41

0.51

1.2

1.5

0.49

0.64

nmol/l

—

Adhesive middle ear disease

1.41

0.51

1.3

0.70

0.53

nmol/l

—

Mental retardation

134

1.34

0.51

1.2

1.3

0.55

0.59

nmol/l

0.17

128

Melanocytic naevi of lower limb, including hip

197

1.27

0.51

1.4

1.3

0.63

0.61

nmol/l

0.10

186

Failed attempted abortion

1.47

0.50

1.0

1.1

0.65

0.44

nmol/l

—

Open wound of lower leg

744

1.13

0.50

1.3

14.52

0.62

nmol/l

0.49

711

Complications following abortion and ectopic and molar pregnancy

189

1.27

0.49

1.1

1.3

0.66

0.63

nmol/l

0.17

180

Other diseases of appendix

1.56

0.49

1.0

1.2

0.49

0.58

nmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

195

1623

0.93

0.49

1.3

1.2

4.86

1.59

nmol/l

0.35

189

1557

Disorders of globe

1.40

0.48

1.5

1.4

0.61

0.68

nmol/l

0.33

Other and unspecified mononeuropathies of upper limb

128

1.33

0.47

1.4

0.58

0.65

nmol/l

0.33

119

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.48

0.47

1.5

1.3

0.58

0.62

nmol/l

—

Thrombocytopenia, unspecified

309

1.20

0.46

1.6

1.3

0.65

0.64

nmol/l

0.04

293

ILD, hospital admissions 1, main diag only

626

1.14

0.46

1.5

1.3

12.76

0.66

nmol/l

0.49

596

Injuries to the hip and thigh

294

2508

1.06

0.46

1.3

3.48

1.83

nmol/l

0.24

283

2400

Other acute viral hepatitis

1.43

0.46

1.6

1.2

0.63

0.51

nmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.43

0.46

1.4

1.2

0.77

0.57

nmol/l

—

Other and unspecified acne

1.40

0.45

1.0

1.5

0.26

0.46

nmol/l

—

Obstructive hydrocephalus

1.40

0.45

1.4

1.3

0.54

0.48

nmol/l

—

Cirrhosis of liver, NAS

210

1.24

0.45

1.3

0.78

0.63

nmol/l

0.77

201

Maternal care for known or suspected fetal abnormality and damage

662

0.88

0.45

1.5

1.3

0.45

0.51

nmol/l

1.46

640

Mild mental retardation

1.40

0.44

1.2

1.3

0.62

0.56

nmol/l

0.20

Acute alcohol intoxication

138

1267

1.09

0.44

1.2

1.3

0.60

2.49

nmol/l

0.90

131

1218

Hereditary corneal dystrophies

152

0.72

0.44

1.1

1.2

0.55

0.64

nmol/l

0.88

143

Malignant neoplasm of breast, HER2-negative

292

1801

1.06

0.44

1.3

1.2

0.65

1.48

nmol/l

0.66

285

1729

Caries of enamel

652

4524

1.04

0.44

1.3

0.56

1.25

nmol/l

1.29

628

4360

Leukaemia of unspecified cell type

1.62

0.43

1.0

1.3

0.48

0.45

nmol/l

—

Chronic ulcer of skin, not elsewhere classified

303

1.19

0.43

1.4

1.3

0.66

0.67

nmol/l

0.04

287

Sequelae of infectious and parasitic diseases

331

1.18

0.42

1.1

1.3

0.67

0.61

nmol/l

0.55

318

Persons encountering health services in circumstances related to reproduction

400

2566

1.05

0.42

1.6

1.3

0.55

1.68

nmol/l

1.14

388

2484

Spirochaetal infections, other/unspecified

197

1841

1.07

0.42

1.3

0.57

2.04

nmol/l

1.04

184

1775

Other/unspecified cytomegaloviral diseases

1.43

0.42

1.5

1.2

0.44

0.58

nmol/l

—

Malignant neoplasm of breast, HER-positive

193

1611

0.93

0.42

1.3

1.2

4.90

1.60

nmol/l

0.35

187

1545

Abrasion of teeth

226

2123

1.07

0.41

1.2

1.3

0.59

1.93

nmol/l

1.11

216

2049

Other and unspecified types of non-Hodgkin lymphoma, hilmo

161

0.74

0.41

1.4

1.3

0.57

0.65

nmol/l

0.45

151

Generalized epilepsy, mode (most common among epilepsy diagnosis)

114

1.32

0.40

1.2

1.3

0.58

0.57

nmol/l

0.07

107

Shoulder region

1.34

0.40

1.0

1.3

0.49

0.52

nmol/l

—

L01XE Protein kinase inhibitors

238

0.80

0.40

1.3

1.2

0.65

0.66

nmol/l

0.05

223

Alzheimer’s disease (undefined)

0.00

0.40

0.0

1.2

—

0.58

—

Colorectal adenocarcinoma

899

1.10

0.39

1.3

1.2

0.62

3.55

nmol/l

0.99

860

Multiple myeloma

103

0.68

0.39

1.4

1.2

0.86

0.67

nmol/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

103

0.68

0.39

1.4

1.2

0.86

0.67

nmol/l

—

Multiple myeloma, including Hilmo

182

0.77

0.39

1.2

1.3

0.76

0.66

nmol/l

0.57

172

Early complications of trauma

169

1.25

0.38

1.6

1.4

0.62

nmol/l

0.02

159

!Aliquae complicationes praecoces traumatis

169

1.25

0.38

1.6

1.4

0.62

nmol/l

0.02

159

Memory loss

410

1.15

0.38

1.3

0.73

0.68

nmol/l

0.46

389

Malignant neoplasm of breast, HER2-negative, including Hilmo

300

1845

1.05

0.37

1.3

1.2

0.65

1.46

nmol/l

0.66

292

1772

Malignant neoplasm of breast, including Hilmo

300

1845

1.05

0.37

1.3

1.2

0.65

1.46

nmol/l

0.66

292

1772

Iridocyclitis in diseases classified elsewhere

1.31

0.37

1.4

1.3

0.56

0.59

nmol/l

—

Hodgkin lymphoma, hilmo

115

0.69

0.37

1.3

0.56

0.59

nmol/l

—

107

Other diseases caused by chlamydiae

1.29

0.36

1.1

1.3

0.51

nmol/l

—

Toxic effect of carbon monoxide

1.29

0.36

1.4

1.2

0.53

0.54

nmol/l

—

Benign neoplasm: Skin of trunk

180

1.23

0.36

1.4

1.3

0.69

0.62

nmol/l

0.49

169

LSIL lesion of the cervix uteri

564

1.12

0.35

1.2

1.3

0.48

0.54

nmol/l

1.55

548

Chronic suppurative otitis media, including avohilmo

338

1.16

0.35

1.2

1.3

0.59

0.63

nmol/l

0.42

322

Contusion of toe(s) with damage to nail

1.37

0.34

1.2

1.3

0.67

0.49

nmol/l

—

Other injuries of upper limb, level unspecified

1.37

0.34

1.2

1.4

0.77

0.48

nmol/l

—

Mesothelioma, including Hilmo

1.37

0.34

1.0

1.2

0.57

0.58

nmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.37

0.34

2.3

1.2

0.73

0.59

nmol/l

—

Malignant neoplasm of breast

292

1814

1.05

0.34

1.3

1.2

0.65

1.48

nmol/l

0.66

285

1742

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.34

0.34

2.5

1.3

0.48

0.54

nmol/l

—

Stenosis and insufficiency of lacrimal passages

462

1.13

0.34

1.3

0.60

0.65

nmol/l

0.66

443

Other autoimmune haemolytic anaemias

1.34

0.34

1.3

0.47

0.59

nmol/l

—

Coxarthrosis, primary, with hip surgery

298

2662

1.05

0.33

1.3

3.47

1.71

nmol/l

0.27

284

2545

Oesophageal obstruction

109

1.29

0.33

1.5

1.2

0.69

0.66

nmol/l

0.13

102

Acute alcohol intoxication, ICD10

109

1008

1.08

0.33

1.2

1.3

0.59

2.95

nmol/l

0.90

104

970

Type1 diabetes, definitions combined, early onset

264

1.17

0.33

1.6

1.3

0.42

0.50

nmol/l

1.27

256

Malignant neoplasm of other and unspecified female genital organs

0.67

0.33

1.0

1.2

0.63

0.68

nmol/l

—

Congenital malformations of aortic and mitral valves

164

1.22

0.32

1.1

1.4

0.53

0.60

nmol/l

0.61

157

Congenital malformations of the respiratory system

1.36

0.32

1.2

1.3

0.52

0.56

nmol/l

—

Prolapse and hernia of ovary and fallopian tube

163

0.79

0.31

1.2

0.75

0.72

nmol/l

0.12

149

All dysplastic lesions of the cervix uteri, vagina or vulva

178

1655

1.06

0.31

1.2

1.3

0.50

1.50

nmol/l

0.77

172

1601

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.35

0.31

1.3

1.2

0.70

0.54

nmol/l

—

Late syphilis

1.33

0.31

1.3

1.2

0.34

0.52

nmol/l

—

Delivery

282

1421

1.05

0.30

1.2

1.3

0.61

1.52

nmol/l

0.77

274

1354

Delivery, wide proxy

223

1124

1.05

0.30

1.2

1.3

0.63

1.00

nmol/l

0.49

216

1064

Amputation of foot

1.31

0.30

1.4

1.2

91.45

0.56

nmol/l

0.47

Myelodysplastic syndrome, including Hilmo

1.29

0.30

1.3

1.2

0.76

0.67

nmol/l

0.53

Cholesteatoma of middle ear

203

1.18

0.30

1.3

0.71

0.65

nmol/l

0.45

192

Lyme disease

192

1822

1.05

0.29

1.3

0.57

2.05

nmol/l

1.04

179

1757

Benign neoplasm: Skin of lip

1.23

0.29

1.7

1.3

0.57

nmol/l

—

Rheumatoid arthritis, including avohilmo

250

2390

1.05

0.29

1.2

1.3

0.63

1.72

nmol/l

0.98

235

2295

Carcinoma in situ of cervix uteri

430

1.12

0.29

1.2

0.49

0.53

nmol/l

0.68

417

Abnormal findings in secretions and smears from cervix uteri vagina vulva

336

2441

1.04

0.29

1.2

1.3

0.59

1.22

nmol/l

0.68

323

2356

Follow-up care involving plastic surgery

195

0.82

0.29

1.2

1.3

0.64

0.63

nmol/l

0.05

188

Fracture of femur

142

1212

1.06

0.28

1.3

6.60

1.97

nmol/l

0.36

137

1155

Portal vein thrombosis

1.29

0.28

1.1

1.3

0.84

0.58

nmol/l

—

Carcinoma in situ of skin of scalp and neck

1.30

0.28

1.5

1.2

0.85

0.59

nmol/l

1.34

Amputation of thigh

1.32

0.28

1.1

1.2

0.72

0.59

nmol/l

—

Mental retardation, wide definition

148

1.21

0.28

1.2

1.3

0.55

0.60

nmol/l

0.22

141

Malignant neoplasm of ovary

269

0.85

0.27

1.1

1.2

0.66

0.65

nmol/l

0.07

259

Spinal enthesopathy

1.23

0.27

1.3

1.2

0.71

0.60

nmol/l

—

Drug-induced osteoporosis with pathological fracture

1.22

0.27

1.0

1.2

0.70

0.62

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

433

1.11

0.26

1.1

1.3

0.67

0.64

nmol/l

0.25

413

Rare circulating lymphoid malignancy, including Hilmo

104

1.25

0.26

1.6

1.2

0.49

0.63

nmol/l

1.66

Other meningitis

1.20

0.26

1.4

1.2

0.55

0.51

nmol/l

—

Carcinoma in situ of breast, other/unspecified

0.66

0.26

1.4

1.2

0.46

0.68

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

169

1.19

0.26

1.3

1.39

0.67

nmol/l

0.45

161

Beningn neoplasm: Meninges, unspecified

1.22

0.25

1.1

1.2

0.53

0.62

nmol/l

—

Contact with sharp object, undetermined intent

1.25

0.24

1.2

1.4

0.53

0.59

nmol/l

0.38

Aggressive periodontitis

0.70

0.24

1.5

1.2

0.78

0.62

nmol/l

—

Peripheral retinal degeneration

124

1.21

0.24

1.3

1.4

0.49

0.63

nmol/l

1.08

117

Malignant neoplasm of eye, brain and central nervous system

180

1.17

0.23

1.4

1.3

0.69

0.65

nmol/l

0.07

170

Systemic atrophies primarily affecting the central nervous system

158

0.82

0.23

1.1

1.3

0.73

0.64

nmol/l

0.55

148

Thyrotoxicosis with toxic single thyroid nodule

1.32

0.23

1.0

1.3

0.76

0.60

nmol/l

—

Other congenital malformations of the digestive system

170

1.17

0.23

1.5

1.2

0.46

0.56

nmol/l

2.21

162

Left ventricular outflow tract obstruction, narrow definition

190

1.16

0.23

1.0

1.4

0.51

0.61

nmol/l

0.92

181

Viral pneumonia (known virus, not influenza)

1.24

0.23

1.4

1.2

0.54

0.59

nmol/l

0.17

Malignant neoplasm of ureter, including Hilmo

1.25

0.22

1.0

1.2

0.80

0.54

nmol/l

—

Other papulosquamous disorders

1.25

0.22

1.2

1.4

0.56

0.53

nmol/l

—

Multiple myeloma and malignant plasma cell neoplasms

189

0.85

0.22

1.3

1.2

0.72

0.66

nmol/l

0.31

177

Congenital malformations of gallbladder, bile ducts and liver

1.22

0.22

1.6

1.4

0.48

0.55

nmol/l

—

Atypical virus infections of central nervous system

1.22

0.22

1.0

1.3

0.50

0.53

nmol/l

—

Malignant neoplasm of base of tongue, including Hilmo

1.19

0.21

1.2

1.3

0.56

0.60

nmol/l

—

Pedestrian injured in other and unspecified transport accidents

1.19

0.21

1.6

1.4

1.14

0.51

nmol/l

—

Acanthosis nigricans

0.00

0.21

0.0

1.3

—

0.48

—

Myeloid leukaemia

1.23

0.21

1.4

1.2

0.48

0.61

nmol/l

1.19

Post-traumatic wound infection, not elsewhere classified

1.23

0.21

1.2

1.3

0.54

0.59

nmol/l

0.28

Malignant neoplasm of liver and intrahepatic bile ducts

1.23

0.21

1.3

1.94

0.63

nmol/l

0.50

Non-follicular lymphoma

429

0.91

0.21

1.3

0.69

0.66

nmol/l

0.11

406

Serous carcinoma of ovary, including Hilmo

198

0.86

0.20

1.1

1.2

0.66

0.65

nmol/l

0.10

190

Malignant neoplasm of brain

145

1.17

0.20

1.4

1.3

0.72

0.62

nmol/l

0.17

135

Atypical mycobacterium lung infection

1.23

0.20

1.5

1.3

0.50

0.60

nmol/l

—

Anisometropia and aniseikonia

127

1.18

0.19

1.5

1.3

54.05

0.56

nmol/l

0.48

121

Schizophrenia

829

0.94

0.19

1.3

0.78

1.96

nmol/l

0.40

799

Schizophrenia or delusion

189

1820

1.04

0.19

1.3

0.66

2.11

nmol/l

1.00

176

1760

Carcinoma in situ of skin of trunk

118

1.19

0.19

2.2

1.2

0.87

0.63

nmol/l

1.33

108

Non-allergic asthma

395

1.09

0.18

1.4

1.3

0.66

0.63

nmol/l

0.15

381

Glucosamine medication

313

2428

1.03

0.18

1.2

1.3

0.67

2.15

nmol/l

1.32

295

2328

Secondary parkinsonism

100

1.20

0.18

1.3

0.74

0.62

nmol/l

0.48

Secondary parkinsonism+Parkinsonism in other disease

100

1.20

0.18

1.3

0.74

0.62

nmol/l

0.49

Varicella [chickenpox]

204

1.13

0.18

1.3

0.51

0.61

nmol/l

0.68

193

Third [oculomotor] nerve palsy

1.13

0.17

1.9

1.3

0.79

0.56

nmol/l

—

Oral lichen planus

131

0.84

0.17

1.1

1.3

0.56

0.62

nmol/l

0.58

123

Anorexia

1.11

0.17

1.1

1.3

0.64

0.50

nmol/l

—

Certain zoonotic bacterial diseases

0.76

0.17

1.2

1.3

0.54

0.55

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs

0.73

0.17

1.2

1.3

0.56

0.60

nmol/l

—

Diffuse large B-cell lymphoma, helper endpoint

194

0.88

0.16

1.4

1.2

0.75

0.64

nmol/l

0.22

183

Diffuse large B-cell lymphoma, including Hilmo

194

0.88

0.16

1.4

1.2

0.75

0.64

nmol/l

0.22

183

Diffuse large B-cell lymphoma

194

0.88

0.16

1.4

1.2

0.75

0.64

nmol/l

0.22

183

Other and unspecified injuries of thorax

1.18

0.16

1.0

1.3

0.59

0.60

nmol/l

—

Other specified/unspecified disorders of bone/cartilage

101

1.19

0.16

1.4

1.3

0.88

0.60

nmol/l

0.74

Schizophrenia, schizotypal and delusional disorders

189

1829

1.03

0.16

1.3

0.65

2.10

nmol/l

1.01

176

1767

Fall involving bed

111

1.17

0.15

1.1

1.2

0.79

0.62

nmol/l

0.48

103

Other and unspecified nonorganic psychotic disorders

106

1014

1.05

0.15

1.2

1.3

0.66

0.55

nmol/l

2.17

982

Burn and corrosion of head and neck

0.76

0.15

1.2

1.4

0.50

0.56

nmol/l

—

Occupational exposure to risk-factors

119

0.84

0.15

2.1

1.4

0.64

0.59

nmol/l

—

114

Coronary artery bypass grafting

115

821

1.04

0.15

1.3

0.70

0.88

nmol/l

0.39

110

780

Disorders of oesophagus in diseases classified elsewhere

1.14

0.15

1.7

1.2

0.86

0.64

nmol/l

—

Alzheimer disease, excluding more controls

501

0.95

0.15

1.4

1.3

0.69

0.70

nmol/l

0.11

476

Diabetic retinopathy, strict definition

118

1000

1.04

0.15

1.3

1.4

9.49

1.26

nmol/l

0.45

113

966

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

102

1.18

0.15

1.2

1.3

0.62

0.58

nmol/l

0.14

Other embolism and thrombosis

663

1.06

0.15

1.3

0.57

0.63

nmol/l

0.87

638

Hepatic failure, not elsewhere classified

140

1.14

0.15

1.4

1.3

0.68

0.63

nmol/l

0.25

132

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

0.79

0.14

1.3

0.51

0.67

nmol/l

—

Impacted teeth

808

1.05

0.14

1.7

1.3

0.49

0.48

nmol/l

0.05

783

Intentional self-harm by sharp object

0.79

0.14

1.4

1.3

0.76

0.52

nmol/l

—

Burn and corrosion of wrist and hand

141

1.14

0.14

1.3

1.4

0.60

0.59

nmol/l

0.06

135

Normal-pressure hydrocephalus

190

0.89

0.13

2.1

1.2

0.76

0.66

nmol/l

0.33

175

Assault by unspecified means

1.18

0.12

1.0

1.4

0.57

0.59

nmol/l

—

Patent foramen ovale

1.18

0.12

4.4

1.3

0.55

0.58

nmol/l

—

Oesophageal varices

158

0.89

0.12

1.1

1.3

0.78

0.63

nmol/l

0.48

151

Mumps

114

1.14

0.12

1.2

1.4

0.59

0.61

nmol/l

0.08

106

Hydrocephalus

323

0.93

0.12

2.1

1.2

0.69

0.67

nmol/l

0.09

304

Diffuse brain injury

1.16

0.11

1.1

1.5

0.56

0.63

nmol/l

0.43

Personal history of malignant neoplasm

347

1.07

0.11

1.1

1.3

0.52

0.63

nmol/l

2.04

330

Other and unspecified corneal deformities and disorders

134

1.12

0.11

1.1

1.3

0.57

0.67

nmol/l

0.66

127

Marginal zone B-cell lymphoma

1.14

0.10

1.2

1.4

0.60

0.56

nmol/l

—

Erythema intertrigo

106

1.13

0.10

1.3

0.58

0.61

nmol/l

0.20

Benign neoplasm: Appendix

1.06

0.09

1.2

0.62

0.54

nmol/l

—

Meningitis

223

1.08

0.09

1.3

0.54

0.62

nmol/l

0.57

212

Acute poliomyelitis

1.11

0.09

1.5

1.2

1.03

0.60

nmol/l

—

Brain glioblastoma

1.11

0.09

1.5

1.10

0.70

nmol/l

—

Mantle cell lymphoma, including Hilmo

1.11

0.09

1.2

1.3

0.61

0.58

nmol/l

—

UC patients in KELA-register (code 208), prior to 1994

194

1.08

0.09

1.1

1.3

0.68

0.67

nmol/l

0.08

184

Cerebral palsy

0.80

0.08

1.2

1.4

0.36

0.54

nmol/l

—

Hypothermia

0.78

0.08

1.0

1.3

0.36

0.58

nmol/l

—

HSIL lesion of the cervix uteri

967

0.97

0.08

1.2

0.49

1.72

nmol/l

0.53

937

Prurigo nodularis

117

1.11

0.08

1.5

1.2

0.55

0.61

nmol/l

0.44

110

Brain glioblastoma and astrocytoma

1.09

0.08

1.4

1.09

0.69

nmol/l

—

Acute otitis externa, noninfective

1.03

0.08

1.0

1.3

0.56

nmol/l

—

Congenital deformities of hip

0.86

0.07

1.0

1.3

0.33

0.53

nmol/l

—

Burns and corrosions of multiple and unspecified body regions

0.83

0.07

1.0

1.4

0.50

0.61

nmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

137

1.10

0.07

2.3

1.3

0.74

0.63

nmol/l

0.40

126

Other overlap syndromes

0.87

0.07

1.3

0.47

0.55

nmol/l

—

Communicating hydrocephalus

0.84

0.07

1.3

1.2

0.54

0.57

nmol/l

—

Oral leukoplakia, including avohilmo

118

1.10

0.07

1.2

1.3

0.56

0.66

nmol/l

0.86

108

Exposure to other specified electric current

1.05

0.07

1.0

1.3

0.58

0.52

nmol/l

—

Embedded and impacted teeth

134

1083

1.02

0.07

1.5

1.3

0.48

0.50

nmol/l

0.18

129

1046

Orthopaedic devices associated with adverse incidents

1.02

0.07

1.0

1.2

0.68

0.64

nmol/l

—

Exposure to smoke, fire and flames

0.88

0.06

1.0

1.3

0.49

0.54

nmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

0.87

0.06

1.1

1.3

0.52

0.58

nmol/l

—

Seropositive rheumatoid arthritis, strict definition

828

1.03

0.06

1.2

1.3

0.65

2.52

nmol/l

0.69

793

L02BX Other hormone antagonists and related agents

173

0.92

0.06

2.3

1.3

0.84

0.65

nmol/l

1.08

164

Chronic suppurative otitis media

285

1.05

0.06

1.2

1.3

0.59

0.63

nmol/l

0.30

272

Melanocytic naevi of scalp and neck

1.11

0.06

1.1

1.3

0.63

0.55

nmol/l

0.58

All dysplastic lesions of the cervix uteri

141

1424

0.98

0.06

1.2

0.49

1.63

nmol/l

0.75

136

1379

Syphilis

105

0.86

0.06

1.2

1.4

0.40

0.62

nmol/l

—

Syphilis

105

0.86

0.06

1.2

1.4

0.40

0.62

nmol/l

—

Erosion and ectropion of cervix uteri

139

1.08

0.05

1.4

1.2

0.71

8.87

nmol/l

0.49

134

Benign neoplasm: Skin of ear and external auricular canal

149

1.07

0.05

1.3

1.2

0.58

0.59

nmol/l

0.04

140

Other disorders of iris and ciliary body

100

1.10

0.05

1.1

1.2

0.65

0.60

nmol/l

0.40

HSIL lesion of the cervix uteri, vagina or vulva

109

1070

1.02

0.05

1.1

1.2

0.50

1.61

nmol/l

0.53

103

1038

Vascular dementia (undefined)

1.10

0.05

1.2

1.3

0.62

0.69

nmol/l

0.23

Chronic iridocyclitis

218

1.06

0.05

1.0

1.3

0.65

nmol/l

0.01

207

Granulomatous disorders of skin and subcutaneous tissue

110

0.91

0.05

1.3

0.60

nmol/l

—

105

Short Achilles tendon (acquired)

110

1.09

0.05

1.1

1.2

0.66

0.63

nmol/l

0.09

104

Diabetic retinopathy

249

1535

1.01

0.05

1.3

1.4

4.83

1.16

nmol/l

0.42

240

1477

Sequelae of other and unspecified infectious and parasitic diseases

252

0.95

0.05

1.0

1.4

0.62

0.59

nmol/l

0.29

244

Bacterial pneumonia (organism specified)

247

2262

0.99

0.04

1.3

4.10

1.95

nmol/l

0.27

232

2173

Antepartum haemorrhage, not elsewhere classified

393

0.97

0.04

1.1

1.3

0.42

0.52

nmol/l

2.25

384

Superficial injury of shoulder and upper arm

537

1.02

0.04

1.1

1.3

0.52

0.61

nmol/l

1.58

515

Single spontaneous delivery

270

1418

1.01

0.03

1.2

1.3

0.62

1.52

nmol/l

0.76

262

1351

Bacterial pneumoniae

231

2019

1.01

0.03

1.3

4.33

2.09

nmol/l

0.26

217

1941

Other and unspecified epidermal thickening

108

0.93

0.03

1.1

1.3

0.53

0.59

nmol/l

—

103

Seropositive rheumatoid arthritis, wide

160

1585

1.01

0.03

1.2

1.3

0.64

1.63

nmol/l

0.69

150

1515

Benign neoplasm: Parotid gland

380

1.03

0.02

1.1

1.3

0.67

0.64

nmol/l

0.25

362

Other/unspecified rheumatoid arthritis

631

0.98

0.02

1.2

1.3

0.59

2.49

nmol/l

0.52

600

Respiratory tuberculosis, not confirmed

147

0.95

0.01

1.1

1.2

0.63

0.64

nmol/l

0.04

137

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

155

1560

0.99

0.01

1.3

0.64

1.64

nmol/l

0.69

145

1492

Failed induction of labour

227

0.97

0.01

1.2

0.43

0.47

nmol/l

0.33

221

Other/unspecified seropositive rheumatoid arthritis

158

1572

1.01

0.01

1.2

1.3

0.64

1.64

nmol/l

0.70

148

1503

Medical treatment for female infertility

107

1056

1.01

0.01

1.3

1.2

0.48

1.59

nmol/l

0.52

107

1026

Problems related to social environment

1.06

0.01

1.5

1.3

0.56

0.54

nmol/l

—

Contact with other sharp object(s)

284

1.02

0.00

1.4

1.3

0.46

0.56

nmol/l

1.95

273

Bacterial pneumonia, not elsewhere classified

215

1889

1.00

0.00

1.3

4.59

2.20

nmol/l

0.26

202

1817

Varicella [chickenpox]

185

0.97

0.00

1.2

1.4

0.54

0.61

nmol/l

0.32

175

Malignant neoplasm of ovary, including Hilmo

358

1.01

0.00

1.2

1.3

0.62

3.84

nmol/l

0.50

344

Other lesions of median nerve

101

0.99

0.00

1.2

0.71

0.69

nmol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

135

0.96

0.00

1.0

1.3

0.41

0.48

nmol/l

0.65

128

Acute nasopharyngitis (common cold)

589

0.99

0.00

1.4

1.3

0.64

0.94

nmol/l

0.39

569

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

103

0.97

0.00

1.1

1.2

0.69

0.65

nmol/l

—

Drug-induced cataract

1.01

0.00

1.6

1.2

80.52

0.59

nmol/l

—

Bacterial meningitis

153

0.98

0.00

1.3

0.53

0.62

nmol/l

0.57

146

Atrial septal defect

150

0.99

0.00

1.3

0.68

0.56

nmol/l

0.68

142

Pedal cyclist injured in collision with motor vehicle

125

1.04

0.00

1.3

0.57

0.60

nmol/l

0.17

117

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.6

—

0.43

—

Disorders of puberty, other/unspecified

0.00

0.0

1.4

—

0.49

—

Other and specified injuries of hip and thigh

1.01

0.00

1.0

1.2

0.60

0.55

nmol/l

—

Other disorders of kidney and ureter in diseases classified elsewhere

0.00

0.0

1.4

—

0.52

—

Melanoma in situ of trunk

0.93

0.00

1.4

1.3

0.66

0.53

nmol/l

—

Pectus carinatum

0.00

0.0

1.0

—

0.53

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.2

—

0.47

—

Chronic drug-induced interstitial lung disorders

0.00

0.0

2.2

—

0.45

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

2.0

—

0.37

—

Late syphilis

1.01

0.00

1.3

1.2

0.34

0.54

nmol/l

—

Other and unspecified mental retardation

1.01

0.00

1.0

1.3

0.54

0.53

nmol/l

—

Other and unspecified thalassaemias

0.00

0.0

1.5

—

0.45

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

2.3

—

0.35

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.9

—

0.41

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

0.48

—

Carcinoma in situ of oesophagus

0.00

-0.00

0.0

1.8

—

0.44

—

Victim of lightning

0.00

-0.00

0.0

1.4

—

0.50

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.2

—

0.42

—

Small cell lung cancer, helper endpoint

1.01

-0.00

1.6

1.2

0.50

0.62

nmol/l

—

Congenital malformations of nose

0.00

-0.00

0.0

3.0

—

0.48

—

Leishmaniasis

0.00

-0.00

0.0

2.2

—

0.50

—

Mature T/NK-cell lymphomas, hilmo

1.02

-0.00

1.2

1.3

0.74

0.55

nmol/l

—

Small cell lung cancer, including Hilmo

0.96

-0.00

1.6

1.2

0.50

0.64

nmol/l

—

Onychogryphosis

0.00

-0.00

0.0

1.3

—

0.50

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

0.53

—

Congenital malformations of nose

0.00

-0.00

0.0

2.7

—

0.47

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.2

—

0.44

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

2.3

—

0.53

—

conjunctival degenerations and deposits

0.95

-0.00

1.8

1.4

0.79

0.65

nmol/l

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

-0.00

0.0

1.6

—

0.46

—

conjunctival scars

0.00

-0.00

0.0

2.1

—

0.41

—

Other infestations

0.99

-0.00

1.3

0.61

0.59

nmol/l

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.2

—

0.42

—

Disorders of copper metabolism

0.00

-0.00

0.0

1.8

—

0.38

—

Functional disorders of polymorphonuclear neutrophils

0.00

-0.00

0.0

2.4

—

0.42

—

Pectus carinatum

0.00

-0.00

0.0

1.0

—

0.53

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.0

—

0.40

—

Syndactyly

0.00

-0.00

0.0

1.0

—

0.40

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

4.2

—

0.90

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

2.0

—

0.42

—

Hypoplasia of dental enamel, prenatal

0.00

-0.00

0.0

1.4

—

0.59

—

Toxic effect of pesticides

0.00

-0.00

0.0

1.2

—

0.42

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.5

—

0.60

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.2

—

0.30

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

0.42

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

0.00

-0.00

0.0

1.5

—

0.45

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

-0.00

0.0

1.2

—

0.45

—

Huntington disease

0.00

-0.00

0.0

1.2

—

0.40

—

Glycosuria

0.00

-0.00

0.0

1.3

—

0.51

—

Thyroiditis, unspecified

0.93

-0.00

2.4

1.3

0.80

0.55

nmol/l

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.9

—

0.44

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.86

-0.00

1.2

1.3

0.50

0.62

nmol/l

—

Endometroid carcinoma of ovary, including Hilmo

0.89

-0.00

1.0

1.2

0.74

0.64

nmol/l

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.8

—

0.48

—

Hypospadias with an incomplete glans penis

0.00

-0.00

0.0

2.1

—

0.47

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

2.0

—

0.48

—

Other histiocytosis syndromes

0.00

-0.00

0.0

1.2

—

0.44

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.4

—

0.36

—

Other and unspecified hydrocephalus

0.91

-0.00

1.0

1.3

0.65

0.60

nmol/l

—

Noonan syndrome

0.00

-0.00

0.0

1.8

—

0.52

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.2

—

0.39

—

Other disorders of choroid

0.98

-0.00

2.0

1.4

0.72

0.59

nmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.92

-0.00

1.4

1.3

0.60

0.57

nmol/l

—

Alcohol abuse counselling and surveillance

0.87

-0.00

1.0

1.3

0.83

0.54

nmol/l

—

Marginal zone B-cell lymphoma, including Hilmo

0.96

-0.00

1.1

1.3

0.59

0.63

nmol/l

—

0.00

-0.00

0.0

1.5

—

0.55

—

Small cell lung cancer

0.96

-0.00

1.6

1.2

0.50

0.64

nmol/l

—

Lichen nitidus

0.00

-0.00

0.0

1.6

—

0.42

—

General autosomal fish scale disease

0.00

-0.00

0.0

1.0

—

0.44

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.00

-0.00

1.0

1.3

0.54

0.53

nmol/l

—

Hyphaema and other vascular disorders of iris and ciliary body

0.95

-0.00

1.2

1.3

0.65

0.57

nmol/l

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

2.4

—

0.36

—

Juvenile dermatomyositis

0.00

-0.00

0.0

2.0

—

0.42

—

Congenital deformities of hip

0.89

-0.00

1.0

1.3

0.33

0.52

nmol/l

—

Feeding problems of newborn

0.00

-0.00

0.0

1.1

—

0.70

—

Melanocytic naevi of upper limb, including shoulder

0.94

-0.00

1.6

1.3

0.96

0.52

nmol/l

—

Aortic hypoplasia

0.00

-0.00

0.0

1.0

—

0.48

—

Need for immunization against certain single viral diseases

0.00

-0.00

0.0

1.2

—

0.42

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

3.1

—

0.80

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

2.0

—

0.38

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.5

—

0.40

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

0.44

—

Melanocytic naevi of eyelid, including canthus

0.98

-0.00

2.8

1.3

0.62

0.50

nmol/l

—

Lipoprotein deficiency

0.00

-0.00

0.0

1.9

—

0.38

—

Linear scleroderma

0.00

-0.00

0.0

1.6

—

0.46

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Normetanephrine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS